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The establishment of genomic approaches including the sequence determination of complete 
bacterial genomes started a new era in microbiological research. Since then more than two 
hundred prokaryotic and eukaryotic genomes have been completely sequenced, and there are 
additional complete genome projects including different bacterial species and strains in progress 
(http://www.tigr.org, http://www.sanger.ac.uk). The continously growing amount of bacterial 
DNA sequence information gives us also the possibility to gain deeper insight into bacterial 
pathogenesis. With the help of comparative genomics, microbiological research can focus on 
those DNA sequences that are present in pathogenic bacteria but are absent in non-pathogenic 
strains. With this knowledge and with the help of molecular biological methods such as PCR, 
DNA-chip technology, subtractive hybridisation, transcriptomics and proteomics we can analyse 
in detail what makes a particular bacterial strain pathogenic. This knowledge also gives us the 
possibility to develop new vaccines, therapeutic approaches or diagnostic tools.  
 
The aim of this work was the structural and functional analysis of DNA regions of uropathogenic 
Escherichia coli strain 536 that belong to the flexible E. coli gene pool. The first part of this 
thesis focused on the identification and structural characterisation of pathogenicity island V of 
strain 536 (PAI V536). PAI V536 is integrated at the pheV tRNA gene at 64 minutes of the E. coli 
K-12 chromosome. In addition to the intact pheV tRNA gene, a truncated copy ('pheV) that 
represents the last 22 bp of this gene’s 3'-end was identified 49 kb downstream of pheV on PAI 
V536. The analysis of the DNA sequence flanked by pheV and 'pheV revealed characteristics that 
are typical of PAIs. This DNA region exhibits homology to IS-elements and prophages and also 
comprises determinants coding for the Pix fimbriae, a phosphoglycerate transport system, an 
autotransporter, as well as for hypothetical proteins. Downstream of 'pheV, the K15 capsule 
determinant (kpsK15) of this strain is located. Structural analysis of the 20-kb kpsK15 locus 
revealed a so far unknown genetic organisation indicative of recombination events between a 
group 2 and group 3 capsule gene cluster. Downstream of the capsule determinant, the genes 
encoding a type II secretion system (general secretion pathway -GSP) are located on PAI V536. 
The K15 capsule locus was functionally characterized. Specific inactivation of each of the 
regions 1 to 3 of the kpsK15 gene cluster, and the use of a K15 capsule-specific antiserum 
demonstrated that this determinant is the functional K15 capsule locus of strain 536. It has been 
shown in an experimental murine model of ascending urinary tract infection with suckling mice 
that the K15 capsule contributes to urovirulence. Interestingly, the K15 capsule is not involved in 
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serum resistance of strain 536. Inactivation of the PAI V536-encoded type II secretion system 
excluded a role of this general secretion pathway for capsule biosynthesis and virulence of strain 
536 in the murine ascending urinary tract infection model. 
 
In the second part of the thesis, the transferability of PAIs was further investigated. Using PAI 
II536 as a model, mobilisation of this island from strain 536 into suitable recipient strains was 
investigated. For this purpose, an antibiotic resistance cassette, the R6K origin of replication as 
well as plasmid pGP704 carrying the mobilisation region of plasmid RP4 have been inserted into 
PAI II536. Transformation with the helper plasmid RP4, resulted a derivative of strain 536 that 
was used as a donor for conjugation experiments, while for recipient the pir + laboratory strain 
SY327 was used. After deletion the circularised PAI II536 was mobilised with the help of the 
conjugative helper plasmid (RP4) into the recipient laboratory strain SY327. The frequency of 
this event was about 10-8. It was also demonstrated that in the transconjugant strains the 
mobilized PAI II536 could be permanently present as a circular form and also can be integrated 
into the chromosome at the same chromosomal insertion site (leuX) as in the donor strain 536. 
Furthermore, after mobilisation and chromosomal integration of PAI II536 it was possible to 
remobilise this PAI back to a PAI II536-negative derivative of strain 536.  
The results obtained in this thesis increase our knowledge of the structure and function of a 
pathogenicity island of uropathogenic E. coli strain 536 and shed some light on the mechanisms 
contributing to genome plasticity and evolution of pathogenic E. coli variants. 
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Mit der Einführung von Genomanalytik einschließlich der Sequenzbestimmung bakterieller 
Genome, startete eine neue Ära in der mikrobiologischen Forschung. Seit Beginn dieser Ära sind 
mehr als 200 prokaryotische und eukaryotische Genome komplett sequenziert worden. Weitere 
Genomanalysen über verschiedene Bakterienspezies und Stämme sind in Arbeit 
(http://www.tigr.org, http://www.sanger.ac.uk). Durch die stetig anwachsende Menge an 
Informationen über bakterielle DNA Sequenzen, sind wir in der Lage, einen tieferen Einblick in 
die bakterielle Pathogenität zu bekommen. Mittels vergleichender Genomanalyse kann sich die 
mikrobiologische Forschung auf bestimmte DNA Sequenzen konzentrieren, welche in 
pathogenen Stämmen vorhanden sind, in apathogenen Stämmen aber fehlen. Mit diesem Wissen 
und durch molekularbiologische Methoden wie Polymerase Kettenreaktion, DNA-Chip-
Technologie, Subtraktiver Hybridisierung, Transkriptom- und Proteom-Analyse können wir im 
Detail untersuchen, welche Faktoren für die Pathogenität eines speziellen Bakterienstammes 
verantwortlich sind. Diese Erkenntnisse geben uns auch die Möglichkeit neue Impfstoffe, 
therapeutische Verfahren und diagnostische Werkzeuge zu entwickeln.  
 
Ziel dieser Arbeit war die Untersuchung der Struktur und Funktion von DNA-Regionen des 
uropathogenen Escherichia coli Stammes 536, welche zum flexiblen Genpool von E. coli 
gehören. Der erste Teil dieser Arbeit konzentriert sich auf die Identifizierung und strukturelle 
Charakterisierung der Pathogenitätsinsel V des E. coli Stammes 536 (PAI V536). Die 
Integrationsstelle von PAI V536 liegt im E. coli K-12 Chromosom beim tRNA Gen pheV bei 64 
Minuten. Zusätzlich zum intakten pheV tRNA Gen wurde auf der PAI V536 eine verkürzte Kopie 
des Gens (´pheV) 49 kb stromabwärts von pheV identifiziert. Diese Kopie repräsentiert die letzten 
22 bp des 3´-Endes von pheV. Eine Analyse der von pheV und ´pheV eingeschlossenen DNA-
Sequenz zeigte typische Eigenschaften einer Pathogenitätsinsel. Die untersuchte DNA-Region 
besitzt Homologie zu IS-Elementen und Prophagen, außerdem beinhaltet sie Determinaten, die 
für Pix Fimbrien, ein Phosphoglycerat-Transportsystem, einen Autotransporter sowie für 
unbekannte Proteine kodieren können. Stromabwärts von ´pheV liegt die K15 Kapsel 
Determinante (kpsK15) des E. coli Stammes 536. Eine strukturelle Analyse des 20-kb kpsK15 
Lokus zeigte eine bislang unbekannte genetische Anordnung, welche auf ein 
Rekombinationsereignis zwischen einem Gruppe 2 und einem Gruppe 3 Kapsel Gencluster 
hinweist. Stromabwärts der Kapsel Determinante sind auf der PAI V Gene lokalisiert, welche für 
ein Typ II Sekretionssystem („General Secretion Pathway“) kodieren. Der K15 Kapsel Lokus 
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wurde funktional charakterisiert. Die spezifische Inaktivierung der Regionen 1 bis 3 des kpsK15 
Genclusters und die Verwendung eines K15 Kapsel-spezifischen Antiserums zeigten, daß es sich 
tatsächlich um den funktionalen K15 Kapsellokus des E. coli Stammes 536 handelt. Im 
Tiermodel einer aufsteigenden Harnwegsinfektion bei neugeborenen und säugenden Mäusen, 
konnte gezeigt werden, daß die K15 Kapsel zur Urovirulenz beiträgt. Interessanterweise trägt die 
K15 Kapsel des E. coli Stammes 536 nicht zur Serumresistenz bei. Die Inaktivierung des in der 
PAI V536 kodierten Typ II Sekretionssystems schließt eine Rolle des „General Secretion 
Pathways“ bei der Kapsel Biosynthese und bei der Virulenz des E. coli Stammes 536 im 
Mausinfektionsmodel einer aufsteigenden Harnwegsinfektion aus. 
 
Im zweiten Teil dieser Arbeit wurde die Mobilisierung von Pathogenitätsinseln untersucht. PAI 
II536 wurde als Model genutzt, um den Transfer einer PAI von E. coli 536 in einen geeigneten 
Rezipientenstamm zu zeigen. Zu diesem Zweck wurde eine Antibiotikaresistenzkassette, der 
Replikationsstartpunkt RK6 und das Plasmid pGP704, das die Mobilisierungsregion des 
Plamides RP4 besitzt, in die PAI II536 inseriert. Nach Transformation des Helferplasmids RP4 
wurde das daraus resultierende Derivat des E. coli Stammes 536 als Donor für 
Konjugationsexperimente mit dem Rezipientenstamm SY327 eingesetzt. Diese 
Mobilisierungsexperimente zeigten, daß die gesamte PAI II536 mit einer Frequenz von ungefähr 
10-8 in einen Rezipientenstamm übertragen werden kann. In den Transkonjuganten konnte PAI 
II536 an derselben chromosomalen Insertionsstelle (leuX) wie im Donorstamm E. coli 536 
inserieren. Weiterhin war es möglich PAI II536, nach Mobilisierung und chromosomaler 
Integration in einem Rezipientenstamm, wieder zurück in ein PAI II536 negatives Derivat von E. 
coli 536 zu transferieren. 
Die Ergebnisse dieser Arbeit erweitern unser Wissen hinsichtlich der Struktur und Funktion einer 
Pathogenitätsinsel des uropathogenen E. coli Stammes 536 und geben Aufschluß über den 
Mechanismus, der zur Genomplastizität und Evolution pathogener E. coli Varianten beiträgt. 
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1 EPIDEMIOLOGY OF URINARY TRACT INFECTIONS 
The urinary tract is the second most common site of bacterial infection in humans (Warren, 
1996). It is accepted that most uropathogens originate from the host microbial flora, and most 
commonly from the faecal flora, but they may also represent 'exogenous' bacteria, that can be 
introduced during diagnostic or therapeutic instrumentation of the urinary tract (Schaeffer, 1997). 
Uncomplicated urinary tract infections (UTI) are most commonly caused by uropathogenic 
Escherichia coli (UPEC) strains which are responsible for more than 80 % of the cases. It is a 
general rule that the more complicated the background in which a urinary tract infection occurs 
is, the lower is the probability that this UTI is caused by E. coli (Schaeffer, 1997). Only a few 
species can initiate infection of the normal urinary tract but a wide range of organisms may cause 
infection in patients with structural or functional abnormalities of the urinary tract or in 
immunocompromised patients. Some of the aetiological agents of UTI beside E. coli (90 %) are 
Proteus spp. (5-8 %), Klebsiella spp. (1-2 %), Enterococcus faecalis (<1 %), Streptococcus spp. 
(<1 %), Staphylococcus aureus (<1 %), and Pseudomonas aeruginosa (10-15 % of the 
nosocomial UTI cases) (Topley and Wilson, 1999). UTIs caused by other unusual organisms, 
such as Acinetobacter spp. (Ng et al., 1996) or group B streptococcus, (Munoz et al., 1997) 
appear to be more frequently reported among patients with diabetes mellitus (DM). Fungal 
infections are also more common than in patients without DM, particularly those involving 
Candida species, occasionally causing dramatic clinical presentations with obstruction of the 
urinary tract through "fungus ball" formation (Patterson et al., 1995). 
Most urinary tract infections are caused by a smear infection with the host’s resident flora. 
Consequently, these microorganisms can cause an ascending urinary tract infection, during 
which they first colonize the urethra (urethritis) and bladder (cystitis). A common symptom of 
such infections is a burning sensation during urination. In some cases, the infection continues to 
ascend further through the ureters in to the kidneys where they cause pyelonephritis. Symptoms 
of this disease type are back pain and fever. Pyelonephritis is a more serious disease than cystitis 
and urethritis because more tissue damage can occur. The high vascularisation of kidneys opens a 
new possibility for bacteria: By passing the vascular barrier, bacteria have the opportunity to 
enter the blood stream and cause septicemia. Once bacteria entered the bloodstream, any organ 
may be infected, and conditions ranging from pneumonia to meningitis may develop.  
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Urinary tract infections are not always ascending infections. Bacteria in the bloodstream can seed 
the kidneys and cause kidney or bladder infection. Such an infection is called hematogenous or 
descending urinary tract infection. While ascending UTIs are mainly caused by Gram-negative 
bacteria, descending UTIs almost always involve Gram-positive bacteria (Peddie et al., 1978). 
 
2 VIRULENCE FACTORS OF UROPATHOGENIC E. COLI STRAINS 
The urinary tract represents an unusual niche for faecal E. coli strains. A long term colonisation 
requires bacterial adhesion, and multiplication as well as defense against the host‘s immune 
system.  
The properties of urine as a bacterial growth medium were already recognized by Pasteur (1863). 
The capacity of urine to support bacterial growth depends on its chemical composition, pH and 
osmolarity. Whereas some chemical constituents, such as glucose and amino acids, serve as 
bacterial nutrients, others, such as urea and organic acids, act as growth inhibitors (Asscher et al., 
1966). The glucose present in normal urine is the main energy source for the growth of urinary 
pathogens and its concentration is normally sufficient to support maximal bacterial growth rates 
(O'Sullivan et al., 1961). The amino acid composition of urine may vary considerably and affects 
bacterial growth (Roberts et al., 1968). Organic acids normally present in urine may be 
bacteriostatic according to the degree of their dissociation, which is pH-dependent. Urea in high 
concentration is bactericidal for uropathogens (Schlegel et al., 1961; Kaye, 1968) but its effect is 
mainly due to an increase in osmolality (Asscher et al., 1968). The growth rate is optimal in a pH 
range of 6.0-7.0 and an osmolality below 200-1100 mosm kg-1 (Asscher et al., 1966). 
Tolerance and utilisation of the components of urine is only one side of the coin. On the other 
hand a urinary tract pathogen also has to have such factors that make it possible to successfully 
colonize the epithelial surface of the urinary tract. Not only adhesins are important in this 
process, but also those factors that help to protect it from those cellular responses that are 
provoked by colonization of the urothelium. Additional factors can help bacteria to invade 
uroepthelial cells, to get into the blood stream, to survive in blood and to possess an 
organotropism forexample to the brain. Those factors that enable bacteria to evoke a pathogenic 
process are called virulence factors:  
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uroepthelial cells, to get into the blood stream, to survive in blood and to possess an 
organotropism forexample to the brain. Those factors that enable bacteria to evoke a pathogenic 
process are called virulence factors:  
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Adhesins 
Bacterial adherence to the epithelial surfaces of the urinary tract is an essential step during 
establishment of an UTI as constant or periodic flow of urine may contribute to clearing of the 
bacteria. Different adherence factors enable the attachment of bacteria to the uroepithelium (Reid 
and Sobel, 1987) and can be subdivided into two major types: fimbrial and afimbrial adhesins. 
Fimbrial adhesins consist of a rod-shaped shaft of 6-7 nm in diameter comprising over a thousand 
major subunits and minor subunits. The adhesin is located at the very tip of the fimbriae, often 
connected with the shaft via a so-called adapter pilus. The role of the major subunits is yet 
unclear, although they have been proposed to be important for adherence onto mammalian 
extracellular matrix proteins (Korhonen, 2000). 
According to the impeding effect of mannose, fimbrial adhesins are divided in to two groups.  
In urinary tract infections in humans (Ofek et al., 1981; Pere et al., 1987) and in experimental 
animal models (van den Bosch et al., 1980) the presence of mannose-resistant (MR) fimbriae 
on E. coli correlates with virulence. A number of different MR fimbriae can be distinguished on 
the basis of the specific receptors to which they bind. The best studied of these are P fimbriae 
(pap – pyelonephritis associated pili) that bind to neutral globoseries glycolipids, including 
globotetraosylceramide and trihexosylceramide, which are antigens of the P blood group system 
(Leffler and Svanborg-Edén 1980). The minimal receptor to which these fimbriae bind is α-d-
Gal-(1→4)-β-d-Gal (Gal-Gal). P fimbriae are expressed in vivo by E. coli in urinary tract 
infections (Kiselius et al., 1989) and the receptors of these fimbriae are widely distributed in the 
kidney and bladder (Johnson, 1997). A number of MR fimbriae that do not recognize the Gal-Gal 
receptor are known as X adhesins or non-P MR adhesins (Johnson, 1997). Thus, S fimbriae bind 
to sialyl glycosides (Hanisch et al., 1993) and G fimbriae bind to N-acetylglucosamine 
(Väisänen-Rhen et al., 1983). Binding sites for S fimbriae are also widely distributed in the 
urinary tract but S-fimbriated E. coli isolates are probably more important in neonatal meningitis 
than in urinary tract infection.  
Many E. coli strains and other members of the Enterobacteriaceae possess fimbriae (e.g. type 1 
fimbriae) whose function can be inhibited by mannose, and requires a special receptor structure 
(Khan et al., 2000). The importance of these fimbriae in the uropathogenic process is not 
convincing but the facts that through binding to uromucoids and poor attachment to renal tissues 
support that they may have a role in the colonization of the urethra and bladder (Hagberg et al., 
1983a, 1983b). Signature tagged mutagenesis and transcriptomics revealed that type 1 fimbriae 
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are expressed in vivo during UTI, so type 1 seems to be important. Ørskov and coworkers (1980) 
suggested that in the colon, where mucus is plentiful, type 1 fimbriae actively maintain 
colonization of E. coli including potentially uropathogenic strains, whereas in the urinary tract 
mucus plays a dual role. Organisms that produce only type 1 fimbriae are flushed out with the 
mucus, whereas those that produce P and other MR adhesins will colonize the epithelium. The 
on-off switches ('phase variation') that control fimbrial expression may be part of this process. It 
was recently shown that expression of the type 1 fimbria is regulated on transcriptional level by a 
promoter situated on an invertible element, which can exist in one of two different orientations. 
Orientation of the invertible element determines if transcription occurs or not. During the course 
of a urinary tract infection, it was observed that the infecting E. coli population alternates 
between fimbriated and nonfimbriated states that profoundly influences colonization of the 
bladder (Gunther et al., 2001, 2002). Not only dynamic systems but also certain allelic variations 
correlate with urovirulence. Certain FimH variants that bind special mannose structures can help 
the uropathogenic process while others not (Sokurenko et al., 1999). Beside these more or less 
known fimbrial adhesins some new fimbrial gene clusters were recently found and identified in 
uropathogenic E. coli strains (Buckles et al., 2004). Their role in the uropathogenic process is not 
always clear (Lügering et al., 2003), and should be cleared.  
Uropathogenic strains have also adhesins that are not pili. These afimbrial adhesins are 
uncommon and their significance in the pathogenesis of urinary infections is unknown. One 
interesting feature is that their receptors are different blood group antigens like N, M and Dr 
(Nowicki et al., 1990). 
 
Toxins 
Many uropathogenic E. coli strains produce exotoxins. Strains without toxin production are less 
virulent (van den Bosch, Emödy and Kétyi, 1982). The first exotoxins that were found are called 
haemolysins (Ludwig and Goebel, 1997). They do not only lyse erythrocytes, but also kill other 
cell types. They belong to the RTX (repeats in toxin) haemolysins because they all contain a nine 
aminoacid tandem repeat. RTX toxins are poreforming toxins and they create pores in the 
membrane of eukaryotic cells. For this activity Ca++ is required (Welch, 1991). The cytotoxic 
necrotizing factor (CNF) belongs to a group of bacterial toxins that modify Rho, a subfamily of 
small GTP-binding proteins that regulate formation of the actin cytoskeleton (Aktories, 1997). 
High sequence homology can be observed between the two CNF variants (Lemichez et al., 1997). 
 14 
are expressed in vivo during UTI, so type 1 seems to be important. Ørskov and coworkers (1980) 
suggested that in the colon, where mucus is plentiful, type 1 fimbriae actively maintain 
colonization of E. coli including potentially uropathogenic strains, whereas in the urinary tract 
mucus plays a dual role. Organisms that produce only type 1 fimbriae are flushed out with the 
mucus, whereas those that produce P and other MR adhesins will colonize the epithelium. The 
on-off switches ('phase variation') that control fimbrial expression may be part of this process. It 
was recently shown that expression of the type 1 fimbria is regulated on transcriptional level by a 
promoter situated on an invertible element, which can exist in one of two different orientations. 
Orientation of the invertible element determines if transcription occurs or not. During the course 
of a urinary tract infection, it was observed that the infecting E. coli population alternates 
between fimbriated and nonfimbriated states that profoundly influences colonization of the 
bladder (Gunther et al., 2001, 2002). Not only dynamic systems but also certain allelic variations 
correlate with urovirulence. Certain FimH variants that bind special mannose structures can help 
the uropathogenic process while others not (Sokurenko et al., 1999). Beside these more or less 
known fimbrial adhesins some new fimbrial gene clusters were recently found and identified in 
uropathogenic E. coli strains (Buckles et al., 2004). Their role in the uropathogenic process is not 
always clear (Lügering et al., 2003), and should be cleared.  
Uropathogenic strains have also adhesins that are not pili. These afimbrial adhesins are 
uncommon and their significance in the pathogenesis of urinary infections is unknown. One 
interesting feature is that their receptors are different blood group antigens like N, M and Dr 
(Nowicki et al., 1990). 
 
Toxins 
Many uropathogenic E. coli strains produce exotoxins. Strains without toxin production are less 
virulent (van den Bosch, Emödy and Kétyi, 1982). The first exotoxins that were found are called 
haemolysins (Ludwig and Goebel, 1997). They do not only lyse erythrocytes, but also kill other 
cell types. They belong to the RTX (repeats in toxin) haemolysins because they all contain a nine 
aminoacid tandem repeat. RTX toxins are poreforming toxins and they create pores in the 
membrane of eukaryotic cells. For this activity Ca++ is required (Welch, 1991). The cytotoxic 
necrotizing factor (CNF) belongs to a group of bacterial toxins that modify Rho, a subfamily of 
small GTP-binding proteins that regulate formation of the actin cytoskeleton (Aktories, 1997). 
High sequence homology can be observed between the two CNF variants (Lemichez et al., 1997). 
 15 
While the cnf1 gene is located on the chromosome (Falbo et al., 1992), the cnf2 gene on a 
plasmid, which was identified as the Vir plasmid (Oswald et al., 1989; Smith, 1974). CNF1 is 
mainly associated with extraintestinal E. coli, and was also reported from a PAI of an 
uropathogenic E. coli strain (Blum et al., 1995). CNF intoxicated eukaryotic cells become 
enlarged and multinucleated as the results of membrane ruffling, formation of focal actin stress 
fibers and absence of cell division (Lemichez et al., 1997). 
Cytolethal distending toxins (CDTs) also make their effect on cell division of the eukaryotic 
cells. They inhibit cellular proliferation by inducing an irreversible cell cycle block at the G2/M 
transition (Comayras, 1997). These toxins that have a unique mode of action (Elwell and 
Dreyfus, 2000), were reported from a number of unrelated microbes including uropathogenic E. 
coli (Bakas, 1996); however their role in uroinfection is unclear.  
 
Iron acquisition systems 
Iron is an essential bacterial nutrient that in the human host is tightly bound to protein carriers, 
such as transferrin or is stored intracellularly. The normal urine contains sufficient iron, probably 
derived from the breakdown of various cells, to allow bacterial growth. During tissue-invasive 
processes iron availability becomes limiting and under these conditions two mechanisms for iron 
scavenging are available. Haemolysin releases haemoglobin from erythrocytes and bacterial 
siderophores (Griffiths, 1997) compete for iron with host iron-binding proteins. Siderophores are 
low molecular weight chelators that are secreted by E. coli, and are able to „steal“ Fe3+ ions from 
host carriers and – by recognizing specific receptors located in the bacterial outer membrane – 
transport it into the bacterial cell (Guerinot, 1994). The genes of siderophores are chromosomally 
or plasmid-encoded. Enterobactin is a wide-spread siderophore in Enterobacteria and has a 
conserved localisation in the E. coli core genome. Many extraintestinal pathogenic E. coli strains 
produce aerobactin, another siderophore which can be chromosomally or plasmid-encoded 
(Dobrindt et al., 2003; Sorsa et al., 2003). 75 % of uropathogens associated with septicaemia 
produce aerobactin (Montgomerie et al., 1984). In the last years, more siderophore systems were 
described in different bacteria like the ferric citrate system (fec) from S. flexneri and E. coli (Luck 
et al., 2001), yersiniabactin (ybt) from Yersinia species and other Enterobacteriaceae, hemin 
uptake system (shu/chu) from S. flexneri and pathogenic E. coli (Torres and Payne, 1997), and 
salmochelin (iro) from Salmonella enterica and E. coli isolates (Bäumler et al., 1996; Dobrindt et 
al., 2003; Sorsa et al., 2003). 
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Lipopolysaccharide (O antigen) 
Lipopolysaccharide (LPS, endotoxin) is a key component of the outer membrane of Gram-
negative bacteria that is responsible for the O antigenic properties. It was suggested before that 
only a restricted range of O serogroups of E. coli is responsible for urinary tract infections (e.g. 
O1, O4, O6, O18, O75) (Roberts et al., 1975). Later it became clear that O antigenic 
lipopolysaccharides are powerful virulence factors (Hull, 1997) directly involved in the 
pathogenesis of urinary tract infection. During pathogenesis they could have different effects. 
Besides inducing the shedding of uroepithelial cells (Aronson et al., 1988), interfering with 
ureteral motility (Thuselius and Araj, 1987) and causing renal damage by the activation of 
granulocytes (Steadman and Topley, 1997) its role in serum resistance is important mainly in 
invasive infections such as pyelonephritis and in urinary tract-derived septicaemia. Susceptibility 
of an organism to complement-dependent bacteriolysis is due to its surface characteristics and 
particularly its O antigen (Porat et al., 1992).  
LPS comprises three distinct regions: Lipid A, the oligosaccharide core, and commonly a long-
chain polysaccharide O antigen. The lipid portion (lipid A) is embedded in the outer membrane 
while the core and O antigen portions extend outward from the bacterial surface. In E. coli, five 
different core structures (K-12 and R1-R4) have been described (Amor et al., 2000; Holst, 1999; 
Rietschel et al., 1992). The O repeating units are highly polymorphic, and more than 190 
serologically distinguished forms in E. coli are known today (Ørskov et al., 1992). The genes 
coding for LPS core synthesis are located at a conserved position on the E. coli K-12 
chromosomal map (81-82 min) (Berlyn, 1998). The wa* (formerly rfa) gene cluster is responsible 
for biosynthesis of the LPS core, whereas the genes required for the O side chain synthesis are 
encoded by the polymorphic wb* (former rfb) genecluster.  
 
Capsule (K antigen) 
Production of an extracellular polysaccharide is a common feature of many bacteria (Whitfield, 
1993). The capsule, which often constitutes the outermost layer of the cell, mediates the 
interaction between the bacterium and its immediate environment, and plays a crucial role in the 
survival of bacteria in hostile environments. These highly hydrated molecules are composed of 
repeating single units joined by glycosidic linkages. A striking feature of bacterial capsular 
polysaccharides is their diversity. In E. coli more than 80 chemically and serologically distinct 
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capsules were described (Jann, 1992). According to the organisation of the corresponding gene 
clusters, their regulation of expression and the biosynthetic mechanism four different groups of 
capsules types can be distinguished (group 1-4) (Figure 1) (Whitfield, 1999). 
Group 1 and 4 capsules resemble those expressed by Klebsiella and Erwinia, and consist of 
colanic acid. A typical feature of group 4 capsules is that they also comprise a subset of amino-
sugars. Although the characteristics of capsule biosynthesis in these groups are not completely 
understood it is known that their genetic information is located on a highly polymorphic region of 
the E. coli chromosome at 45 minutes position in which the biosynthetic genes of a number of 
other cell surface polysaccharides are also located (Berlyn, 1998). 
The biochemistry and genetics of capsule production of group 2 and 3 capsules is relatively well 
understood. These capsules contain N-acetyl-neuraminic acid and they are structurally 
homologous to capsules of N. meningitidis and H. influenzae. Their gene cluster shows a 
conserved modular genetic  
 
Fig. 1: Genetic organisation of group 1 to 4 capsule determinants of E. coli. A, Group 1 (K30) 
and 4 (K40) capsule determinants are associated with LPS and other cell surface 
polysaccharide gene clusters. B, The locus of group 2 (K5) and 3 (K10) capsule gene 
clusters is not associated with other surface polysaccharide genes and they exhibit a typical 
structure consisting of a variable region (region 2) which is flanked by two conserved 
regions (region 1 and 3).  
 
kps   F  E D  U C   S                    T   M
region region 2  region 3  
Group 2 capsules (K1, K5 etc.)
kps  M‘ D M T  E                    C    S 
region region region 
Group 3 capsules (K10) B., 
A., Group 1 (K30) and 4 capsules
galF cps (capsule) gnd rfb (LPS cluster) 
orfX      wza wzb  wzc     wbaP       wzy      wcaN           orfZ    wbaZ  wzX 
                                                              orfY        wcaO  
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organisation consisting of three regions. A highly variable antigen specific region (region 2) that 
encodes for the enzymes of capsule biosynthesis is flanked by two conserved regions (region 1 
and 3) (Roberts, 1996). Translocation across the cytoplasmic membrane is mediated by the KpsC, 
M, S and T proteins, whereas translocation across the periplasm and the outer membrane involves 
the KpsD and E proteins  (Bliss, 1996; Roberts, 1996; Whitfield, 1999). In case of the group 2 
capsule, there are two additional genes, kpsF and U. The role of KpsF is unknown while KpsU is 
a CMP-3-keto-3-deoxy-manno-octulosonate (CMP-KDO) synthetase, which is a ligase necessary 
for the successful translocation through the inner membrane (Roberts, 1996). 
Most of the known group 2 and 3 capsule gene clusters are located at position 64 minutes on the 
E. coli K-12 chromosome, and they are associated with the tRNA genes serA and pheV (Ørskov, 
1974; Ørskov, 1976; Vimr, 1991). 
 
Susceptibility factors 
In addition to the above mentioned bacterial virulence-associated factors, there are host factors or 
certain conditions that facilitate colonization by uropathogens. A number of anatomical, 
physiological or pathological factors render individuals susceptible to urinary tract infection 
(Hooton, 2001), while others, for unknown reasons, hinder the pathogenic process.  
 
3 PATHOGENICITY ISLANDS AND GENOMIC ISLANDS 
In the genome of pathogenic bacteria specific genes encode virulence factors that are not present 
in the non-pathogenic variant of a species. In the early 1980s blocks of chromosomal regions 
were identified, which carry virulence genes that are exclusively associated with virulent strains 
of the species. It was also observed that these blocks can delete from the core genome which 
leads to the loss of the encoded virulence gene, and leads to a reduced virulence. These deletable 
large chromosomal regions are designated pathogenicity islands (PAIs) and were initially 
described in a uropathogenic E. coli strain (Blum et al., 1994). Since then, several new islands 
have been described from different organisms. The increasing information about PAIs revealed 
the characteristic features of these unstable chromosomal regions (Hacker and Kaper, 1999). 
PAIs: 
- carry genes encoding one or more virulence-associated genes. 
- are present in the genome of pathogenic bacteria and absent from the genome of non-
pathogenic members of the same or closely related species.  
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- occupy relatively big genomic regions (10 < 200 kb). 
- have a different G+C content compared to the core chromosome. 
- represent distinct genetic elements, often flanked by “direct repeats” (DR). 
- are often associated with tRNA genes. 
- carry often kryptic or functional mobility genes like IS elements, transposases and integrases. 
- Frequently represent unstable DNA regions.   
Although PAIs have common features, they exist in the genomes of various pathogens with the 
capacity to cause different infections. The encoded virulence factors, the size, and the presence of 
different mobility genes make PAIs individual. Their mosaic-like structure is the result of 
continuous recombination events. With the help of mobility genes or simple recombination 
processes PAIs always renew themselves by loosing unnecessary genes and gaining new useful 
virulence associated genes. Traits of this dynamism became evident by comparing different PAIs 
(Rumer et al., 2003). 
There are also evidences that PAIs are able to cross the borders between species. The High 
Pathogenicity Island (HPI) of Yersinia is a good example for this. It means that there must be a 
process with which complete PAIs or at least big fragments can be transferred to another species 
by horizontal gene transfer. 
PAIs not only carry virulence associated genes that are characteristic for different pathotypes, but 
also directly or indirectly have an effect on the fitness of bacteria. That is why in the last years 
the definition of PAIs were extended to the more general concept of  “genomic islands” (GEIs). 
Such islands can be divided into subtypes according to the niche in which they increase the 
fitness of a bacterium. “Symbiosis island” of Mesorhizobium loti (Sullivan and Ronson, 1998) 
and the “ecological islands” of pollutant-degrading bacteria (van der Meer and Sentchilo, 2003) 
are good examples for the genomic island concept. 
 
4 The uropathogenic E. coli strain 536 
The uropathogenic E. coli strain 536 (O6:K15:H31) was isolated from a patient with an acute 
renal pelvis inflammation (Berger et al., 1982). Since then, different virulence-associated factors 
have been identified from which several are associated with one of the four characterized PAIs of 
this strain. These include two α-hemolysin variants encoded on PAI I536, and PAI II536, P-related 
fimbriae (PAI II536), S-fimbriae (PAI III536), the yersiniabactin siderophore system (PAI IV536) 
(Dobrindt et al., 2002). At the time starting with this thesis there were also data available that 
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suggested the presence of a fifth PAI encompassing the K15 capsule determinant (Figure 2) 
(Dobrindt et al., 2002; Janke et al., 2001).  
 
Beyond the PAI-encoded virulence genes, this strain carries other small integrated fragments 
coding for additional factors that are also important in the pathogenic process, like the hemin 
receptor (chuA), enterobactin and an LPS of the O6 serogroup (Berger et al., 1982). There are a 
couple of virulence-associated genes and hypothetical proteins that are still uncharacterized. The 
completion of the strain 536 genome sequencing project will enable a more thorough analysis 
also at functional level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Chromosomal map of the uropathogenic E. coli strain 536. This map is based on the 
chromosomal map of E. coli K-12 strain MG1655 and depicts the chromosomal localisation 
of the known PAIs and some other virulence-associated genes. 
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5 Horizontal gene transfer – genome plasticity – bacterial evolution 
Since the early experiments of Griffiths (1928) we have known that bacteria do in fact exchange 
genetic information. We know already that this not only happens under artificial conditions but 
also in nature. There are three fundamentally distinct mechanisms by which such genetic transfer 
can occur. Isolated DNA molecules from the environment/medium can be taken up through 
transformation. DNA can also be transferred by a process in which a close cell to cell contact is 
required and which is called conjugation. The third form of DNA transfer is mediated by 
bacterial viruses (bacteriophages).  
The best studied process is conjugation. Special genes (tra-transfer functions such as pili 
formation, origin of transfer (oriT), nick formation etc.) encode for proteins necessary for this 
process and are often carried by plasmids that can transfer themselves by conjugation. These self-
transmissible plasmids are usually large (>25kb) and have a more or less broad host range. The 
RP4 plasmid that also carries three antibiotic resistance markers for example has a size of 60 kb 
(Pansegrau et al., 1994), and can mediate DNA transmission by conjugation also to Gram-
positive bacteria and even to yeast (Bates et al., 1998; Heinemann et al., 1989; Trieu-Cuot et al., 
1987). Another type of plasmids is not self-transmissible but by having one or two mob genes 
they are mobilizable. These mobilisable plasmids can be transferred in the presence of a self-
transmissible helper plasmid (e.g. RP4), but not alone. They can acquire antibiotic resistance 
markers and they play an important role in spreading antibiotic resistance traits (Brunton et al., 
1979). In this process conjugative transposons can also take part. They can excise themselves 
from the chromosome of the donor strain by forming a covalently closed circle that does not 
replicate but integrates into the recipient’s chromosome. These elements that can excise and 
integrate, such as prophages, and transfer by conjugation, such as plasmids, have been found in 
various bacteria (Burrus et al., 2004). Specificity of the integration is determined by the integrase 
or recombinase that are encoded on these elements. There are such integrases that are really site-
specific and are able to integrate into the core chromosome in certain sites. Others appear to be 
not so specific and can be integrated in several places of the host’s genome. Site-specific excision 
and low specificity of integration in the same cell lead to the intracellular transposition of the 
element, and result in multiple copy number of this element (Umeda and Ohtsudo, 1989).  
A common feature of all the forms of gene transfer between bacteria is the requirement for the 
transferred DNA to be inserted into the recipient chromosome by recombination. General or 
homologous recombination occurs between homologues regions of DNA, which must be highly 
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similar but do not have to be identical. Other recombination events that do not appear to require 
regions of homology are often referred to as non-homologous or illegitimate recombination. 
These events were shown to be due to the action of insertion sequences (Naas et al., 1995).  
Comparative studies of the structure of selected genes among those species where genetic 
exchange frequently occurs have shown that portions of the genes are markedly different from 
those of other members of the species. Such sequences have been referred to as mosaic genes 
(Brunder and Karch, 2000). Comparative analyses of multiple representatives of the genomes of 
particular species have also demonstrated that beside genes the whole bacterial genomes are 
relatively variable and fluid structures (Brunder and Karch, 2000). The plasticity is mainly the 
result of rearrangement of genes within the genome and acquisition of novel genes by horizontal 
gene transfer systems, e.g. plasmids, bacteriophages, transposons, gene cassettes or pathogenicity 
islands. Plasticity does not only mean of the acquisition of new genes (Figure 3) but also involves 
the process of gene loss, which also can contribute to virulence (Maurelli et al., 1998). 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Mechanisms involved in genome evolution (modified from Dobrindt and Hacker, 2001). 
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The second aim was to get deeper insight into bacterial genome plasticity that is hypothetised to 
be also driven by pathogenicity islands. Using PAI II536 as a model, we wanted to verify the 
transferability of a complete PAI with conjugation. 
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1 BACTERIAL STRAINS, COSMIDS AND PLASMIDS 
All the bacterial strains that were used in this work are listed in this chapter. 
Table 1a: Laboratory E. coli strains used in this study 
E. coli  strain 
 
Characteristics Reference 
MG1655 K12 Blattner et al., 1997 
DH5α F-, endA 1, hsdR17(rk-, mk-, supE44, thi-1, 
recA1, gyrA96, λ-, ∆(argF-lac)U169 
Φ80dlacZ∆M15 
Bethesda Research 
Laboratories, 1986 
SY327 λpir F-, araD ∆(lac pro), argE(Am), recA56 
RifR gyrA λpir 
Miller and Mekalanos, 
1988 
Sm10 λpir thi1, thr1, leuB6, supE44, tonA21, lacY1, 
recA::RP4-2-Tc::Mu, KmR, λpir 
Miller and Mekalanos, 
1988 
XL1-blue supE44, hsdR17, recA1, endA1, gyrA46, 
thi, relA1, lac-, F-(proAB+, lacIq, lacZ 
∆M15, Tn10 (TetR)) 
Bullock et al., 1987 
 
 
Table 1.b: Wild type bacterial strains and their mutants used in this study 
536 O6:K15:H31, ent+, chu+, fec-, hly+, fim+, 
sfa+, prf+, fla+, microcin-, SmR 
Berger et al., 1982 
536rfaH::cat 536, rfaH inactivated by a cat cassette, SmR, 
CmR 
Nagy et al., 2000 
536∆kpsSCK10 536, kpsSCK10 have been partially deleted 
and inactivated by insertion of cat cassette, 
K15 capsule-, SmR, CmR 
This study 
536∆kpsC'K5 536, kpsC'K5 has been partially deleted and 
inactivated by insertion of cat cassette, K15 
capsule+, SmR, CmR 
This study 
536∆kpsCK10 536, kpsCK10 has been partially deleted and This study 
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inactivated by insertion of cat cassette, K15 
capsule-, SmR, CmR  
536∆R2-1 536, region 2 of the kpsK15 determinant has 
been partially deleted and inactivated by 
insertion of cat cassette, K15 capsule-, SmR, 
CmR (serum resistant) 
This study 
536∆R2-2 536, region 2 of the kpsK15 determinant has 
been partially deleted and inactivated by 
insertion of cat cassette, K15 capsule-, SmR, 
CmR 
This study 
536∆kpsMT 536, kpsMT have been partially deleted and 
inactivated by insertion of cat cassette, K15 
capsule-, SmR, CmR 
This study 
536∆kpsK15 536, the complete kpsK15 determinant has 
been deleted and replaced by insertion of cat 
cassette, K15 capsule-, SmR, CmR 
This study 
536gsp::cat 536, genetic region between gspD and L has 
been deleted and inactivated by insertion of a 
cat cassette, SmR, CmR  
This study 
RZ532 O6:K+:H31, pap/prs+, sfa/foc+, fim+, aer-, 
hly+ 
Zingler et al., 1992 
IMI402  ETEC strain, isolate 34344f (O6:K15:H_) IMIB strain collection 
IMI403  ETEC strain, isolate C9221a (O6:K15:H16) IMIB strain collection 
IMI415  E. coli isolate E642 (O6:K15) IMIB strain collection 
536-21 536, PAI I536-, PAI II536-, hly-, fim+, sfa+, prf--
, ent+, fla+, serum sensitive, SmR 
Hacker et al., 1983 
536-114 536, PAI I536- Knapp, 1982 
536-225 536, PAI II536- Knapp, 1982 
SY327M23 SY327 containing PAI II536 integrated into 
leuX, hly+, prf+, NalR, CmR 
This study 
SY327M46 SY327 containing PAI II536 integrated into This study 
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leuX, hly+, prf+, NalR, CmR 
SY327M54 SY327 containing PAI II536 integrated into 
leuX, hly+, prf+, NalR, CmR 
This study 
SY327M26 SY327 containing PAI II536 in a circular 
form, hly+, prf+, NalR, CmR 
This study 
SY327M59 SY327 containing PAI II536 in a circular 
form, hly+, prf+, NalR, CmR 
This study 
SY327M77 SY327 containing PAI II536 in a circular 
form, hly+, prf+, NalR, CmR 
This study 
536mob_10 536, pir is integrated in the λattB site This study 
536-19mob 536, pirλatt, mobGP704 in PAI II536 
SmR, ApR, CmR 
This study 
536-19/1mob 536, pirλatt, mobGP704 inserted in PAI II536, 
pRP4, SmR, ApR, CmR, TcR, KmR 
This study 
 
 
Table 1c: Plasmids and cosmids used in this study 
Designation Description Reference 
pUC19 ApR, orif1, lacZ Yanisch-Perron et 
al., 1998 
pACYC177 ori p15a, ApR, KmR New England 
Biolabs 
pACYC184 ori p15a, CmR, TcR  New England 
Biolabs 
SuperCos 1 Cosmid vector, ApR, Stratagene 
pBaleoBac11 oriS, sopA/B, sopC, repE, CmR New England 
Biolabs 
pGEM®-T Easy Cloning vector, ApR Promega 
pBluescript-II KS Cloning vector, ApR Stratagene 
pLDR8 int gene expression vector, KmR Diederich et al., 
1992 
 27 
leuX, hly+, prf+, NalR, CmR 
SY327M54 SY327 containing PAI II536 integrated into 
leuX, hly+, prf+, NalR, CmR 
This study 
SY327M26 SY327 containing PAI II536 in a circular 
form, hly+, prf+, NalR, CmR 
This study 
SY327M59 SY327 containing PAI II536 in a circular 
form, hly+, prf+, NalR, CmR 
This study 
SY327M77 SY327 containing PAI II536 in a circular 
form, hly+, prf+, NalR, CmR 
This study 
536mob_10 536, pir is integrated in the λattB site This study 
536-19mob 536, pirλatt, mobGP704 in PAI II536 
SmR, ApR, CmR 
This study 
536-19/1mob 536, pirλatt, mobGP704 inserted in PAI II536, 
pRP4, SmR, ApR, CmR, TcR, KmR 
This study 
 
 
Table 1c: Plasmids and cosmids used in this study 
Designation Description Reference 
pUC19 ApR, orif1, lacZ Yanisch-Perron et 
al., 1998 
pACYC177 ori p15a, ApR, KmR New England 
Biolabs 
pACYC184 ori p15a, CmR, TcR  New England 
Biolabs 
SuperCos 1 Cosmid vector, ApR, Stratagene 
pBaleoBac11 oriS, sopA/B, sopC, repE, CmR New England 
Biolabs 
pGEM®-T Easy Cloning vector, ApR Promega 
pBluescript-II KS Cloning vector, ApR Stratagene 
pLDR8 int gene expression vector, KmR Diederich et al., 
1992 
 28 
pLDR9 Cloning vector for integration into the λ-
attB, KmR 
Diederich et al., 
1992 
pCVD442 oriR6K, mobRP4, sacB, ApR Donnenberg and 
Kaper, 1991  
pKD46 oriR101, repA101 ts, araC-ParaB, Red 
recombinase γ, β, exo, ApR 
Datsenko and 
Wanner, 2000 
pKD3 oriR6K, FRT site, CmR Datsenko and 
Wanner, 2000 
pKD4 oriR6K, FRT site, KmR Datsenko and 
Wanner, 2000 
pCP20 ApR, CmR Cherepanov et al., 
1995 
pGP704 oriR6K, mobRP4, M13 tg131, ApR Mekalanos 
pSG704 oriR6K, mobRP4, M13 tg131, CmR This study 
RP4 oriV, trf, Tra, oriT, pri, ApR, KanR, TetR Pansegrau 
pCos25/52 contains the first 3rd of PAI V536, ApR This study 
pCos6b38 contains the second 3rd of PAI V536, ApR Janke et al., 2001 
pCos24/23 contains the third 3rd of PAI V536, ApR This study 
pCos2/13 contains a 7-kb insert downstream from 
Type-II GSP, ApR 
This study 
pBal-kompK15 pBeloBAC11, contains the complete kpsK15 
locus of strain 536, CmR 
This study 
 
 
2 OLIGONUCLEOTIDES 
Oligonucleotides used in this study were ordered from Sigma ARK Genosys (Steinheim) or 
MWG Biotech (Ebersberg). Annealing temperatures were always calculated according to the 
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pLDR9 Cloning vector for integration into the λ-
attB, KmR 
Diederich et al., 
1992 
pCVD442 oriR6K, mobRP4, sacB, ApR Donnenberg and 
Kaper, 1991  
pKD46 oriR101, repA101 ts, araC-ParaB, Red 
recombinase γ, β, exo, ApR 
Datsenko and 
Wanner, 2000 
pKD3 oriR6K, FRT site, CmR Datsenko and 
Wanner, 2000 
pKD4 oriR6K, FRT site, KmR Datsenko and 
Wanner, 2000 
pCP20 ApR, CmR Cherepanov et al., 
1995 
pGP704 oriR6K, mobRP4, M13 tg131, ApR Mekalanos 
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GE Healthcare/Amersham Biosciences Europe (Freiburg), Clontech (Heidelberg), Difco 
(Augsburg), Gibco BRL (Eggenstein), Invitrogen (Karlsruhe), MBI Fermentas (St. Leon-Roth), 
Merck (Darmstadt), Molecular Probes (Poort Gebouw), New England Biolabs (Frankfurt am 
Main), Oxoid (Wesel), Promega (Heidelberg), Quiagen (Hilden), Roche Diagnostics 
(Mannheim), Sigma-Aldrich (Taufkirchen), Schleicher & Schuell (Dassel), Stratagene 
(Heidelberg), Dianova (Hamburg). 
 
The following kits have been used in this study: 
- “ECLTM Direct Nucleic Acid Labeling and Detection System”, GE Healthcare/Amersham 
Biosciences Europe (Freiburg) 
- “PRISMTM BigDyeTerminator-Cycle Sequenzierkit“, PE Applied Biosystems (Weiterstadt) 
- “Expand Long Template PCR System“, Roche Diagnostics (Mannheim) 
- “ReadymixTM REDTaqTM PCR System“, Sigma-Aldrich (Taufkirchen) 
- “SuperScriptTM II RNase H- Reverse Transcriptase“, Invitrogen (Karlsruhe)  
- “pGEM® T-easy Vector System I”, Promega (Mannheim) 
- “QIAquick Gel Extraction Kit”, Qiagen (Hilden) 
- “QIAGEN Midi and Maxi Kit“, Qiuagen (Hilden) 
 
4 MEDIA AND BUFFERS 
Distilled water was used for all media. All media were autoclaved for 20 minutes. For agar plates, 
15 g bacteriological agar (Difco Laboratories, Detroit, MI, USA) per one liter of medium was 
added before autoclaving. 
 
Luria-Bertani medium (LB)  for 1000 ml (Sambrook et al., 1989): 
Trypton  10 g 
Yeast Extract 5 g 
NaCl  5 g 
 
X-Gal medium: 
After autoclaving LB-medium supplemented with the following additives: 
IPTG (0.1 M)      0,5 ml/l 
X-Gal (2 %, (w/v) in N,N`-dimethylformamide) 3 ml/l 
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Blood Agar plates (3-5%): 
 Before plating out the autoclaved and pre-cooled LB agar medium, washed cow blood 
was added so that the end contcentration was 3-5 %. Blood was centrifuged at 5,000 rpm for 10 
minutes, and upper phase (serum) was cautiously discarded. Blood cells were resuspended in 
sterile physiological NaCl solution. If serum was not clear enough this step was repeated.   
 
M9 lactose medium: 
800 ml dH2O supplemented with 15 g agar was autoclaved and pre-cooled to 60-70 °C. 
200 ml 5x M9 salt solution and 100 µl 1 M CaCl2 were added that were separately autoclaved. 
Then the sterile filtered (0.22 µm) components of the medium like MgCl2, casamino acids, 
lactose and thiamine were added as written below.  
 
5 x M9 salts 
 Na2HPO4 x 2 H2O 60 g 
 KH2PO4  15 g 
 NaCl   2,3 g 
 NH4Cl   5 g 
 dH2O   1000 ml 
 
Casamino acids (10 %) 30 ml 
1 M MgCl2  2 ml 
1 M CaCl2  0,1 ml 
Lactose (20%)  10 ml 
Thiamine (0.2 %) 1 ml 
dH2O   750 ml 
 
Stock solutions of antibiotics and their working concentrations: 
     mg/ml  µg/ml 
Ampicillin   100  100 
Chloramphenicol  20  20 
Kanamycin   100  100 
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Streptomycin   10  10 
Tetracycline   5  10 
 
5 EQUIPMENTS 
- Autoclave     Webeco 
- Centrifuge     Heraeus Biofuge 13R 
      Heraeus Megafuge 1.0R 
      Eppendorf 5415 C 
      Beckman J 2-21 
- Clean bench     Nunc Inter Med 
- Electrophoresis chamber   Bio Rad 
- Electroporator    BioRad, Gene Pulser transfection 
- X-ray films     Hyperfilm, ECL 
- Gene linker     BioRad 
- Hot Plate     Eppendorf Thermostat 5320 
- Hybridisation oven    HybAid 
- Ice machine     Scotman AF-20 
- Incubator     Mammert Tv40b 
      Heraeus B5050E 
- Magnetic stirrer    GLW 
- Micro pipettes    Gilson, Eppendorf 
- Microwave oven    Moulinex 
- Nylon membrane    Byodine, Nytran 
                                                                        Optitran BA-S 85 
- PCR Thermocycler    Eppendorf, Biometra 
- pH-Meter     WTW pH523 
- Photometer     Pharmacia Ultrospec 3000 
- Platform Shaker    Bühler E55 swip 
      Innova TM 4300 
- Power Supply    BioRad 200mA, 500V 
- Rotation mixer    eppendorf mixer 5432 
- Sequence analyser    ABI Prism 
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- Shaker     GLW 
      GFL Water bath 
      Innova TM 4300 
- Speedvac concentrator   INIVAPO 150H Uniequipe 
- Sterile filter     Schleicher & Schuell 0.22µm 
- Vacuum blotter    Pharmacia 
- Vacuum oven    Heraeus instruments VTR 5036 
- Vortexer     GLW 
- Water bath     GLW 1083 
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6 METHODS 
In cases where “rpm” values are given instead of “g” values centrifugation was carried out in 
Eppendorf centrifuge 
 
6.1 Isolation of plasmid DNA 
 
6.1.1 Rapid boiling plasmid isolation (with alkaline and heat lysis) 
For screening plasmid clones containing the correct DNA insert after ligation, this fast plasmid 
isolation protocol was used. Cells from an agar plate or from O/N LB cultures were collected and 
resuspended in 150 µl lysis buffer containing 2 mg/ml lysozyme. After 5 minutes incubation at 
room temperature, samples were boiled at 100 ºC for 40 seconds and placed on ice for 10 
minutes. After 10 min centrifugation (13,000 rpm) pellets were removed with a toothpick and 0.4 
vol 5M NH4-acetate (pH 7.5) and 1 vol of isopropanol was added to the supernatant in order to 
precipitate the DNA. Precpitated DNA was collected by centrifugation (15 min, 13,000 rpm) and 
washed with 70 % ethanol. After drying, the plasmid DNA was resuspended in 20 µl sterile dH2O 
or in TE buffer.  
Lysis buffer: 10 mM Tris-HCl (pH 8.0) 
8 % (w/v) Sucrose 
0,5 % (w/v) Triton X-100 
50 mM EDTA 
 
6.1.2 Plasmid mini and maxi preparation (QIAGEN Plasmid Purification System) 
Bacteria were collected from 1.5 ml O/N LB culture by centrifugation (2 min, 13,000 rpm) and 
the pellet was resuspended in 150 µl Buffer I. After 10 minutes incubation at room temperature 
150 µl Buffer II was added. After clearing up 150 µl Buffer III was added to the solution, and it 
was placed on ice for 10 min to precipitate the proteins. Following centrifugation (10 min, 13,000 
rpm), the supernatant (~400 µl) was collected in another tube. From this, plasmid DNA can be 
precipitated or can be purified with diatomaceous earth or by phenol/chloroform extraction.  
 
Buffer I    Buffer II    Buffer III 
50 mM Tris-HCl (pH 7.5)  1 % (w/v) SDS   3 M Na-acetate 
10 mM EDTA (pH 8.0)  0.2 M NaOH     
RNase 10 mg/ml   
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For a maxi preparation, 50 ml O/N LB culture were used. After centrifugation (15 min, 6,000 
rpm - Beckman J 2-21), the cells were suspended in 4 ml Buffer I and 100 µl lysozyme (100 
mg/ml) was added. After 15 min incubation in room temperature, 4 ml Buffer II and then 4 ml 
Buffer III were added, and the mixture was placed on ice for 15 min. After centrifugation (30 
min, 13,000 rpm), the supernatant was column filtered into another tube and the DNA was 
precipitated with 0.7 volume isopropanol. By thorough mixing and centrifugation, the DNA 
pellet was transferred to a 2 ml Eppendorf tube and washed with 70 % (v/v) ethanol. After 
centrifugation (10 min, 13,000 rpm), the pellet was resuspended in 500 µl dH2O and 50 µl 5 M 
NH4-acetate was added. Then, equal quantiy of phenol/chloroform was added. After shaking the 
tube, the solution was centrifuged (10 min, 13,000 rpm) and the supernatant was transferred to 
another tube where double quantity of 96 % (v/v) cold (-20 °C) ethanol was added to precipitate 
the DNA. After centrifugation (15 min, 13,000 rpm) the pellet was washed with 70 % (v/v) 
ethanol and centrifuged for 5 minutes. Alcohol was discarded and the pellet was dried. Plasmid 
DNA was solved in 100 µl water. 
 
6.1.3 Plasmid isolation using diatomaceous earth 
In order to obtain highly purified plasmid DNA (for sequence analysis), the following method 
was used. Plasmid prep was performed as described in (6.1.2). After precipitation the proteins 
with buffer three, the DNA solution was mixed with 900 µl L6 Buffer, and 50 µl diatomaceous 
earth suspension (20 % (m/v)) was added. It was shaked well and left for 1 min at room 
temperature to allow binding of the DNA to the diatomaceous earth. Then the suspension of the 
diatomaceous earth was filtered through a special filter and diatomaceous earth particles were 
washed with 2 ml washbuffer. DNA was eluted from the diatomaceous earth particles with 50 µl 
dH2O by centrifugation (30 sec, 13,000 rpm in an Eppendorf centrifuge) into an Eppendorf tube.  
 
L6 Buffer    Diatomic earth suspension    Washbuffer  
100 ml 0,1 M Tris-HCl (pH 6.4) 10 g diatomaceous earth 10 ml  5 M NaCl 
8.8 ml  0,5 M EDTA (pH 8)  50 ml dH2O              5 ml  1 M Tris-HCl (pH 7.5) 
13.2 ml dH2O    500 µl  ccHCl   2.5 ml  0,5 M EDTA (pH 8) 
2.6 ml  Triton X-100   250 ml  dH2O 
120 g  Guanidin thiocyanate   250 ml  EtOH 
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6.2 Isolation of chromosomal DNA (Grimberg et al., 1989) 
1 ml O/N LB culture was centrifuged (4 min, 8,000 rpm) and then washed with 1ml TNE buffer. 
The pellet was resuspended in 270 µl TNEX buffer containing 30 µl lysozyme (5 mg/ml) and 
incubated at 37 ºC for 30 min. Then, 15 µl proteinase K (20 mg/ml) was added and the mixture 
was incubated for 2 hours at 65 ºC. After the solution became clear, 15 µl 5 M NaCl and 500 µl 
EtOH were added and incubated on ice for 15 min to precipitate DNA. Precipitated DNA was 
collected by centrifugation (15 min, 13,000 rpm) and the pellet was washed twice with 80 % 
(v/v) ethanol. After moderate drying, the isolated nucleic acid was resuspended in 100 µl water. 
 
  TNE buffer    TNEX buffer 
  10 mM Tris (pH 8)   10 mM Tris (pH 8) 
  10 mM NaCl    10 mM NaCl 
  10 mM EDTA (pH 8)   10 mM EDTA (pH 8) 
       1 % (v/v) Triton X-100 
 
6.3 Phenol/Chloroform extraction 
Protein contaminations were removed from DNA probes by phenol/chloroform extration. One 
volume of phenol/chloroform/isoamyl alcohol (25:24:1, v/v/v) was added to the DNA sample and 
was carefully mixed. The sample was centrifuged for at least 2 minutes. Then, the upper aqueous 
phase was transferred to a new Eppendorf tube. The supernatant was extracted again with 
chloroform to remove traces of phenol from the aqueous DNA solution. The clear supernatant 
was then transferred to a new tube in order to precipitate the DNA as described below. 
 
6.4 Precipitation of nucleic acids 
In order to obtain pure and concentrated DNA samples, DNA was precipitated after a 
phenol/chloroform extraction by the addition of 0.1 volume 3 M Na-acetate (or 5 M NH4-acetate) 
and 2 volumes ice-cold absolute ethanol. After incubation (15 min at –20 ºC), the DNA was 
pelleted by centrifugation (15 min, 13,000 rpm). After resuspension in dH2O or TE buffer, the 
DNA concentration was assessed on an agarose gel or by optical density measurement.  
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6.5 Measuring the concentration of nucleic acids 
The concentration of nucleic acids was measured as the absorption at a wavelength of 260 nm. 
Using a 1-cm wide quartz cuvette, the absorption of 1 (A260=1) equals to nearly 50 µg/ml of 
double stranded DNA, 40 µg/ml of RNA or nearly 33 µg/ml of single stranded oligonucleotides. 
Accordingly, the DNA concentration can be calculated. The purity of the DNA samples can be 
measured at a wavelength of 280 nm due to the absortion by aromatic amino acids of proteins. 
The quotient of these two values (A260/A280) indicates the purity of the DNA sample. If the value 
is above 1.8, the DNA is very pure. 
 
6.6 Digestion of DNA with restriction enzymes 
Purified DNA samples that do not contain traces of phenol, can be specifically digested by 
restriction endonucleases. 1 unit (U) of enzyme is able to digest 1 µg DNA in 1 hour. The 
aqueous DNA solution, containing a suitable concentration of a reaction buffer, is incubated with 
the required quantity of the restriction enzyme form time periods ranging from 1 hour to O/N 
incubation. The incubation temperature is ususally 37 ºC. The restriction is usually stopped by 
heat inactivation (20 min, 80 ºC), phenol/chloroform extraction, the use of DNA purification kits 
or by the addition of 5x loading buffer.  
General restriction buffer: 330 mM Tris-Acetate (pH 7.9)  
    660 mM K-acetate       
    100 mM Mg-acetate    
    5 mM DTT     
    1 mg/ml BSA        
    dH2O      
10 × Stop-Mix: Bromphenol blue 0.25 % 
   Xylene cyanol  0.25 % 
   Ficoll type 400 25 % 
 
6.7 Horizontal gelelectrophoresis 
For the separation of DNA fragments, horizontal gelelectrophoresis was performed under non-
denaturing conditions. Depending on the size of the DNA fragments to be separated, the agarose 
concentration varied between 0.8-2 % (w/v) in running buffer (1 × TAE or 1 × TBE). In order to 
have a visible running front and to prevent diffusion of the DNA, 0.2 vol Stop-Mix was added to 
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For the separation of DNA fragments, horizontal gelelectrophoresis was performed under non-
denaturing conditions. Depending on the size of the DNA fragments to be separated, the agarose 
concentration varied between 0.8-2 % (w/v) in running buffer (1 × TAE or 1 × TBE). In order to 
have a visible running front and to prevent diffusion of the DNA, 0.2 vol Stop-Mix was added to 
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the samples before loading. The electrophoresis was carried out using a voltage in the range 
between 16-120 V. The gels were stained in ethidium bromide solution (10 mg/ml), then washed 
with water and photographed under an UV-transilluminator.  
 50 x TAE-buffer    10 x TBE-buffer 
 Tris   242 g   Tris   108 g 
 Acetic acid  57.1 ml  Boric acid  55 g 
 0.5 M EDTA (pH 8) 100 ml   0.5 M EDTA (pH 8) 40 g 
 dH2O  add to 1000 ml  dH2O  add to 1000 ml 
 
6.8 Isolation of DNA from agarose gel 
After staining the gel in ethidium bromide, it was checked under UV light and the required DNA 
band was cut out of the gel and extracted with one of the two following methods. 
6.8.1 DNA isolation from agarose gels using the QIAquick® Gel Extraction Kit (Qiagen) 
The piece of the agarose gel containing the DNA fragment was placed in an Eppendorf tube and 
the required quantity of QG buffer (supplied by the manufacturer) was added. Upon incubation 
for 10 min at 50 ºC, the agarose was totally melted and the solution was pipetted onto a 
QIAquick® spin column. After centrifugation (30 sec, 13,000 rpm) the spin column was washed 
with 500 µl QG buffer to remove the remaining agarose traces (30 sec, 13,000 rpm) and then 
washed with 750 µl PE buffer. The column was then centrifuged again as described above to 
remove remaining traces of PE buffer. The column was transferred to a new Eppendorf tube and 
20 µl water was added to elute the DNA. It was left for 2 minutes at RT and then centrifuged for 
1 minute with maximum speed in an Eppendorf bench centrifuge. 
 
6.8.2 DNA isolation from agarose gels using the Geneclean® kit (Qbiogene) 
The cut out portion of the agarose gel was mixed in an Eppendorf tube with 3 vol NaI solution 
and melted at 50 ºC. Then, 5-7 µl glass milk (supplied by the manufacturer) was added and the 
mixture was incubated for 5 minutes at room temperature. The glass milk particles with adhering 
DNA were pelleted (20 seconds, full speed in an Eppendorf centrifuge) and washed with 1 ml 
washing solution. This step was repeated and the wash solution was removed from the pellet with 
a pipette. The pellet was then resuspended in 10 µl dH2O and incubated at 50 ºC for 5 minutes. 
The eluted DNA was separated from the glassmilk by centrifugation (1 min, 13,000 rpm) and 
transferred into a new Eppendorf tube.   
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6.9 Dephosphorylation and phosphorylation of DNA fragments 
If vector DNA is digested with one restriction enzyme, the ligation efficency can be increased by 
dephosphorylation of the ends of the linearized vector thereby preventing religation of the cut 
vector DNA. For this purpose, the digested DNA sample is incubated with alkaline phosphatase 
(isolated from shrimp (SAP) or the calf intestine (CIP)) which catalyses the removal of 5' 
phosphate groups from DNA, RNA and ribo- and deoxyribonucleoside triphosphates. Since CIP- 
or SAP-treated fragments lack the 5' phosphoryl termini required by DNA ligases, they can not 
re-ligate. Dephosphorylation requires a suitable reaction buffer and incubation for 60 min at 37 
ºC. Inactivation of SAP is achieved by incubation for 20 min at 80 ºC, wheras for inactivation 
and removal of CIP a phenol/chloroform extraction is recommended. 
To increase the ligation efficiency, DNA fragments cut out with one enzyme should be 
phosphorylated using the polynucleotide kinase (PNK). Phosphorylation of the DNA at the 5' 
hydroxyl termini of DNA hinders religation. 
 
6.10 Ligation of DNA 
The linearised vector and the insert DNA fragment can be ligated by a DNA ligase. Ligation 
efficiency is affected by the ratio of vector- and insert DNA molecules which should optimally be 
1:3. “Sticky end” ligation was usually carried out O/N at 16 ºC or 4 ºC while blunt end ligations 
were carried out O/N at room temperature.  
Ligation into the pGEM®-T Easy vector requires an ”adenine“ overhang at the 3' ends of the PCR 
product. Some DNA polymerases add an “A” to the 3'-end of the DNA strand. When necessary, a 
”tailing“ reaction was carried out: 2-300 ng DNA fragment, 1 µl 10x PCR buffer, 0.3 µl MgCl2, 
1µl dATP (2 mM), 1 µl Taq was incubated for 30 minutes at 70 ºC. After incubation 2-3 µl from 
this mixture was directly used for ligation. 
 
6.11 Polymerase Chain Reaction (Saiki et al., 1988) 
With this method it is possible to amplify a DNA region in vitro. Theoretically, one double 
stranded DNA moleculare can be amplified in 25 reaction cycles to more than 8 million copies. 
The key enzyme of this amplification by the so-called polymerase chain reaction (PCR) is the 
heat stable Taq DNA polymerase which functions at extremely high temperatures. PCR is used 
not only for DNA amplification but also for site-directed mutagenesis. The main components 
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required for PCR are: DNA (template), dNTPs (nucleotides), primers (oligos), reaction buffer, 
MgCl2, Taq DNA polymerase and water. 
For screening purposes requiring only amplification of selected DNA regions, the Quiagen Taq 
polymerase system and the REDMIX system (Sigma, Deisenhofen) was used. If necessary, e.g. 
for cloning experiments, enzyme systems providing a DNA polymerase with proof reading 
activity were used, e.g. the DAp Goldstar system (Eurogentec) and the Expand Long Template 
PCR System (Roche Diagnostics), to avoid incorporation of point mutations into the PCR 
products. 
A conventional reaction mixture is composed as follows: 
 10 x Taq-polymerase buffer  10µl 
 20 mM dNTP-mix   4 µl 
 0.5 µg/µl primer 1   2 µl 
 0.5 µg/µl primer 2   2 µl 
 100 ng/µl template-DNA  1 µl 
 Taq DNA polymerase  1µl 
 25 mM MgCl2 depends on the length of the PCR product 
 H2O    add to 100 µl 
 
This reaction mixture is kept for 2 minutes at 94 ºC. After this initial denaturation step, DNA 
amplification occurs during 25 reaction cycles. One cycle consists of three steps: 30 seconds 
DNA double strand denaturation (94 ºC), 30 seconds primer annealing to the DNA template, at a 
temperature which depends on the primer sequence and a third an primer elongation step (72 ºC), 
which depends on the length of the product. 
  
6.12 Preparation of bacteria competent for DNA uptake by transformation 
Genetic manipulation of bacteria requires that the target cell should be able to take up plasmids or 
DNA fragments. These bacteria should be competent for the uptake of naked DNA. This can be 
achieved by different methods.  
6.12.1 Bacterial DNA uptake upon CaCl2 treatment and heat shock  
1 ml of an O/N LB culture was used for inoculation of a fresh 50 ml LB culture. Cells were then 
grown to an OD600 of 0.5 and incubated for 30 min on ice. The culture was centrifuged for 5 min 
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at 2000 × g at 4 °C and the pellet was resuspended in 17.5 ml ice-cold 0.1 M CaCl2 and incubated 
on ice for 30 min. After a second centrifugation step, the cells were resuspended in 2.5 ml ice-
cold 0.1 M CaCl2 solution and either used immediately, or ideally they were frozen at –80 °C 
after the addition of 50 % (v/v) glycerol. 
For transformation, 50 µl of competent cells were thawn on ice and ca. 100 ng of plasmid DNA 
was added to the cell suspension. After incubation on ice for 30 min, the cells were incubated at 
42 °C for 90 sec and then again placed immediately on ice for 5 min. 1 ml LB was added and the 
cell suspension was incubated at 37 °C for 1 h, allowing the expression of the selection marker 
before the mixture was plated on selective LB agar. 
 
6.12.2 Transformation by electroporation 
For transforming DNA into wild type strains, the more efficient electroporation was used. The 
efficiency of electroporation is affected by factors such as the voltage gradient, resistance and 
capacitance. The genetic background of the host cells, as well as the post-pulse treatment, the 
topological form and treatment of DNA samples also contribute to the electroporation efficiency 
observed (Zhu and Dean, 1999). 
To prepare electro-competent bacterial cells, 50 ml of late exponential (OD600 0.7-0.9) culture 
was used. The cells were pelleted (7 min, 5,000 rpm) and washed three times with decreasing 
volumes of sterile cold destilled water (50 ml, 25 ml and 10 ml). Then, the cells were 
resuspended in 5 ml cold sterile 10% (v/v) glycerol/water solution and centrifuged again. The 
cells were resuspended in 150 µl 10 % (v/v) glycerol/water solution and 50 µl aliquots of this 
suspension were frozen at –80 ºC or immediately used for electroporation. 
For transformation, a 50 µl aliquot of cold electro-competent cells was mixed with DNA (0.1-3 
ng) – dependending on the strain and DNA (plasmid or linear)), and transferred into a precooled 
electroporation cuvette. The dry surfaced cold cuvette was placed between the electrodes and 
they were discharged. Conditions of the electroporation depended on the bacterial host 
background. For a K-12 strain, electroporation with1.8 kV, 400 Ω and 25 µF is sufficient, but for 
electroporation of wild type strains (where capsules and complete LPS is present) the use of 2.0 
kV with 800 Ω is more efficient. After the electric pulse, the cuvette was placed on ice for 1 
minute and bacteria were washed out with LB, transferred into an Eppendorf tube and incubated 
at 37 ºC for 1 hour to allow the expression of the selection marker. This mixture was then plated 
out on selective media and incubated as required.  
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6.13 Conjugation 
For conjugation experiments, late log phase cultures of the donor and the recipient strain were 
mixed in a ratio of 3:1 (or as indicated) and plated on LB agar plates. From the starting cultures, 
serial dilutions were made to determine their CFUs. After O/N incubation, the cells were 
resuspended from the plates with 1.5 ml physiological NaCl solution. The cell suspension was 
then diluted tenfold and samples (100 µl) were plated on selective media that should only allow 
growth of transconjugants. For the calculation of the rate of conjugation, samples were also 
plated selective media that only allow growth of the recipient strain. Next day, the colonies were 
counted and checked. To assess the efficiency of the conjugation, the rate of conjugation was 
calculated: 
 
rate of conjugation =  number of conjugants  /  number of recipients 
 
 
6.14 Pulsed-field gel electrophoresis (PFGE) 
High molecular weight DNA was prepared as follows: The bacteria were grown O/N in 10 ml LB 
medium at 37 °C. 4 ml of the culture was harvested by centrifugation and the pellet was washed 
two times with SE buffer. After resuspending the cells in 1 ml SE buffer, the OD600 was measured 
(100 µl cells + 900 µl SE buffer). When necessary, the OD600 had to be adjusted in the range 
between 0.6 and 0.7. A 2 % (w/v) LGT agarose solution was prepared and cooled down to 45-50 
°C. 900 µl of the bacterial suspension was mixed with 900 µl agarose and transferred into 
appropriate moulds. After solidification at 4 °C, agarose blocks were cut in pieces with an 
approximately identical size (0.5 × 0.3 × 0.1 cm), and then incubated in 5 ml NDS solution 
(freshly supplemented with 2 mg/ml proteinase K) overnight at 50 °C on a shaker. For the 
complete removal of the proteinase K, the agarose plugs were afterwards washed at least four 
times for 2 h with TE buffer. Plugs were stored at 4 °C in TE buffer until digestion. Before using 
the agarose plugs, they were incubated in 1 x restriction buffer (1 h, at 50 ºC in 1 ml buffer) to 
remove traces of TE because of the EDTA included in the TE buffer that could impair proper 
restriction of the DNA. After 1 hour, the restriction buffer was removed and 150 µl fresh 
restriction buffer was added that already contained the suitable restriction enzyme. Agarose plugs 
were incubated for 3 hours with 30 U of the restriction enzyme at 37 ºC.   
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SE buffer    TE buffer     
75 mM NaCl    10 mM Tris-HCl (pH 7.5)   
25 mM EDTA (pH 7.4)  5 mM EDTA (pH 7.5)     
 
      
 NDS buffer    LGT buffer    
1 % N-laurylsarcosine  10 mM Tris-HCl (pH 7.5) 
  0.5 M EDTA (pH 9.5)  10 mM MgCl2 
Proteinase K (2 mg/ml)  LGT agarose 2 % 
     0.1 mM EDTA (pH 7.5) 
 
Separation of the digested high molecular weight DNA fragments was carried out on a 0.8 % 
(w/v) agarose gel (1 × TBE buffer; see section IV.3.1.1) by horizontal gelelectrophoresis. Gels 
were run for 21-24 h with pulse periods of 0.5-50 s. After staining in ethidium bromide solution 
(10 mg/ml), gels were photographed on an UV-transilluminator. 
 
6.15 Southern-blot analysis 
DNA fragments were electrophoretically separated according to their size on 0.8-1 % (w/v) 
agarose gels. After staining in an ethidium bromide solution, and documentation of the fragment 
pattern by photography, the separated DNA fragments were tansferred to a nylon membrane (Pall 
Biodyne B, 0,45 µm). Before transfer, the gel was prepared for blotting by rinsing it for nine 
minutes in the following solutions: 
- 1) 0.25 N HCl for fragmentation of the DNA fragments 
- 2) Solution 1 for denaturation of the double stranded DNA (0.5 M NaOH; 1.5 M NaCl) 
- 3) Solution 2 for neutralisation (0.5 M Tris (pH 7.4); 1.5 M NaCl). 
In order to transfer the DNA by capillary blotting to the nylon membrane, the gel was placed 
upside down on top of several layers of Whatmann papers that were sitting in a tray of 20 x SSC 
buffer. Above the gel, the nylon membrane (pre-soaked in 2 x SSC) was placed avoiding air 
bubbles between them. Additional layers of Whatman paper (pre-soaked in 20 x SSC) were 
placed above as well as a thick layer of dry paper towels on top on which a heavy bottle was 
placed. After overnight blotting, the membrane was treated for 1 min with 0.4 N NaOH and then 
with 0.2 M Tris-HCl (pH 7.5). After drying, the DNA was fixed on the membrane by UV-light. 
 42 
SE buffer    TE buffer     
75 mM NaCl    10 mM Tris-HCl (pH 7.5)   
25 mM EDTA (pH 7.4)  5 mM EDTA (pH 7.5)     
 
      
 NDS buffer    LGT buffer    
1 % N-laurylsarcosine  10 mM Tris-HCl (pH 7.5) 
  0.5 M EDTA (pH 9.5)  10 mM MgCl2 
Proteinase K (2 mg/ml)  LGT agarose 2 % 
     0.1 mM EDTA (pH 7.5) 
 
Separation of the digested high molecular weight DNA fragments was carried out on a 0.8 % 
(w/v) agarose gel (1 × TBE buffer; see section IV.3.1.1) by horizontal gelelectrophoresis. Gels 
were run for 21-24 h with pulse periods of 0.5-50 s. After staining in ethidium bromide solution 
(10 mg/ml), gels were photographed on an UV-transilluminator. 
 
6.15 Southern-blot analysis 
DNA fragments were electrophoretically separated according to their size on 0.8-1 % (w/v) 
agarose gels. After staining in an ethidium bromide solution, and documentation of the fragment 
pattern by photography, the separated DNA fragments were tansferred to a nylon membrane (Pall 
Biodyne B, 0,45 µm). Before transfer, the gel was prepared for blotting by rinsing it for nine 
minutes in the following solutions: 
- 1) 0.25 N HCl for fragmentation of the DNA fragments 
- 2) Solution 1 for denaturation of the double stranded DNA (0.5 M NaOH; 1.5 M NaCl) 
- 3) Solution 2 for neutralisation (0.5 M Tris (pH 7.4); 1.5 M NaCl). 
In order to transfer the DNA by capillary blotting to the nylon membrane, the gel was placed 
upside down on top of several layers of Whatmann papers that were sitting in a tray of 20 x SSC 
buffer. Above the gel, the nylon membrane (pre-soaked in 2 x SSC) was placed avoiding air 
bubbles between them. Additional layers of Whatman paper (pre-soaked in 20 x SSC) were 
placed above as well as a thick layer of dry paper towels on top on which a heavy bottle was 
placed. After overnight blotting, the membrane was treated for 1 min with 0.4 N NaOH and then 
with 0.2 M Tris-HCl (pH 7.5). After drying, the DNA was fixed on the membrane by UV-light. 
 43 
Blotting of high molecular weight DNA fragments from PFGE was carried out by vacuum 
blotting. A nylon membrane (Biodyne B) of appropriate size was shortly preincubated in dH2O 
and then soaked for 10 min in 20 × SSC. Afterwards, DNA was transferred from an agarose gel 
to the membrane using a vacuum blotter (Amersham-Pharmacia) by applying a 50 mbar vacuum. 
DNA transfer from a pulsed-field gel required UV irradiation (for fragmentation of the high 
molecular weight DNA). The gel was then pre-treated as described for the capillary blot. After 
this pre-treatment, the gel was covered with 20 x SSC solution and was subjected to a 50 mbar 
vacuum for 2 h. After DNA transfer, the nylon membrane was incubated for 1 min in 0.4 N 
NaOH and 1 min in 0.25 M Tris-HCl, pH 7.5 (for neutralisation). The membrane was then 
shortly dried and the DNA was fixed on the membrane by exposure to UV light. 
 
20x SSC 
NaCl   175.3 g  
Na-citrate  88.2 g  
H2O   add to 1000 ml 
    
6.15.1 Hybridisation of a labelled DNA probe to a nylon membrane (”ECL™ kit“, GE 
Health care/Amersham Biosciences Europe) 
To detect a DNA fragment of interest among all the DNA fragments blotted on the nylon 
membrane, a peroxidase-labelled DNA probe was hybridised to the denatured DNA blotted on 
the membrane. For this purpose, the membrane was rinsed in 2 x SSC for 10 minutes and then 
placed into a hybridisation tube that contained 10 ml ECL blocking reagent. For one hour, the 
membrane was incubated at 42 ºC. For the labelling with horseradish peroxidase, a sample of a 
suitable DNA fragment was denaturated (5 min at 95 ºC), and then cooled on ice (5 min). 
Consecutively, corresponding volumes of labelling reagent and glutaraldehyde solution were 
added and carefully mixed with the DNA. This mixture was incubated for 10 minutes at 37 ºC. 
The labelled DNA probe was added to the hybridisation tube containing the membrane and the 
blocking reagent, and was incubated O/N or for at least 4 hours at 42 °C.  
After hybridisation, the membrane was washed twice for 20 minutes in wash solution (0.5 x SSC, 
0.4 % SDS). After washing the membrane with 2 x SSC solution, the membrane was incubated in 
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Blotting of high molecular weight DNA fragments from PFGE was carried out by vacuum 
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20x SSC 
NaCl   175.3 g  
Na-citrate  88.2 g  
H2O   add to 1000 ml 
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membrane was removed from this solution, shortly dried, packed in saran wrap, and exposed for 
a suitable time period to the hyperfilm-ECL. The hyperfilm was subsequently developed. 
  
6.16 Colony blot 
For screening a cosmid library, the colony blot technique was used where single colonies were 
transferred from agar plates to a nylon membrane (Pall Biodyne B, 0,45 µm). The bacterial cells 
were lysed and the DNA was denaturated by incubating the membranes (with the colonies on the 
upper side) for 5 min on a Whatman filter paper saturated with solution 1 (see section 6.15). After 
short drying, the membranes were laid on Whatman filter paper saturated with neutralisation 
solution 2 (see section 6.15) for 5 min. The DNA was fixed at 80 °C for 30 min, and afterwards 
the membranes were incubated in solution 3 for 6-12 h at 37 °C. After removal of the cell debris 
for 1 min in 2 × SSC the colony blots were ready for hybridisation as described before.  
 
6.17 Mutagenesis 
For the construction of bacterial mutants two different approaches have been used. One of them 
is based on the the pCVD442 suicide vector and allelic exchange (Donnenberg et al., 1991) while 
the other took advantage of the use lambda Red integrase system that can mediate site-specific 
integration of linear DNA fragments into the chromosome (Datsenko and Wanner, 2000). 
6.17.1 Allelic exchange using the pCVD442 suicide vector 
This method is based on the integration of a DNA construct consisting of the inactivated gene of 
interest and its flanking regions (~1 kb up- and downstream region) in the suicide vector 
pCVD442. This plasmid, that contains the π protein-dependent origin of replication (oriR6K), 
can only replicate in pir-positive E. coli strains such as strains SY327λpir and Sm10λpir. 
Transfer by conjugation from donor strain Sm10λpir into a non-pir recipient (like, e.g. strain 
536) results chromosomal integration or loss of the suicide plasmid as the π protein required for 
plasmid replication is not expressed in this strain. Chromosomal insertion in strain 536 can only 
occur via homologous recombination between the up- and downstream regions of the inactivated 
gene construct located on the plasmid and their homologous sequences within the chromosome 
thereby exchanging the functional chromosomal gene by the inactivated copy introduced on the 
suicide plasmid. Selection for chromosomal suicide plasmid insertion is based on antibiotic 
resistances encoded on the suicide plasmid or on the host chromosome. Suitable candidate clones 
resistant to ampicillin and streptomycin were incubated for two 12 h periods without selective 
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pressure at 37 ºC in order to allow for allelic exchange and the loss of the suicide plasmid 
backbone. Selection for mutant candidates was done on agar plates supplemented with suitable 
antibiotics and 5 % (w/v) sucrose plates at room temperature. If the suicide vector backbone has 
not been lost, the cells cannot grow on sucrose because the pCVD442-encoded SacB laevan 
sucrase transforms sucrose to the polymer laevan which is toxic for E. coli. Selected mutants 
were checked by PCR and Southern-blot.   
 
6.17.2 Gene inactivation by lambda Red recombinase-mediated site-specific insertion of 
linear DNA fragments (Datsenko and Wanner, 2000) 
The lambda Red recombinase-expressing plasmid pKD46 was electroporated into UPEC strain 
536. The overnight culture (grown at 30 °C) of this strain was used as a starter culture and was 
diluted 1:100 in 50 ml LBAmp medium. For induction of the lambda Red recombinase expression, 
20 mmol L-arabinose was added to the medium and the culture was grown at 30 ºC till it reached 
OD600 0.6. For better induction –because, strain 536 metabolizes L-Arabinose-, at this cell 
density, additional 10 mmol L-arabinose was added to the culture. It was placed on 30 °C to 
incubate. After 20 minutes cells were harvested (5,000 rpm, 5 min) and washed twice with 50 ml 
and with 20 ml ice-cold sterile water, respectively. Then, the cells were washed in 5 ml ice-cold 
10 % (v/v) glycerol/water solution. The pellet was afterwards resuspended in 150 µl 10 % (v/v) 
glycerol/water solution. 50 µl aliquots were directly used for electroporation (10 kVs/cm; 600 
Ohm; 0.25 F) with the purified suitable linear DNA fragments usually generated by PCR with 
specific primers whose 5' ends were homologous to the priming sites 1 and 2 of the plasmids 
pKD3 or pKD4. The 3' ends of the primers used were homologous to the flanking region of the 
genes to be inactivated. PCR with these primers using pKD3 or pKD4 as template DNA resulted 
in amplification of PCR products that consisted of an antibiotic resistance marker flanked by two 
FRT sites. The extreme 5'- and 3'-ends of the PCR products represented the homologous 
sequences required for site-specific integration of the DNA fragment into the chromosome. The 
FRT sites facilitated later the elimination of the resistance marker genes with the help of the 
pCP20 plasmid. After electroporation cells were incubated in 1 ml LB for 1.5 hours at 30 ºC. For 
recombination cells were left O/N at 20 ºC temperature and then plated on selective plates. Cm- 
and Km-resistant recombinant candidates were selected and tested by PCR and Southern blot 
analysis. 
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6.17.3 Integration of genes into the λ attachment site 
In order to complement bacterial mutants with a single copy gene, the gene of interest can be 
inserted into the host chromosome. For this purpose the system that was described by Diederich 
and coworkers (1992) was used, which allowed the integration of any DNA fragment into the 
bacteriophage λ attachment site attB of the E. coli chromosome. The corresponding gene (that 
must not contain a NotI restriction site) was cloned into one of the plasmids pLDR9, 10, or 11. 
They differ only in their resistance markers (Km, Cm, Tet) and as the result of this in their 
restriction pattern. After ligation, the plasmid was cut with NotI and the two fragments were 
separated. The fragment containing the gene of interest, the attP site and a bla gene, but no the 
origin of replication was religated. After ligation, the circularised fragment was transformed into 
the recipient strain that contained the helper plasmid pLDR8 (KmR) coding for a λ integrase that 
catalyses the recombinaiton between the attP and the attB site thereby inserting the gene of 
interest into the chromosome. The temperature–sensitive replicon of this plasmid allows 
replication at 30 ºC. Competent cells were prepared from an O/N culture grown at 30 °C that was 
then diluted 1:20, and incubated for 90 minutes at 37 ºC to partially de-repress the temperature-
dependent λ PR promoter that directs expression of the int gene to achieve a basic level of Int 
protein in the cell. Upon transformation, these competent cells were incubated O/N at 42 ºC on 
ampicillin plates in order to further induce int expression and to inhibit replication of pLDR8. 
Ampicillin-resistant clones were checked by PCR (primers ATT1 and ATT2) and by Southern 
blot analysis for correct chromosomal complementation with a single copy gene. 
 
6.18 Sequence analysis 
The nucleotide sequence of DNA inserts cloned into BACs, cosmids or plasmids was determined 
from both ends using dye terminator chemistry. For a final reaction volume of 10 µl 4 µl 
“Premix” and 10 pmol primers were used. The concentration of the DNA template varied 
between 0.1-1 µg depending on the quality and the source (cosmid, plasmid, or PCR product). 
The sequencing reaction includes the following steps: The DNA was initially denaturated at 95 
ºC for 2 minutes and then for 30 sec as the first step of every reaction cycle. Annealing (30 sec) 
of the primer was carried out at a temperature depending on the primer while the elongation step 
was carried out at 45 to 60 ºC for 4 min. This reaction cycle was repeated 25-35 times. After the 
PCR, the DNA was precipitated with pure absolute ethanol and was washed with 70 % ethanol. 
The PCR product was dried in a speed vac, and resuspended in 20 µl Hi-Di formamide. 
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Large scale sequence determination of the three cosmid clones (pCos6b38, pCos24/23, 
pCos25/52) was carried out at the Göttingen Genomics Laboratory. For this purpose, small insert 
libraries (2-2.5 kb) were generated by mechanical shearing of DNA (Oefner et al., 1996). After 
end repair with T4 polymerase, the fragments were ligated into the prepared pTZ19R vector. 
Isolated plasmids were sequenced from both ends using the dye terminator chemistry and 
analyzed on ABI337 sequencers (Applied Biosystems). The Phrap software implemented in the 
Staden software package was used for assembly and editing of the sequence data (Staden et al., 
2000). 
Homology searches as well as searches for conserved protein domains were performed with the 
BLASTN, BLASTX and PSI- and PHI-BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) 
programs of the National Center for Biotechnology Information (NCBI) (Altschul et al., 1997). 
Putative ORFs were identified using Vector NTI® (InforMax) and the NCBI ORF finder 
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html) softwares. Prediction of membrane spanning 
regions of proteins was carried out with the TMpred software 
(http://www.ch.embnet.org/software/TMPRED_form.html). The sequences were submitted to the 
EMBL nucleotide sequence database. 
 
 
6.19 RNA methods 
6.19.1 Total cell RNA isolation 
In order to quantify transcript levels of the genes of interest, total RNA was isolated and analysed 
by RT-PCR and Northern Blots. 
Working with RNA requires a ”nuclease free environment“. All steps were carried out with 
gloves. All the surfaces were cleaned with absolute ethanol before work and all the solutions used 
were prepared with 0.1 % (v/v) DEPC (diethyl pyrocarbonate) water. 1 ml DEPC was added to1 
liter water, vigorously shaken and then placed O/N at 37 ºC to inacticvate RNases. The next day, 
the DEPC-treated water was autoclaved and then ready to use. RNases can also be inactivated by 
the addition of 0.1 M NaOH; 1 M EDTA or chloroform.  
 
6.19.2 Small quantity RNA isolation (Qiagen RNeasy kit) 
2 ml of a bacterial culture (OD600=1) were centrifuged (4 min, 5.000 rpm). The pellet was 
suspended and then vortexed in 100 µl TE buffer containing lysozyme (400 µg/ml). After 
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incubation for 5 min at room temperature, 350 µl RLT buffer were added. The sample was 
vortexed and then centrifuged for 2 minutes at 13.000 rpm. The supernatant was transferred to a 
new tube and suspended with 250 µl absolute ethanol. This mixture was pipetted into a RNeasy 
mini column and centrifuged for 15 sec, (13,000 rpm). The cloumn was washed with 700 µl RW1 
buffer and then with 500 µl RPE buffer (15 sec, 13.000 rpm). The column was washed a third 
time with RPE buffer (2 min, 13,000 rpm). The RNA was eluted from the column by addition of 
30 µl water for two minutes, and centrifuged (1 min, 13,000 rpm). 
 
6.19.3 Large quantity RNA isolation 
Large quantities of total RNA were extracted from 10 ml cultures that were immediately poured 
on equal volume of -80 °C cold crushed ice. The bacterial cells were spun down at 4 °C for 15 
min (6,000 rpm). The pellet was resuspended in 0.6 ml of ice-cold buffer (10 mM KCl, 5 mM 
MgCl2, 10 mM Tris; pH 7.4) and then immediately added to 0.6 ml of hot lysis buffer (0.4 M 
NaCl, 40 ml EDTA, 1 % sodium dodecyl sulfate) to which 1 % (v/v) β-mercaptoethanol and 100 
µl of water-saturated phenol were added immediately before. This mixture was incubated at 100 
°C for 40 seconds. Cell debris was removed by centrifugation (10 min, 13,000 rpm) and the 
supernatant was extracted five times with (1:1, v/v) phenol-chloroform solution. RNA was 
precipitated with ethanol, washed and dried. The dried pellet was dissolved in sterile DEPC-
treated water. 
 
6.20 Reverse Transcription PCR (RT-PCR) 
For the Reverse Transcription PCR (RT-PCR) 15 µg of the total RNA preparation was digested 
with 0.5 units / µl of Rnase-free DNase I (Roche, Germany) for 1 hour at 37 °C to eliminate 
traces of DNA. The 100 µl DNA-free total RNA solution was mixed with 350 µl RLT buffer 
(Qiagen, Germany) and 250 µl absolute ethanol and subsequently transferred to a RNeasy spin 
column. This column was centrifuged (15 sec, 10.000 rpm) and washed with 500 µl RPE buffer. 
After a second centrifugation –to get rid of the RPE remnants- the purified RNA was eluted wit 
30 µl water. For reverse transcription, 2-5 µg RNA was mixed with 3 µg of random primers 
(Amersham Biosciences, Freiburg) and then denaturated for 10 minutes at 70°C. After cooling 
down on ice, cDNA synthesis was performed with the Super Script II RNase H- Reverse 
Transcriptase (Invitrogen) system at 46°C. After 1 hour, the reaction was stopped by alkaline 
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hydrolysis of the RNA with 0.25 M NaOH (15 min, 65 °C). The pH was restored by addition of 
50 mM Tris-HCl, pH 7.5. The cDNA was purified with QIAquick Gel Extraction Kit PCR 
purification kit (Hilden, Germany) and amplified by PCR with specific primers. Isolated total 
RNA (that still contained DNA traces) served as a positive control, whereas the same preparation 
after DNAse digestion was used as a negative control. 
 
6.21 Gel electrophoresis of RNA 
RNA was separated on 1.2 % (w/v) agarose gels to which MOPS buffer and formaldehyde were 
added after cooling of the agarose solution to 55 °C. After solidification, the gel was placed in an 
electrophoresis chamber floated with 1x MOPS buffer. Before electrophoresis, the RNA samples 
(10 µg of the RNA sample was diluted in 40 µl DEPC-treated H2O to which 10 µl 5x RNA 
loading buffer was added) were denatured by heating to 65 ºC for 5 minutes. The samples were 
then cooled on ice. The RNA marker was also treated under identical conditions. Electrophoresis 
was carried out for 2 hours at 120 V. The gel was washed in water for half an hour in order to 
remove remaining formaldehde and then stained in ethidium bromide solution.  
 
RNA gel      10x MOPS 
Agarose  1.3 g    MOPS   41.8 g 
10 x MOPS buffer 100 ml    H2O   800 ml 
cooling down at 60 ºC    pH 7  (with 10 N NaOH) 
10x MOPS  11.4 ml   Na-acetate (3 M) 16.6 ml 
37 % Formaldehyde 3.5 ml    EDTA (0.5 M) 20 ml 
       pH 7 and filtration! 
 
6.22 Northern blot analysis 
After staining, the separated RNA fragments can be transferred to a nylon membrane as described 
before. The detection of transcripts of interest is carried out as described for Southern blot 
analysis under 6.15.1. 
 
6.23 Isolation of LPS 
The cells from 1 ml overnight culture were collected by centrifugation and treated as described 
for the isolation of genomic DNA in section 6.2 (Grimberg et al., 1989). After incubation with 
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was carried out for 2 hours at 120 V. The gel was washed in water for half an hour in order to 
remove remaining formaldehde and then stained in ethidium bromide solution.  
 
RNA gel      10x MOPS 
Agarose  1.3 g    MOPS   41.8 g 
10 x MOPS buffer 100 ml    H2O   800 ml 
cooling down at 60 ºC    pH 7  (with 10 N NaOH) 
10x MOPS  11.4 ml   Na-acetate (3 M) 16.6 ml 
37 % Formaldehyde 3.5 ml    EDTA (0.5 M) 20 ml 
       pH 7 and filtration! 
 
6.22 Northern blot analysis 
After staining, the separated RNA fragments can be transferred to a nylon membrane as described 
before. The detection of transcripts of interest is carried out as described for Southern blot 
analysis under 6.15.1. 
 
6.23 Isolation of LPS 
The cells from 1 ml overnight culture were collected by centrifugation and treated as described 
for the isolation of genomic DNA in section 6.2 (Grimberg et al., 1989). After incubation with 
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proteinase K, 600 µl phenol were added to the clear solution, then it was carefully mixed and 
centrifuged for 10 min (13,000 rpm). The supernatant was transferred to a new tube and 20-50 µl 
were used for electrophoresis. 
 
6.24 Polyacrylamide gel electrophoresis (PAGE, Laemmli et al., 1970) 
Protein or LPS samples were separated and analysed on polyacrylamide gels. The size of the gels 
was 15 × 17.5 × 0.5 cm, and the electrophoresis was performed overnight at RT and 30 V. The 
samples were loaded on top of the “collecting gel” after heating for 10 min at 90°C in 4 × loading 
buffer. 
 
Separation gel (13 % (w/v)) 
30 % acrylamide, 0.8 % bisacrylamide 13 ml 
1.5 M Tris-HCl, pH 8.8   7.3 ml 
dH2O         9 ml 
10 % SDS     300 µl 
APS (100 mg/ml)    150 µl 
TEMED       10 µl 
 
Collecting gel (5 % (w/v)) 
30 % acrylamide, 0.8 % bisacrylamide 2.7 ml 
1.5 M Tris-HCl, pH 8.8      4 ml 
dH2O         9 ml 
10 % SDS     160 µl 
APS (100 mg/ml)    160 µl 
TEMED        8 µl 
 
10 × Electrophoresis buffer 
Tris         30 g 
Glycine     144.4 g 
10 % SDS     100 ml 
dH2O to a final volume of   1000 ml 
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4 × Loading buffer 
0.25 M Tris-HCl, pH 6.4   2.5 ml 
SDS      0.25 g 
EDTA         4 mg 
86 % (v/v) Glycerin       4 ml 
β-Mercaptoethanol    0.5 ml 
Bromphenol blue    0.4 mg 
dH2O to a final volume of     10 ml 
 
 
6.25 Staining of LPS in polyacrylamide gels with silver nitrate (Tsai et al., 1982) 
After electrophoresis, the polyacrylamide gels were stained with AgNO3. All used devices were 
carefully washed with 70 % (v/v) ethanol. The gels were fixed overnight in 100 ml 1 × fixation 
solution. Next day, the solution was replaced by 100 ml 1 × periodate solution and the gels were 
incubated for 5 min. After that, the gels were washed three times for 30 min with dH2O. Then, 
the gels were incubated for 10 min in silver nitrate solution and subsequently washed three times 
for 10 min with dH2O. The gels were developed in developing solution preheated to 60 °C, and 
when the colour intensity of the stained bands was appropriate, the reaction was stopped by 
washing with 50 mM EDTA solution for 10 min. 
 
2 × fixation solution     Periodate solution  
Isopropanol   250 ml   Na-periodate (NaIO4) 0.87 g 
Acetic acid    70 ml   1 × fixation solution  100 ml 
dH2O to final volume of 500 ml 
 
Silver nitrate solution     Developing solution 
1 M NaOH  1.4 ml    2.5 % (w/v) Na2CO3  100 ml 
NH3 (33 %)     1 ml    40 %  (v/v) Formaldehyde   27 µl 
dH2O    70 ml 
20 % (w/v) AgNO3 1.25 ml 
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Immuno techniques 
6.26 Production of a polyclonal antiserum against the K15 capsule antigen  
A K15 capsule-specific serum was produced according to the protocol described by Kiesewalter 
and Seltmann (1968). Briefly, O/N culture of bacteria (the E. coli strain 536) was washed and 
incubated overnight in 50 % (v/v) ethanol at 4 °C to denature protein antigens. After washing, 
bacteria were diluted to 2 x 108 CFU/ml in phosphate-buffered saline (PBS). Rabbits were 
immunized with 0.2; 0.5; 1.0; and twice 2.0 ml of bacterial suspensions in 4-day intervals. Four 
days following the last inoculation, test sera was taken and their titres were tested by tube 
agglutination. Afterwards, the rabbits were sacrificed and their sera were collected and diluted 
1:10 in sterile saline containing 0.3 % (v/v) phenol as a preservative. Removal of non-specific 
antibodies was achieved by absorption with live and boiled cells of uropathogenic E. coli strain 
RZ532 (O6:K+:H31) which does not express a K15 capsule. For this, a 0.5 g aliquot of wet E. coli 
strain RZ532 cells was suspended in 1 ml of the diluted serum and this suspension was incubated 
for 1 h at 37 °C and overnight at 4 °C. Next day, the cells were pelleted, resuspended in saline, 
and boiled for 1 h. Following centrifugation, the pellet was resuspended in the same serum and 
the suspension was incubated again for 1 h at 37 °C and subsequently overnight at 4 °C. After 
centrifugation, aliquots of the serum were stored at –20 °C. By this procedure, the serum became 
free of any immunoreactive antibodies except those against the K15 capsule antigen. This was 
confirmed by an enzyme-linked immunoabsorbent assay (ELISA). 
 
6.27 Enzyme-linked immunoabsorbent assay (ELISA) 
96-well plates (C.E.B., France) were coated overnight with 0.2 ml of bacterial suspension (109 
CFU/ml in coating buffer) at 4 ºC. The following day, the plates were washed with PBS + 0.5 % 
Tween20 (washing puffer), and then blocked with PBS containing 2 % (w/v) bovine serum 
albumin (BSA) for 1h at 37 ºC. The K15-specific serum was diluted in PBS + 0.5 % BSA and 
pipetted into the antigen-coated 96-well plates. After incubation for 90 min the plates were 
washed three times with the washing buffer. The bound K15-specific antibodies were detected 
with a commercial anti-rabbit immunoglobulin conjugated with horseradish peroxidase (HRPO) 
(Dako A/S, Denmark). The ELISA substrate was ortho-phenylenediamin (Sigma) dissolved in 
citric acid buffer containing 3 % H2O2. Optical density was measured at 490 nm in a conventional 
ELISA plate reader. Duplicates were used for each strain and dilution, and assays were repeated 
twice. 
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6.28 Immunofluorescence microscopy 
1 ml bacterial O/N culture was washed once and the cells were resuspended in water. 20 µl of 
this suspension was dropped on a glass slide. After drying (37 ºC for 20 min) a 1:4 dilution of 
absorbed K15-specific antiserum was added. After 1 hour incubation at 37 ºC, the glass slide was 
carefully washed twice by dipping it into PBS for ten seconds. Texas red-labelled anti-rabbit IgG 
(Dianova, Hamburg) was added and the slide was again incubated for 1 hour at 37 ºC. After 
incubation, the slide was washed again in PBS (two times for ten seconds) and the Texas red-
labelled anti-IgG antibody that bound the K15-specifc antibodies was observed by 
epifluorescence microscopy. To excitate the dye, the wavelength 596 nm was used (emission 
wavelength is 620 nm).  
 
6.29 Serum resistance assay 
O/N culture of bacteria grown in LB medium was washed with saline and diluted to 106/ml cells. 
100 µl aliquots of the cell suspension were mixed with an equal volume of fresh normal (no 
bacterial infection, and no antibiotics taken recently) human serum and incubated at 37 ºC for 4 
hours in microtiter plates. Samples were taken at 0 h, 0.5 h, 1 h, 2 h, 3 h, and 4 h time points. 10 
µl from each sample was taken out and diluted 100x in saline in Eppendorf tubes. The number of 
viable cells was determined by plating onto LB plates following an overnight incubation at 37 ºC. 
In addition, serum resistance assays were performed with heat-inactivated (56 ºC for 30 min) 
serum as a negative control. Three samples of every bacterial strain were analyzed and the assays 
were performed in triplicates. 
 
In vivo virulence assays 
6.30 Ascending urinary tract model 
In order to study the virulence of E. coli strain 536 and its derivatives, intravesical infection of 2-
3-day old suckling CFLP mice (Gödöllö, Hungary) were performed. Bacteria were grown 
overnight at 37 ºC in LB medium and then harvested by centrifugation, washed once and 
normalized to the required inoculum density (107/ml) in PBS. 0.025 ml of this bacterial 
suspension containing 0.05 % Pontamin Sky Blue dye (Searle Pharmaceuticas, High Wybcombe) 
were infected into the bladder directly through the abdominal wall. The stain, which has no toxic 
or antibacterial effect served as an indicator of successful inoculation. For every strain 6-14 infant 
 53 
 
6.28 Immunofluorescence microscopy 
1 ml bacterial O/N culture was washed once and the cells were resuspended in water. 20 µl of 
this suspension was dropped on a glass slide. After drying (37 ºC for 20 min) a 1:4 dilution of 
absorbed K15-specific antiserum was added. After 1 hour incubation at 37 ºC, the glass slide was 
carefully washed twice by dipping it into PBS for ten seconds. Texas red-labelled anti-rabbit IgG 
(Dianova, Hamburg) was added and the slide was again incubated for 1 hour at 37 ºC. After 
incubation, the slide was washed again in PBS (two times for ten seconds) and the Texas red-
labelled anti-IgG antibody that bound the K15-specifc antibodies was observed by 
epifluorescence microscopy. To excitate the dye, the wavelength 596 nm was used (emission 
wavelength is 620 nm).  
 
6.29 Serum resistance assay 
O/N culture of bacteria grown in LB medium was washed with saline and diluted to 106/ml cells. 
100 µl aliquots of the cell suspension were mixed with an equal volume of fresh normal (no 
bacterial infection, and no antibiotics taken recently) human serum and incubated at 37 ºC for 4 
hours in microtiter plates. Samples were taken at 0 h, 0.5 h, 1 h, 2 h, 3 h, and 4 h time points. 10 
µl from each sample was taken out and diluted 100x in saline in Eppendorf tubes. The number of 
viable cells was determined by plating onto LB plates following an overnight incubation at 37 ºC. 
In addition, serum resistance assays were performed with heat-inactivated (56 ºC for 30 min) 
serum as a negative control. Three samples of every bacterial strain were analyzed and the assays 
were performed in triplicates. 
 
In vivo virulence assays 
6.30 Ascending urinary tract model 
In order to study the virulence of E. coli strain 536 and its derivatives, intravesical infection of 2-
3-day old suckling CFLP mice (Gödöllö, Hungary) were performed. Bacteria were grown 
overnight at 37 ºC in LB medium and then harvested by centrifugation, washed once and 
normalized to the required inoculum density (107/ml) in PBS. 0.025 ml of this bacterial 
suspension containing 0.05 % Pontamin Sky Blue dye (Searle Pharmaceuticas, High Wybcombe) 
were infected into the bladder directly through the abdominal wall. The stain, which has no toxic 
or antibacterial effect served as an indicator of successful inoculation. For every strain 6-14 infant 
 54 
mice were intravesically infected and the assays were repeated four times. Mice that survived 
infection, were sacrificed 21 days post-infection. The bladder and both kidneys were removed, 
homogenized in PBS, and aliquots were plated onto agar plates containing a selective antibiotic. 
Colonies were counted after overnight incubation. Additionally, bacterial counts were determined 
from the urine and blood samples.  
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1 Analysis of the fifth PAI of the UPEC strain 536 
Genomic differences between the UPEC strain 536 and the non-pathogenic E. coli strain 
MG1655 were previously identified by suppression subtractive hybridisation (SSH) (Janke et al., 
2001). Altogether, 22 SSH-fragments were found that showed homology to already known strain 
536-specific genes or that represented novel genes that were only present in strain 536 but that 
had not been characterised before. One of these fragments showed similarity to a capsule export 
protein encoding gene, kpsC, of an E. coli K10 strain (GenBank accession no. AF127177).  
The fact that capsule gene clusters are often mapped near the tRNA genes serA (Orskov and 
Nyman, 1974; Orskov et al., 1976) or pheV (Swenson et al., 1996; Welch et al., 2002) and that 
PAIs are also frequently associated with tRNA-encoding genes suggested that a fifth PAI of the 
UPEC strain 536 (PAI V536) might have been found. A cosmid library was used to verify this 
hypothesis and to map the genetic structure of the hypothetical PAI and the downstream 
sequences. 
With a kpsCK10 specific probe a cosmid clone (pCos6b38) was isolated and sequenced. Sequence 
analysis of this 41,565 bp- cosmid clone is summarised in the thesis of Janke (2000). It revealed 
that also in E. coli 536, capsule genes are located close to a 5’ deleted pheV. In this work, 
junction cosmids of pCos6b38 were identified to further characterise the novel PAI of 536 and to 
define the borders of the 536 specific DNA region. 
 
1.1 Mapping of PAI V536 and its flanking regions by overlapping cosmid clones 
1.1.1 Cosmids that overlap the right side of pCos6b38 
By using specific DNA probes to both ends of pCos6b38, the genomic cosmid library was 
screened for overlapping cosmid clones. Primers Genrev 6buni and Genrev 6brev were used to 
amplify a 275 bp-product located at the right end of pCos6b38 where kpsC is located. Five clones 
(pCos5/52, pCos8/55, pCos8/75, pCos22/76 and pCos24/23) that contained the right end of 
pCos6b38 (as was confirmed by the screening PCR and by colony hybridisation) were further 
analysed for their degree of overlap by determining the sequence of their ends with primers 
SuperCos uni and SuperCos rev (Table 2).  
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Table 2: Sequence analysis of the ends of cosmid clones that overlap with pCos6b38. 
 Homology of the sequences obtained 
 Forward primer Reverse primer 
pCos5/52 hypothetical amino transferase K-12 genome, position 71435-71317, 
minutes 65-68 
pCos8/55 kpsD K-12 genome, position 73270-73150, 
minutes 65-68 
pCos8/75 K-12 genome, position 77250-76447, 
minutes 65-68 
kpsF 
pCos22/76 K-12 genome, position 81947-81823, 
minutes 65-68 
kpsC 
pCos24/23 No homology No homology 
pCos6b38 No homology K-12 genome, position 37653-37748, 
minutes 84.5-86.5 
  
According to these results and by comparison of the restriction pattern of an EcoRI digest, the 
relative orientation of the five cosmids to pCos6b38 and to each other was determined (Fig. 4). 
Sequence analysis of four cosmids had revealed homology to the region of 65-68 minutes of the 
E. coli K-12 chromosomal map. The fact that the tRNA gene pheV is located at 64 minutes 
(position 64,760 to 64,835) further supported our hypothesis that a new PAI was found that was 
associated with pheV of the UPEC strain 536. 
 
Fig. 4: Relative orientation of the five candidate cosmid clones to pCos6b38. The left side of the 
figure shows the relative position of the cosmid clones. Below, the orientation and order of 
kps genes as determined from the sequence analysis of pCos6b38 are also depicted. On the 
right side, the EcoRI restriction patterns of the candidate clones (pCos1/44 is included as a 
negative control that does not contain kps genes)) are shown. F: sequenced with primer 
SuperCos uni; R: sequenced with SuperCos rev. 
CK10 pCos6b38 
     kps   F  E   D  U  C‘K5   S       
R F 
pCos8/55   F 
pCos8/75   R
pCos22/76   R
Structure of the 
kps locus in strain 536 as 
later was revealed 
Candidate 
clones 
with homologies 
R 
F 
F 
pCos24/23   F 
pCos5/52   F R 
R 
10k
1k
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1.1.2 Conserved components of a capsule locus (kpsM and kpsT) are present on the 
cosmids that overlap pCos6b38 
The sequence analysis of pCos6b38 had revealed that downstream of a 'pheV gene, the right end 
of this cosmid contains the genes of the conserved regions of group 2 and 3 capsules (thesis of 
Janke, 2000, see also below). Although this capsule locus showed similarity to the capsule 
determinants of both group 2 and 3, it also showed a novel structure that had not been described 
before. Nevertheless, for a functional capsule transport machinery two additional conserved 
genes kpsM and kpsT were missing. To verify the presence of these two conserved transporter 
genes on the chromosome of strain 536, primers were designed based on the known sequences of 
genes kpsM and kpsT from K5 and K10 capsule types that are the best studied representatives of 
group 2 and group 3 capsules, respectively (Fig. 1). PCRs with these primers were performed 
with strain 536 DNA, and with the six cosmid clones containing the capsule gene cluster of strain 
536. Additionally, probes for Southern hybridisations were amplified from K5 and K10 strains, 
respectively. With the exception of pCos6b38, similar results were obtained for E. coli 536 and 
the tested cosmid clones (Table 3). 
 
Table 3: Presence of K5-specific kpsM and kpsT genes on the chromosome of strain 536 
 
 kpsT kpsM 
K5 specific PCR - - 
K5 specific Southern blot + + 
K10 specific PCR - - 
K10 specific Southern blot - - 
 
We could gain two pieces of information from these results: (i) The two missing conserved genes 
that were necessary for the capsule transport through the bacterial inner membrane were present 
on the overlapping cosmid clones. This suggested that we had identified a functional capsule 
determinant of strain 536. (ii) Southern blot experiments showed that kpsT and kpsM of strain 
536 were different from that of the K10 capsule type, but both of them were similar to the 
representatives of K5, which belongs to the group 2 capsules. However, no product was amplified 
with K5 specific primers suggesting that sequence differences prevented successful binding of 
the oligonucleotides.  
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1.1.3 Identification of pCos24/23 as the cosmid covering the most 3’ end of PAI V536 and 
its flanking regions  
Hybridisation with the K5-specific kpsM and kpsT probes to the digested 5 candidate cosmid 
clones revealed that all of them contain these capsule component transport genes. To determine 
their exact location relative to the conserved genes that were already known from the sequence 
analysis of pCos6b38, and to find the K15-specific variable region (Region 2) a suitable cosmid 
clone for further sequence determination had to be identified. The analysis of the cosmid ends 
revealed that four of them were identical to a region of the core chromosome of E. coli K-12 
strain MG1655 encoding a putative general secretion pathway (position 71,000 to 82,000) (Table 
4). Assuming that the novel PAI was inserted at the 3‘ end of pheV (~ position 65,000) we 
calculated a nearly 25 kb insertion between pheV ('pheV) and the secretion pathway genes. On 
average, cosmid vectors carry inserts of about 40 kb. Only one cosmid (pCos24/23) showed no 
homology to any known E. coli gene at its ends. To unravel whether this region was also present 
on the other four cosmids (e.g. between capsule genes and the secretion pathway genes) or 
whether the insert of pCos24/23 was larger thereby covering another possible integration in the  
 
Fig. 5: Sequence analysis of the non-overlapping ends of the five cosmid clones revealed 
homology to downstream sequences of pheV and also suggested integrated 536 specific 
elements (represented by reversed triangles) into the K-12 backbone. The kps locus was 
suggested to be nearly 25 kb, downstream of it the genes of a general secretion pathway 
were present and analysis of the reverse end of pCos24/23 revealed an additional 
integration into the chromosome of strain 536. (Standing green triangles represent the other ends of 
those cosmids that are overlapping with pCos6b38 on one end. The numbers under the names of each cosmid 
and pheV represent the sequence homology relative to the chromosomal position of MG1655.)  
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core chromosome, we sequenced all cosmids with two primers. One of them corresponded to the 
end of pCos5/52 (Fig. 5) and the other to the end of pCos24/23. All five cosmids contained the 
pCos5/52-specific part, but only pCos24/23 could be sequenced with its specific primer. This 
result strongly supported that the best candidate for a more thorough sequence analysis to reveal 
the exact structure of a new PAI-associated capsule locus and the downstream sequences, was the 
cosmid pCos24/23. Determination of its nucleotide sequence was performed in collaboration with 
G. Gottschalk’s group at the University of Göttingen. 
 
1.1.4 A 7 kb-region is inserted downstream of the general secretion pathway locus in E. 
coli strain 536 
As discussed above, the ‘right’ end of pCos24/23 had no homology to any known sequence at the 
nucleotide level. Only some weak homology to a saframycin Mx1 synthase B from a Myxococcus 
species (T18551) was detected on the protein level. Continuing to sequence this cosmid with the 
primer Safrev, 1,400 bp upstream of the right end we found similarity to the gene b2981. This is 
one member of the general secretion pathway locus which is present in E. coli strain MG1655 
and this is the region where the inserts of the other 4 cosmids (that overlapped pCos6b38) ended 
(Figure 5). During the construction of gene libraries, false assemblies of Sau3A I fragments can 
sometimes occur. Therefore, it had to be verified whether the insert of pCos24/23 corresponds to 
the real chromosomal structure of strain 536. To rule out the possibility of an insertion of a 
Sau3A I fragment downstream of the general secretion pathway gene cluster, the right end of 
pCos24/23 was checked for recognition sites of Sau3A I, but none was found. Additionally, a 
PCR was carried out with primers b2981fw and Safrev that connected b2981 and the putative 
saframycin Mx1 synthase B gene. A product of the expected size was amplified with E. coli 536 
as a template, indicating that downstream of the general secretion pathway genes, an insertion is 
present in strain 536 that was further investigated.  
To determine the size of this integration we screened the 536 genomic library for cosmids 
overlapping with pCos24/23 by the above described PCR (b2981 and Safrev). Altogether, six 
cosmid clones (pCos1/33, pCos2/13, pCos9/11, pCos9/47, pCos11/62 and pCos21/63) were 
found to be positive for this probe. Sequence analysis of the ends of these cosmids revealed that 
downstream of the general secretion pathway genes, an about 7-kb insertion seemed to be 
present. Furthermore, it indicated that the major part of the six new cosmids were E. coli K-12 
sequences that were already known from the database. Overlapping primer pairs were used to 
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reveal if all of the known genes from this part of the strain MG1655 chromosome were present or 
some might have been deleted (Figure 6). With these primers, PCRs were carried out with strain 
536, pCos2/13 and K-12. Strain 536 and pCos2/13 yielded the same results. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 6: Overlapping PCRs downsteram of the GSP genes have revealed further differences 
between the genome of the UPEC strain 536 and the K-12 strain MG1655. Instead of a 
transposon 5 gene (trs5_9 - greenish-yellow ORF) a 7 kb integration (orf99-106) was 
localized in the genome of strain 536. Function of the hypothetical proteins encoded by 
these genes is not known or only hypothetical. 
  
Between b2981 and yghQ in strain K-12, a transposon 5 (trs5_9) was present. With a long 
distance PCR with primers starting from these two genes, a nearly 7-kb product (involving orf99-
106, see Appendix) was obtained from E. coli strain 536. This almost 7-kb fragment was 
sequenced using pCos2/13 as template. Sequence analysis of these genes revealed a genetic 
region that’s function is not known. Similarites to unknown hypothetical proteins (orf100, 103, 
104), a hypothetical protein (orf101) that shows high similarity to the putative acyl carrier protein 
AcpP, a protein that shows similarity to a hypothetical transferase (orf102), and to a hypothetical 
protein (orf106) with suggested ATP binding motif were revealed. This genetic region is also 
present in Shigella flexneri 2a and in the UPEC strain CFT073.  
 
glcC       b2981   trs5_9    yghQ        yghR       yghT        pitB            gsp     b2989    hybG        hybE         hybC  hybB     hybA      b2997    b2999 b3001         yghA  b3004  
yghS                                                                  hybF        hybD                                             b2998 b3000        yqhA    
7kb 
K12 
536
b2981_F  Saf _R  - + 
b2981_F  yghQ_R  + - 
yghQ_F  yghS_R  + + 
yghS_F  pitB_R  + + 
pitB_F  gsp_R  + + 
gsp_F  hybF_R  + + 
hybF_F  hybD_R  + + 
hybD_F  hybA_R  + + 
hybA_F  b2998_R  + + 
b2998_F  b3001_R  + + 
b3001_F  b3004_R  + + 
 
K12 536 
primer pairs results of PCRs 
 61 
reveal if all of the known genes from this part of the strain MG1655 chromosome were present or 
some might have been deleted (Figure 6). With these primers, PCRs were carried out with strain 
536, pCos2/13 and K-12. Strain 536 and pCos2/13 yielded the same results. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 6: Overlapping PCRs downsteram of the GSP genes have revealed further differences 
between the genome of the UPEC strain 536 and the K-12 strain MG1655. Instead of a 
transposon 5 gene (trs5_9 - greenish-yellow ORF) a 7 kb integration (orf99-106) was 
localized in the genome of strain 536. Function of the hypothetical proteins encoded by 
these genes is not known or only hypothetical. 
  
Between b2981 and yghQ in strain K-12, a transposon 5 (trs5_9) was present. With a long 
distance PCR with primers starting from these two genes, a nearly 7-kb product (involving orf99-
106, see Appendix) was obtained from E. coli strain 536. This almost 7-kb fragment was 
sequenced using pCos2/13 as template. Sequence analysis of these genes revealed a genetic 
region that’s function is not known. Similarites to unknown hypothetical proteins (orf100, 103, 
104), a hypothetical protein (orf101) that shows high similarity to the putative acyl carrier protein 
AcpP, a protein that shows similarity to a hypothetical transferase (orf102), and to a hypothetical 
protein (orf106) with suggested ATP binding motif were revealed. This genetic region is also 
present in Shigella flexneri 2a and in the UPEC strain CFT073.  
 
glcC       b2981   trs5_9    yghQ        yghR       yghT        pitB            gsp     b2989    hybG        hybE         hybC  hybB     hybA      b2997    b2999 b3001         yghA  b3004  
yghS                                                                  hybF        hybD                                             b2998 b3000        yqhA    
7kb 
K12 
536
b2981_F  Saf _R  - + 
b2981_F  yghQ_R  + - 
yghQ_F  yghS_R  + + 
yghS_F  pitB_R  + + 
pitB_F  gsp_R  + + 
gsp_F  hybF_R  + + 
hybF_F  hybD_R  + + 
hybD_F  hybA_R  + + 
hybA_F  b2998_R  + + 
b2998_F  b3001_R  + + 
b3001_F  b3004_R  + + 
 
K12 536 
primer pairs results of PCRs 
 62 
1.1.5 Identification of cosmids covering the left end of PAI V536  
It was reported before, that the first gene of several PAIs integrated into pheV or pheU (Rabbit 
specific EPEC strain–LEE-PAI (Tauschek et al. 2002), bovine specific E. coli strain - afa-8 gene 
cluster containing PAI, S. flexneri – she PAI (Rajakumar et al. 1997), EHEC O157:H7, UPEC 
strain CFT073 – PAI II) is a P4-like integrase gene and encodes a predicted protein of 421 amino 
acids that is designated as a site-specific recombinase Int-phe (Figure 7). 
 
 
 
 
 
Fig. 7: Screening approach for chromosomal 
insertions in pheV. P4 integrase-
specific sequences were used. The 
primer pair used for screening the 
genome library for cosmid clones that 
contain the left end of PAI V536 are 
indicated by arrows. 
 
A primer was designed corresponding to the 5’end of this gene and another corresponding to the 
3’end of the gene yqgA1 located just upstream of pheV in the genomes of the EHEC strain and K-
12. Screening the 536 genome library, two positive clones were found (pCos1/26 and 
pCos25/52). Comparison of the ends of these two cosmids revealed that one end of pCos21/26 
was homologous to a chromosomal sequence 25 kb upstream of pheV while the other end showed 
no homology. One end of pCos25/52 showed homology to a gene 3 kb upstream of pheV in the 
E. coli core chromosome while the other end was overlapping with the left end of pCos6b38. 
This common part encompassed more than 5 kb. However the two overlapping ends of these 
cosmids did not fit exactly to each other. Sequence of the last 2 kb of pCos25/52 was uncertain 
and did not alow the two overlapping cosmids to fit exactly to each other. Analysis of this 2 kb 
revealed a Sau3A cutting site in the beginning of this 2 kb fragment and two additional ones 
inside it. This made it clear that during the construction of the genomic cosmid library from the 
chromosome of strain 536 (digested with Sau3A) a small piece of DNA was ligated between the 
cosmid vector and the longer genomic part. Sometimes this happens during the construction of 
genomic libraries. 
In summary, with four cosmids (pCos25/52, pCos6b38, pCos24/23 and pCos2/13) the whole PAI 
V536, and its downstream sequences were revealed (Figure 8).  
yqgA 
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1.2 Sequence analysis of PAI V536 and its downstream sequences 
1.2.1 ORFs of PAI V536 
Sequence analysis of the four overlapping cosmids (pCos25/52, pCos6b38, pCos24/23 and 
pCos2/13) revealed a mosaic-like structure of PAI V536, which is typical for PAIs. PAI V536 is 
inserted at the 3’ end of the pheV tRNA gene at minute 64 on the chromosome. The upstream 
region of pheV corresponds to the gene order of E. coli K-12 strain MG1655. Downstream of 
pheV, a P4-like integrase gene is present which is nearly identical to the integrase genes found in 
other PAIs integrated at one of the two phe tRNA genes (see also above). Beside the complete 
pheV, a 5’ truncated copy was identified 49 kb downstream. This organisation strongly resembles 
to PAI III536 of this strain in which downstream of a truncated thrW tRNA gene additional 
integrated sequences are present. In case of PAI V536, the 25-kb K15 kps locus , the genes for a 
general secretion (type II) pathway and a 7-kb insertion were identified downstream of the 
truncated pheV.  
The size of the sequence located between the two tRNA genes is 48,708 bp. It contains 58 
putative ORFs and has a G+C content of 47.7 %. This part is characterised by the presence of 
kryptic or active IS elements, transposases, prophage genes, a pix fimbrial gene cluster, the genes 
coding for a phosphoglycerate transport system (pgt), an autotransporter (agn43), and 
hypothetical ORFs.  
The sequence is available under the accession number: AJ617685. The summarised list of the 
ORFs can be found in the appendix (A/4). 
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1.2.2 Mobile genetic elements of PAI V536  
Mobile genetic elements play an important role in genome flexibility and in gene rearrangements. 
IS elements, transposase and prophage genes are almost always reported to be present on 
different PAIs, and are also found on PAI V536.  
As already discussed, just downstream of pheV is an ORF that shows high homology to a P4-like 
integrase that is found in many enterobacterial PAIs associated with a Phe-tRNA gene. 
Fragments of different IS elements are also indicators for gene rearrangements. Upstream of the 
pix fimbrial gene cluster, two ORFs (orf2 and orf3) are located that code for a putative IS110 
integrase and a transposase like protein. Between the fimbrial gene cluster and the 
phosphoglycerate transport system, an R6 transposase gene, and just downstream of the 
phosphoglycerate transport system, an IS2 transposase gene (insA) were found. Furthermore, 
there are two complete IS elements: IS911 (orf29-30) and IS100 (orf33-34) present. Interestingly, 
both of them can also be found on PAI I536. An additional remnant of an IS element was detected 
in the middle of the kps locus, between the truncated kpsCK5 and the kpsSK10 genes. This ORF 
shows homology at the protein level to IS1230B of a Salmonella enteritidis strain. 
Upstream of the truncated pheV gene, high level homology to prophage genes (L0007-L0011) 
was detected that were first described in the genome of EHEC strain EDL933. These prophage 
genes are also present in PAI II536. 
 
 
1.2.3 Gene clusters of PAI V536 
Two large gene clusters were localised between pheV and 'pheV (Figure 9, Table 5). From orf6 to 
orf13 the recently described pix fimbrial gene cluster is present (Lügering et al., 2003). The 
operon consists of 8 genes from which the last 5 (pixC, D, J, G, F) showed partial homology at 
the nucleotide level to a novel fimbrial gene cluster that is encoded by the large plasmid 
(pSFO157 – ECO131667) of the sorbitol-fermenting Enterohaemorrhagic E. coli O157:H- 
(Brunder et al., 2001). The first three genes of this cluster are similar to the genes of a 
pyelonephritis-associated pilus operon (pap) of E. coli (ECU26449). The organisation of the 
three fimbrial clusters is compared in Figure 10. The pap gene cluster shows a complete structure 
because it contains the tip fibrillum genes papK, E and F and a complete regulatory system (papI 
and B) that is located upstream of the structural genes. It is known that upstream of these latter 
two genes some small sequences are also important for regulation. SfppSFO157 completely lacks 
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the regulatory genes and only part of a fibrillum gene (sfpF) is present. The pix gene cluster is 
organised similarly to sfp but it has a regulatory gene pixB upstream of pixA. pixB shows only  
 
Fig. 10: Comparison of the genetic structures of pap, sfp and pix gene clusters. 
 
partial homology to papB/prfB, but seems to be intact. pixB encodes a putative negative regulator 
of the gene cluster, but a hypothetical positive regulator that could have a homologous function to 
papI is missing. Regulatory sequences upstream of pixB are also missing. 
Transcriptional analysis with RT-PCR of the pix fimbrial gene cluster in strain 536 at 37 ºC 
revealed that the structural gene pixC is not transcribed but that the repressor pixB was expressed 
(Figure 11). 
Fig. 11:
Analysis of pixB and pixC transcription 
at 37ºC by RT-PCR. Under the 
conditions used, expression of pixB 
hindered the transcription of pixC. (a.: 
PCR from total RNA; b.: PCR from 
DNAse digested total RNA; c.: PCR 
after reverse transcription)  
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The second large gene cluster (orf16-19) of PAI V536 codes for a complete phosphoglycerate 
transport system that consists of three regulators and a transporter protein. This system is 
involved in the uptake of different phosphoglycerates (Goldrick, 1988) and activated sugars, and 
was originally described in S. enterica serovar Typhimurium LT2 (accession no. AE008808). 
Similar to S. enterica and CFT073, the four genes are present but in strain 536 an additional fifth 
small ORF (orf20) was detected that showed weak homology on protein level to a 
phosphoglycerate mutase of Bacillus stearothermophilus (accession no. T46865). Analysis by 
RT-PCR revealed that the phosphoglycerate transport system is transcribed under laboratory 
conditions at 37 °C (data not shown).  
 
1.3 Structural analysis of PAI V536  by comparing to other bacterial genomes 
Many DNA fragments of PAI V536 show similarity at the nucleotide level to chromosomal 
regions of other E. coli strains (e.g., strain CFT073 –UPEC, EDL933 –EHEC O157:H7, 239 KH  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Sequence comparison of PAI V536 to other bacterial sequences using the BLAST 
software. A mosaic like structure of PAI V536 and its downstream sequences was found 
with high homology to different sections of the genome of UPEC strain CFT073. 
Additional homology can also be detected with sequences of different other pathogenic 
strains. 
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89 -human and bovine pathogenic, two ETEC strains), of Shigella flexneri 2a (she and SRL 
PAIs), and of Salmonella enterica serovar Typhimurium LT2. Many fragments of PAI V536 are 
also nearly identical to sequences of different virulence plasmids of E. coli (pB171, pSFO15), 
Shigella spp. (pWR501, and pWR301) and to the Y. pestis plasmids pMT1 and pCD1. The 
highest homology was shown to the completely sequenced genome of strain CFT073 which is, as 
strain 536, an uropathogenic E. coli isolate. Segments 1, 2, 8, 12 and 17 of the CFT073 genome 
(18 segments altogether) show homology to PAI V536. These findings indicate a mosaic-like 
structure between the two UPEC genomes with a high variance between the sequences.  
A frame-like homology can be observed among PAI V536, PAI I536, PAI II536, PAI IICFT073 and the 
SRL PAI of S. flexneri 2a where the presence of integrase genes and the remnants of prophages 
are characteristics that have been proposed to have played a role in the acquisition of these PAIs. 
Inside this frame, homology to additional integrase genes and IS elements were detected that may 
have taken part in the acquisition and deletion of different genes and gene clusters. Figure 12 
demonstrates that the phosphoglycerate transport system shows homology to PAI ICFT073 (also 
designated as pheU island). Only partial homology can be seen to the pix cluster of PAI V536. 
Such homology to the conserved part of other fimbrial clusters is evident in the cases of PAI II536, 
PAI IICFT073 and PAI ICFT073.  
 
1.4. Presence of the PAI V536 and its genes in a collection of E. coli strains 
To investigate the distribution of sequences that are present on PAI V536 within the species E. 
coli, 140 strains of the institute’s strain collection were screened with PCRs. It is noteworthy to 
mention that the composition of this strain collection is focussed on ExPEC strains. PAI V536 
screening primers were specific for the pix, pgt, kps and gsp gene clusters (the results are shown 
in the appendix). Because of its novel structure PCRs were performed on all the three regions of 
the capsule locus. 
According to the results, beside strain 536 only one strain was detected to be positive for all the 
seven PCRs (E642, a newborn meningitis strain). Furthermore, only one additional strain (764- a 
classic UTI strain) seems to possess the complete K15 specific kps sequence. This correlates with 
the information we have on serotype because this strain also expresses the K15 capsule type. The 
incidence of the gspD gene which is a member of the general secretion pathway is rather high 
(77%). Interestingly most of the GSP genes are missing from the genome of CFT073. The 
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phosphoglycerate transport system has a much lower incidence (38%) while the occurence of 
kpsCK5 gene is high (63,5%).  
 
2 Structural analysis of the capsule determinant of the UPEC strain 536 
2.1 The capsule locus of the UPEC strain 536 shows a ”mixed“ genetic structure 
Sequence analysis of pCos6b38 strongly suggested that PAI V536 is inserted at the 3'end of the 
pheV tRNA gene and is associated to the capsule locus. As the capsule locus responsible for the 
K15 antigenic properties of strain 536 was not yet known it was hypothesised that parts of the 
functional capsule locus of this strain was found (B. Janke, PhD thesis). In this work, the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13: Genetic organisation of the capsule locus of E. coli strain 536. A. Organisation of 
group 2 (left) and group 3 (right) capsule gene clusters. B. A mixed genetic structure of the 
capsule locus is hypothesised to be responsible for the K15 antigenic properties of E. coli 
536: Region 1 shows a mixed structure; the first 5 genes (kpsFEDUC) show high homology 
to K5 (one member of the group 2 capsules), the additional kpsS and C are on the 
complementary strand and show homology to the capsular determinant of K10 (one 
member of the group 3 capsules). C. Control PCRs were carried out with three ETEC 
strains that also have K15 capsules. In these cases, the PCRs –similarly to strain 536- were 
positive and resulted in the appropriate product sizes. Localisation of the regions amplified 
by the test PCRs are indicated by black lines.  
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complete gene cluster was identified and its sequence analysed (see chapter 1 of the results). It 
was verified that the capsule determinant of this strain is associated with the tRNA gene pheV. Its 
organisation showed features that were characteristic for both group 2 and 3 capsule determinants 
(Figure 13) with two conserved regions flanking a highly variable region. In strain 536, region 1 
that encodes transport functions has 5 ORFs (kps F, E, D, U, C) and shows high nucleotid 
homology to the capsule determinant of K5 and K1, two representatives of group 2 capsules. 
However, the fifth gene of the transcriptional unit (kpsC, later termed kpsC’K5) was nearly 150 
bases shorter than its homologues in K1 and K5 gene clusters. Downstream of kpsC'K5  the sixth 
gene (kpsS) was missing but instead a hypothetical transposase gene was present (orf66). This 
ORF showed homology at protein level to an IS1230B transposase from S. enteritidis 
(NP717743). 
Complete kpsC and S genes were identified downstream of the transposase gene but on the 
complementary strand. kpsS showed similarity to A. hydrophila (AF375657) and kpsC to E. coli 
K10 (termed later kpsCK10). The latter is a well studied representative of group 3 capsules 
(Clarke, 1999).  
Upstream of kpsS and kpsCK10, region 2 is located that contains 5 ORFs (orf69-73) and similarly 
to the kpsS and C genes they were transcribed from the complementary strand. The start and stop 
codons of the first four genes (ORF73-70) are overlapping, while the fourth and fifth genes 
(ORF69) are separated by a 290-bp non-coding region. None of these five genes showed 
significant homology to any known sequence at the nucleotide level, but at the protein level, two 
of them (ORFX and Y) were similar to enzymes of sugar biosynthesis. Homology was found to a 
putative glycosyltransferase from Actinobacillus (AAC26630) and a mannosyltransferase B of an 
Aquifex species (NP213361). Up- and downstream of region 2, small (~50 bp) AT-rich repetitive 
sequences were identified that could be traces of genetic rearrangements. Nevertheless the G+C 
content of this region is significantly lower than that of the whole PAI V536 and other downstream 
sequences. 
Upstream of the biosynthetic genes, the missing conserved capsular genes were identified. The 
genes kpsM and T show homology to the genes for K5, K2 and K4 which belong to group 2 
capsules and form region 3. They are members of the ABC (ATP binding cassette) transporter 
family (Silver et al., 2001; Higgins, 2001).  
The mixed genetic organisation of the K15 capsule or any other capsule types was not known 
before. Therefore it was tested whether other isolates with the K15 capsule type have the same 
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capsules and form region 3. They are members of the ABC (ATP binding cassette) transporter 
family (Silver et al., 2001; Higgins, 2001).  
The mixed genetic organisation of the K15 capsule or any other capsule types was not known 
before. Therefore it was tested whether other isolates with the K15 capsule type have the same 
 72 
genetic organisation as E. coli 536. From the strain collection of the Institute for Molecular 
Biology of Infectious Diseases, three K15 strains (IMI405, 406, 415) were checked by PCR 
concentrating on 5 parts of the K15 capsule locus. The following primer pairs were used (Figure 
13c): IHFfw-KpsErev, 13165fRT-14167rRT, 14400RT-orf5fw, orf2fw-orf3end, MT1-MT4). In all 
the five cases the size of the products equalled with that of strain 536.  
 
2.2 Regulatory sequences of the capsule locus 
We have found all the conserved genes that are necessary for capsule transport through the 
bacterial inner membrane, and our data suggested that the antigen-specific region was also 
localised. As capsule expression depends also on different environmental signals, the presence of 
additional regulatory sequences is also expected. Therefore, we compared the regulatory 
sequences of other capsule determinants with that of K15 sequences. 
 
 
 
 
 
 
Fig. 14: Nucleotide sequence of the 5' end of the kpsF gene (region 1) and its upstream region. 
Bold, start codon of kpsF; italic, Shine-Dalgarno sequence; underlined, sequences 
matching the consensus IHF binding site; green bold, conserved AT-rich regions that are 
also present in the region 3 promoter. 
 
Similar to group 2 capsule gene clusters, two hypothetical integration host factor (IHF) binding 
sites were found upstream of kpsF in E. coli 536 (Figure 14). IHF is a histone-like DNA-bending 
protein and binding of IHF at these sites is predicted to change the DNA conformation thereby 
altering the efficiency of transcription and/or mediating the action of other regulatory factors. 
However, IHF is only required for optimal gene expression of group 2 capsules (Rowe et al., 
2000). 
Region 3 contains the genes kpsM and T organized in a single transcriptional unit. Similarly to 
other group 2 capsule representatives, in the case of K15 no consensus sequences for alternative 
sigma factor or other DNA-binding proteins (like IHF) have been described. However, 
transcription of region 3 is affected by an antitermination process, conferred by the antiterminator 
AGGAAATAATCAATTGATAAATTGTTTTTGGTCTTAATAGTCAAGTTGGAAACAT
TTTAATAAATGATAAAAATCCTAAATTCCTTGTTCATAATGTAGGGGTGTGTTAA
ATAGGTGGGCAAAATTTGGTTCCCCTTCTCGCCTGTAATATTGCAGCATCTTCGCA
CCTCCATGAGACATTGCGACTTAATAAGAAGGTGATAAGTCCTGCATATAAGCAT
GGACTGACCATGGTTTTATATTCATTAAAAATTTTGTTACAACCCATTGATTTAGC
ATAAATAAATTATAGTGGGTTCGGGTTTGTTGTGACTGTGGCATTATTTCCGTGCA
AAGGAGCTGATATGTCTGAAAGACATTTACCTGATGACCAGAGCAGTACTATC 
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RfaH (Figure 15) and an ops (operon polarity suppressor) element, located within a nucleotide 
sequence region called JUMPstart (just upstream of many polysaccharide gene start). In this 
process, RfaH binds to the RNA polymerase holoenzyme and prevents recognition of 
downstream termination signals. The interaction of RfaH and the RNA polymerase requires the 
ops element that must be located upstream of the genes to be transcribed. At this site, the RNA-
polymerase recruits RfaH and possibly other proteins, to promote transcriptional elongation. 
Mutations in RfaH or deletion of the ops sequence abolish detectable group 2 capsule expression 
at 37 °C. 
 
Fig. 15: a., Promoter sequence of the K15-specific Region 3. Bold, start codon for kpsM; italic, 
Shine-Dalgarno sequence; red and bold, ops element. b., Examples of different 
JUMPstart sequences of E. coli operons that are RfaH dependent (Figure is kindly 
supplied by G. Nagy).  
 
3 Functional analysis of the K15 capsule in the uropathogenic process 
Mapping of the capsule locus has revealed its genetic structure. Similarity to known group 2 and 
3 capsule determinants suggested that this was a functional gene cluster, but its structure showed 
a mixed organisation that was not described before. A transcriptional analysis was carried out to 
elucidate the role of the two kpsC genes and to reveal the transcriptional organisation of this 
locus. Furthermore, knock-out mutants were constructed to verify that this locus codes for 
enzymes that are responsible for the K15 antigenic properties of strain 536. 
 
3.1 Transcriptional analysis of the capsule locus 
Reverse Transcription PCR (RT-PCR) was carried out with kpsC specific primers for the capsule 
locus of strain 536 to examine their role in capsule transport. Primers C5in_fw and C5in_rev were 
used to check the transcriptional activity of the truncated kpsCK5 gene, which showed high 
homology at nucleotide level to K5 while primers 13165fRT and 14167rRT were used for the 
other kpsC gene that was encoded on the complementary strand, and showed slight homology at 
 
rfb 
rfa
tra 
CAGTGTATTGGTAGCTGTTAAGCCAAGGGCGGTAGCGTA
CCTGAAGAGATTAGGAGCACATCATCAAATGGCAAGA 
CAGTGCTCTGGTAGCTGTTAAGCCAGGGGCGGTAGCGT
CAGTATTCAGGTAGCTGTTGAGCCTGGGGCGGTAGCAT
CGAGTGCCCTGTGCGTGAAAAGGGATGGGCGGTAGCGT
LPS   O-antigen 
LPS   core
F - 
a. 
b. 
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protein level to the K10-specific allele. The results of the RT-PCR revealed that both kpsC genes 
were transcribed (Figure 16).  
 
C‘K5 CK10    
a.         b.        c         a.          b.      c.    
2kb
 
Fig. 16: RT-PCR analysis of kpsC'K5 and kpsCK10 has revealed that both of them are transcribed. 
PCRs were carried out from: a, total RNA; b, total RNA after treating with DNase; c, 
cDNA. (Left part corresponds to the end of region 1 –see Fig 13; PCR products are 
symbolised under the arrows)  
 
By producing mutants of both kpsC genes, their role was further analysed (see below). To reveal 
the transcriptional organisation of the kps locus additional RT-PCRs were performed. From the 
isolated total RNA, cDNA was synthesised with random primers. After DNA was totally digested 
with DNAse the questionable parts of the kps locus were amplified with specific primers. From 
the PCR results, the presence of transcriptional units of the capsule locus could be determined as 
follows (Figure 17):  
Positive products from RNA and cDNA were amplified with primers kpsCK10 and orf5, orf5 and 
orf4, and orf1 and kpsT. These results suggest the presence of a transcript encompassing kpsT to 
kpsS. The transposase gene located between kpsC'K5 and kpsS could also be amplified with inner 
primers indicating that it is transcribed. From the literature, it is known that all genes of region 1 
in group 2 capsules are organised in a single transcriptional unit (Whitfield, 1999). Therefore, it 
can be assumed that the K15 capsule locus is organised in two transcriptional units (Figure 17).  
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F  E   D  U  C‘K5 S  CK10 T  M
ISfw-ISrev,        kpsC’K5 – kpsS,  kpsCK10 – orf5,      orf5 – orf4, orf1 – kpsT
a.   b.   c.                            a.      b.     c.       a.     b.    c.              a.   b.    c.            a.    b.   c.   
mRNAmRNA
trs orf5  orf4           orf1  
 
Fig. 17: Analysis of the transcriptional organisation of the K15 capsule locus by RT-PCR. From 
the results two transcriptional units were identified. The truncated region 1 
(kpsFEDUC'K5) forms one transcriptional unit while the second one involves the genes of 
region 3 (kpsMT), region 2 and the kpsCK10 and S genes. (PCRs were carried out from: a, 
total RNA; b, after treating with DNase; c, cDNA).  
 
3.2 Mutants of the hypothetical K15 capsule locus 
Mutants were constructed for all three regions of the capsule determinant. Region 1 and 2 
mutants were prepared with derivatives of the suicide vector pCVD442. In region 1, kpsS and 
kpsCK10 were replaced by a kanamycin casette while in the case of region 2 the first four genes 
(ORF70-73) were deleted. For deletion of kpsS and kpsC'K5, a 4.6 kb product was amplified with 
primers kpsSCfw_XbaI and kpsSCrev_SacI and ligated with pGEM®-T. The resulting plasmid 
was digested with the restriction enzymes BstBI and BsiWI that removed an internal 2.8-kb 
fragment encompassing the two genes, and leaves a ~900-bp flanking region on each side. A 
kanamycin cassette that had been amplified from pACYC177 with primers Kan_BstBI and 
Kan_BsiWI,  and subsequently digested with BstWI and BstBI and then inserted into the 
linearised vector. Positive clones on kanamycin plates were checked and after plasmid isolation 
the kanamycin cassette with the two flanking fragments corresponding to the capsule locus was 
 75 
F  E   D  U  C‘K5 S  CK10 T  M
ISfw-ISrev,        kpsC’K5 – kpsS,  kpsCK10 – orf5,      orf5 – orf4, orf1 – kpsT
a.   b.   c.                            a.      b.     c.       a.     b.    c.              a.   b.    c.            a.    b.   c.   
mRNAmRNA
trs orf5  orf4           orf1  
 
Fig. 17: Analysis of the transcriptional organisation of the K15 capsule locus by RT-PCR. From 
the results two transcriptional units were identified. The truncated region 1 
(kpsFEDUC'K5) forms one transcriptional unit while the second one involves the genes of 
region 3 (kpsMT), region 2 and the kpsCK10 and S genes. (PCRs were carried out from: a, 
total RNA; b, after treating with DNase; c, cDNA).  
 
3.2 Mutants of the hypothetical K15 capsule locus 
Mutants were constructed for all three regions of the capsule determinant. Region 1 and 2 
mutants were prepared with derivatives of the suicide vector pCVD442. In region 1, kpsS and 
kpsCK10 were replaced by a kanamycin casette while in the case of region 2 the first four genes 
(ORF70-73) were deleted. For deletion of kpsS and kpsC'K5, a 4.6 kb product was amplified with 
primers kpsSCfw_XbaI and kpsSCrev_SacI and ligated with pGEM®-T. The resulting plasmid 
was digested with the restriction enzymes BstBI and BsiWI that removed an internal 2.8-kb 
fragment encompassing the two genes, and leaves a ~900-bp flanking region on each side. A 
kanamycin cassette that had been amplified from pACYC177 with primers Kan_BstBI and 
Kan_BsiWI,  and subsequently digested with BstWI and BstBI and then inserted into the 
linearised vector. Positive clones on kanamycin plates were checked and after plasmid isolation 
the kanamycin cassette with the two flanking fragments corresponding to the capsule locus was 
 76 
cut out with restriction enzymes XbaI and SacI. In a next step, the 2.2-kb fragment was directly 
ligated with pCVD442 and transformed into SY327 λpir. After selection on sucrose plates as 
described before clones were checked by PCR and Southern-hybridisation. 
For region 2 mutants, the same strategy was used but for the integration of a tetracyclin cassette 
(also from pACYC177) the restriction enzymes BglII and StyI were used. Another mutant was 
also generated for region 2 with linear PCR products according to the method described by 
Datsenko and Wanner (see materials and methods). Other mutants (∆kpsC'K5, ∆kpsCK10, ∆kpsMT 
and ∆kpsK15) of the capsule locus were also constructed with the same method. The exact 
distances of the mutations relative to 'pheV are as follows (Table 4): 
 
Table 4: Characteristics of the different deletion mutants within the K15 capsule locus 
Region deleted Position  
(relative to 'pheV) 
Size of the deletion [bp] 
kpsC'K5 6,017 – 6,837 820 
kpsSCK10 8,886 – 11,590 2,704 
kpsCK10 10,403 – 11,873 1,470 
kps∆R2-1 and ∆R2-2  13,548 – 16,308 2,760 
kpsMT 18,466 – 19,429 963 
kpsK15 610 - 20,355 19,745 
 
 
After the mutants have been confirmed with PCR and Southern blot (Figure 18) loss of the 
capsule was detected with serological methods. 
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Fig. 18: Mutants of the K15 capsule locus were checked with Southern hybridisation. 
Chromosomal DNA of each strain was digested with BglI (This enzyme cuts only in the 
hybridised sequences of Region 3 (kpsMT).) and was run in 1% agarose gel (a). 
Hybridisation of gene specific probes (written on the bottom of each membrane, b-e) were 
hybridised with the chromosomal DNA of wild type and mutant strains to detect the loss 
of gene(s) in question (b-e). Order of strains is the following: 1, Marker; 2, E. coli 
MG1655; 3, E. coli 536 wt; 4, E. coli 536∆kpsC'K5; 5, E. coli 536∆kpsCK10; 6, E. coli 
536∆kpsSCK10; 7, E. coli 536∆R2–1; 8, E. coli 536∆R2–2; 9, E. coli 536∆kpsMT 10, E. 
coli 536∆kpsK15; 11, Marker. 
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3.3 The capsule locus downstream of 'pheV is responsible for K15 antigenic properties in 
strain 536 
Mutants of the K15 capsule locus were first tested with serological methods. All of them were 
tested for capsule production or loss of capsule with a K15-specific antiserum. With this absorbed 
polyclonal antiserum, it was revealed in ELISA that with one exception all the mutants had lost 
their ability to express or synthesise the K15 capsule (Figure 19). In contrast to a kpsCK10 
deletion, that of kpsC'K5 did not have any effect on capsule expression. Therefore it can be 
assumed that even though both of them are transcribed (Figure 16) only kpsCK10 is required for a 
functional protein. 
A
B
C
D
E
F
G
1    2     3     4     5     6     7      8    9    10   11   12
 
Fig. 19: Detection of K15 capsule production of E. coli strain 536 and different derivatives by ELISA. 
Unabsorbed polyclonal serum (O-K serum) was used in line G. In lines A-C and D-F, two 
different charges of absorbed serum was used (absorbtion was made with strain RZ532 
O6:K+:H31, non-K15). 1, 536-wt; 2, RZ532; 3, E. coli 536∆kpsSCK10; 4, E. coli 536∆R2-2; 5, E. 
coli 536∆kpsMT; 6, E. coli 536∆kpsCK10; 7, E. coli 536∆kpsC'K5; 8, E. coli 536∆kpsK15; 9, E. coli 
536∆kpsK15 (pBeloBAC11); 10, E. coli 536∆kpsK15 (pBAC); 11, 536rfaH; 12, E. coli 536∆R2-1. 
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Fig. 20: Detection of K15 capsule expression of E. coli strain 536 and derivatives by 
immunofluorescence microscopy. a-b, 536 wt; c-d, 536∆kpsK15; e-f, MG1655. 
Experiments were made by the T-RED labelled absorbed anti-K15 serum. Phase contrast 
images are on the left side, while immunfluorescence images of the same preparation are 
on the right side. 
a b
c d 
e f
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Fig. 20: Detection of K15 capsule expression of E. coli strain 536 and derivatives by 
immunofluorescence microscopy. a-b, 536 wt; c-d, 536∆kpsK15; e-f, MG1655. 
Experiments were made by the T-RED labelled absorbed anti-K15 serum. Phase contrast 
images are on the left side, while immunfluorescence images of the same preparation are 
on the right side. 
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3.4 Deletion and complementation of the whole capsule locus of strain 536  
For complementation experiments the capsule mutant of E. coli strain 536∆kpsK15 was used 
which lacks the complete kps gene cluster. This ~20-kb deletion was complemented with a BAC 
clone (pBAC29B-41) that contained the complete kpsK15 locus of strain 536 (personal 
communication M. Emmerth). Since in this BAC clone additional upstream and downstream 
sequences were present, the risk for homologous recombination was relatively high. Therefore 
we constructed a double mutant of strain 536 in which beside the K15 capsule-encoding locus the 
gene recA was also deleted. In the absence of functional RecA, the BAC clone was no longer able 
to integrate into the chromosome by homologous recombination. For further experiments, a 
derivative of the BAC clone 29B-41 was constructed which carried a deletion of a 30-kb PmlI 
fragment (designated later pBAC29B-41/30S).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21: Complementation strategy for strain 536∆kpsK15. The K15 capsule mutant of strain 536 
was complemented with pBAC29B-41. For size reduction, a 30-kb PmlI fragment was cut 
out from pBAC29B-41. The vector was then religated (pBAC29B-41/30S) and 
electroporated into the double mutant 536∆K15∆recA.  
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     kps  F  E  D   U   C          S      C                            T  M 
∆pheV 
Kan 536∆kpsK15 (kan) 
536 wild type 
536∆kpsK15∆recA 
∆recA 
recA 
kps 
locus 
20kb 
BAC_ 
29B-41 
PmlI cutting 
sites 
100kb
70kb
PmlI 
536∆kpsK15∆recA 
containing pBAC29B-
41/30S 
 80 
 
3.4 Deletion and complementation of the whole capsule locus of strain 536  
For complementation experiments the capsule mutant of E. coli strain 536∆kpsK15 was used 
which lacks the complete kps gene cluster. This ~20-kb deletion was complemented with a BAC 
clone (pBAC29B-41) that contained the complete kpsK15 locus of strain 536 (personal 
communication M. Emmerth). Since in this BAC clone additional upstream and downstream 
sequences were present, the risk for homologous recombination was relatively high. Therefore 
we constructed a double mutant of strain 536 in which beside the K15 capsule-encoding locus the 
gene recA was also deleted. In the absence of functional RecA, the BAC clone was no longer able 
to integrate into the chromosome by homologous recombination. For further experiments, a 
derivative of the BAC clone 29B-41 was constructed which carried a deletion of a 30-kb PmlI 
fragment (designated later pBAC29B-41/30S).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21: Complementation strategy for strain 536∆kpsK15. The K15 capsule mutant of strain 536 
was complemented with pBAC29B-41. For size reduction, a 30-kb PmlI fragment was cut 
out from pBAC29B-41. The vector was then religated (pBAC29B-41/30S) and 
electroporated into the double mutant 536∆K15∆recA.  
Region 1 Region 2 Region 3 
     kps  F  E  D   U   C          S      C                            T  M 
∆pheV 
Kan 536∆kpsK15 (kan) 
536 wild type 
536∆kpsK15∆recA 
∆recA 
recA 
kps 
locus 
20kb 
BAC_ 
29B-41 
PmlI cutting 
sites 
100kb
70kb
PmlI 
536∆kpsK15∆recA 
containing pBAC29B-
41/30S 
 81 
The resulting 70-kb recombinant BAC vector pBAC29B-41/30S contained the complete K15 
capsule locus but its size was reduced compared to the original clone (pBAC29B-41). The BAC 
clone pBAC29B-41/30S was electroporated into strain 536∆kpsK15∆recA. After re-isolation of the 
plasmid, it was verified that integration into the chromosome had not occurred and 
complementation was detected by ELISA (Figure 19). 
 
3.5 The K15 capsule contributes to pathogenicity of E. coli strain 536 
After verification that the capsule locus that was found downstream of PAI V536 was really 
functional, encoding the enzymes of K15 capsule biosynthesis and export, we tested all the 
mutants in an ascending urinary tract infection model (Table 5). In this model, bacteria were 
inoculated into the bladder of newborn mice. Non-pathogenic strains cause no death while the 
lethality of the wild type UPEC strain 536 is nearly 100%.  
 
Table 5: Virulence of E. coli strain 536 and different K15 capsule mutants in an ascending 
urinary tract infection model.  
 
Strain No. of 
infected mice 
Lethality 
[%] 
 
MG1655 
 
 
19 
 
0 
  
536 wt 
 
 
21 
 
100 
 
536∆kpsSCK
10 
 
 
27 
 
14.8 
 
536∆R2-2 
 
 
20 
 
10 
 
536∆kpsMT 
 
 
24 
 
8.3 
 
536∆kpsK15 
 
 
21 
 
19 
 
536∆kpsC'K5 
 
 
12 
 
91.7 
 
536∆kpsCK10 
 
 
13 
 
15.4 
 
With the exception of strain 536∆kpsC'K5, all tested mutants proved to be avirulent. This 
correlates with the results of the ELISA assay where strain 536∆kpsCK5 was shown to express the 
K15 capsule. Loss of the K15-specific extracellular polysaccharide had attenuated the strain 536 
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indicating that the K15 capsule plays an important role in the pathogenic process of an ascending 
urinary tract infection. 
 
Serum resistance experiments with 50 % human serum were carried out with selected mutants to 
examine further the role of the K15 capsule in systemic infection. As a negative control, the rfaH 
mutant of strain 536 was used, which expresses neither LPS nor capsule, and is also known to be 
serum sensitive. 
 
Fig. 21: Role of the K15 capsule for serum resistance of E. coli strain 536 and different mutants 
was investigated in 50 % human serum. Strain 536 has the ability to avoid the bactericidal 
activity of human serum. Loss of the K15 capsule showed no effect on this ability because 
in those mutants where only capsule was lost (536∆kpsSCK10, 536∆R2-2, 536∆kspMT) 
bacteria stayed resistant against serum. Because of the impaired LPS synthesis the RfaH 
mutant of strain 536 was known to lost its serum resistance and it was used as a negative 
control. Serum resistance experiment was also made with the GSP mutant 536∆gsp 
(resistant) and the 536∆R2-1 (sensitive – data not shown, details see in text). 
 
Almost all tested K15 capsule mutants were serum resistant and a significant decrease in serum 
resistance was not detected. Only small reductions were observed indicating that the K15 capsule 
type does not play a role for serum resistance. Only one mutant was serum sensitive (536∆R2-1). 
This mutant was constructed with the help of the suicide plasmid vector pCVD442. However, the 
other region 2 mutant, (536∆R2-2) that was constructed using linear DNA fragments and 
practically deleted exactly the same sequence did not show a reduced serum resistance. It can be 
assumed that the first mutant may carry a secondary mutation somewhere in the chromosome 
which is responsible for causing the serum sensitivity. Clearing up this question we prepared LPS 
from strain 536 and its different mutants and detected the O6 LPS side chain expression by SDS-
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PAGE (Fig. 22). It became evident that the “first” region 2 mutant (536∆R2-1) that was made 
with the suicide vector pCVD442 had a more fainter LPS pattern and the core region seemed also 
damaged that had correlated with the serum sensitivity of this mutant and not loss of capsule.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22: Detection of O6 LPS side chain expression of strain 536 and different capsule 
mutants by SDS-PAGE: lane 1, E. coli strain 536; lane 2, E. coli K-12 strain MG1655; 
lane 3, E. coli strain 536∆kpsSCK10 (region 1 mutant); lane 4, E. coli strain 536∆R2-1 (“first 
region 2 mutant”); lane 5, E. coli strain 536∆kpsMT (region 3 mutant); lane 6, E. coli strain 
536 ∆R2-2 (“new region 2 mutant”); lane 7, E. coli strain 536rfaH (negative control).  
 
  
4 Analysis of downstream sequences of the K15 capsule determinant 
Structural analysis of the pCos24/23 revealed that downstream of the K15 capsule determinant a 
genetic region was localised that showed no significant homology at the nucleotide level to 
known genes. Nevertheless, considerable homology was detectable at the deduced amino acid 
level. The proteins encoded by eight putative ORFs localised in this region of PAI V536 exhibited 
homology to components of a type II secretion system (general secretion pathway, gsp). Type II 
secretion systems play a role in the assembly and secretion of the cholera toxin in Vibrio cholerae 
(eps) (Overbye et al., 1993), the secretion of pullulanase in Klebsiella oxytoca (pul) (Pugsley and 
Reyss, 1990), the secretion of extracellular enzymes of Erwinia carotovora (out) (Reeves et al., 
1993, and are also present in Pseudomonas aeruginosa (xcp) (Filloux et al., 1990) and 
Xanthomonas campestris (xps) (Thomas and Trust, 1995).  
A DNA region with 99 % homology at the nucleotide level was also described in an 
enterotoxigenic E. coli strain (Tauschek, 2002; AF426313). In this ETEC strain, the type II 
secretion system is involved in secretion of a heat-labile enterotoxin. 
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Comparison of this chromosomal region of strain 536 to that of E. coli strains MG1655 and 
CFT073 (Fig. 23) revealed that yghD (orf76) is the last gene, which is commonly present in all 
strains analysed. According to a new nomenclature, this gene is the M-type component (gspM) of 
the general secretion pathway. A major part of the next gene (gspL) that is partially absent in 
strain MG1655 is completely present in strains CFT073 and 536. The next gene gspK (orf78) is 
already completely missing from the chromosome of MG1655, and is only partially present in the 
genome of the UPEC strain CFT073. From this gene additional seven genes (gspJ, I, H, G, F, E, 
D) are present in this genomic region of strain 536 that are completely missing from the genome 
of MG1655 and CFT073. This part shows high homology at the nucleotide level to the recently 
described type II secretion system-encoding gene cluster of an O78:H11 ETEC strain, and plays a 
role in the secretion of a heat-labile enterotoxin of the ETEC strain H10407 (Tauschek, 2002; 
AF426313). The next gene that was common again in MG1655 and 536 was gspC (orf86) or 
yghF. 81,194 bases downstream of pheV in strain 536 an ORF is located (orf89, yghJ) that is also 
present in MG1655 and was found to be the largest orf in PAI V536 and downstream sequences. 
yghJ can also be found in MG1655 and earlier was thought to be two genes (b2973 and b2974). 
Sequence homology to the genome of CFT073 comes back at yghK. This is the gene, which is  
 
Fig. 23: Comparison the common parts of the general secretion pathway genes among three 
different E. coli strains. A nearly 8 kb insertion can be found in strain 536 (b) relative to the 
equivalent genomic part of the K-12 strain MG1655 (a), while the genome of CFT073 (c) 
shows a dramatic reduction of this part, hypothetically because of an integration of an IS 
element.   
genomic part of CFT073 
downstream of the kps 
gspD  L  
yghK 
insG 
genomic part of strain 536 
downstream of the kps 
gspD   L   K    J  I HG    F      E         D      C   
yghF  G 
pppA / 
b2972 
b2973-b2974 
yghK
genomic part of MG1655 
downstream of pheV 
gspM   L  C  
yghD    E   F   G
pppA/ 
b2972 
b2973-b2974 
yghK yghJ 
yghJ yghD   E 
yghD   E
a. 
b. 
c
 84 
Comparison of this chromosomal region of strain 536 to that of E. coli strains MG1655 and 
CFT073 (Fig. 23) revealed that yghD (orf76) is the last gene, which is commonly present in all 
strains analysed. According to a new nomenclature, this gene is the M-type component (gspM) of 
the general secretion pathway. A major part of the next gene (gspL) that is partially absent in 
strain MG1655 is completely present in strains CFT073 and 536. The next gene gspK (orf78) is 
already completely missing from the chromosome of MG1655, and is only partially present in the 
genome of the UPEC strain CFT073. From this gene additional seven genes (gspJ, I, H, G, F, E, 
D) are present in this genomic region of strain 536 that are completely missing from the genome 
of MG1655 and CFT073. This part shows high homology at the nucleotide level to the recently 
described type II secretion system-encoding gene cluster of an O78:H11 ETEC strain, and plays a 
role in the secretion of a heat-labile enterotoxin of the ETEC strain H10407 (Tauschek, 2002; 
AF426313). The next gene that was common again in MG1655 and 536 was gspC (orf86) or 
yghF. 81,194 bases downstream of pheV in strain 536 an ORF is located (orf89, yghJ) that is also 
present in MG1655 and was found to be the largest orf in PAI V536 and downstream sequences. 
yghJ can also be found in MG1655 and earlier was thought to be two genes (b2973 and b2974). 
Sequence homology to the genome of CFT073 comes back at yghK. This is the gene, which is  
 
Fig. 23: Comparison the common parts of the general secretion pathway genes among three 
different E. coli strains. A nearly 8 kb insertion can be found in strain 536 (b) relative to the 
equivalent genomic part of the K-12 strain MG1655 (a), while the genome of CFT073 (c) 
shows a dramatic reduction of this part, hypothetically because of an integration of an IS 
element.   
genomic part of CFT073 
downstream of the kps 
gspD  L  
yghK 
insG 
genomic part of strain 536 
downstream of the kps 
gspD   L   K    J  I HG    F      E         D      C   
yghF  G 
pppA / 
b2972 
b2973-b2974 
yghK
genomic part of MG1655 
downstream of pheV 
gspM   L  C  
yghD    E   F   G
pppA/ 
b2972 
b2973-b2974 
yghK yghJ 
yghJ yghD   E 
yghD   E
a. 
b. 
c
 85 
common again in all the three strains. In CFT073, members of the type II secretion system are 
missing. Between the truncated gspK and the yghK gene an insG (c3703, accession number 
AE016766) can be found, which is a transposase gene of the insertion element IS4.  
Transcription of the gsp gene cluster was studied by RT-PCR. With primers gspDfwRT and 
gspDrevRT, gspD transcripts could not be detected from cDNA of exponentially growing cells 
(not shown). The gsp genes that were absent in strain MG1655 but were present in strain 536 
have been deleted: altogether 6,870 bases were deleted involving the genes gspD, E, F, G, H, I, J 
and K. This deletion started 70,970 bases downstream of pheV and ended at position 77,840. The 
resulting deletion mutant was tested for capsule production and was also tested in the ascending 
urinary tract infection model. Neither loss of capsule expression nor virulence attenuation could 
be detected. 
 
As described in section 1.1.4, a 7 kb insertion was localised on the cosmid pCos2/13 relative to 
the E. coli K-12 situation. This DNA region exhibited homology to the genomic regions of S. 
flexneri 2a (accession number: AE015315) and the UPEC strain CFT073 (accession number: 
AE016766) genomes. According to the sequence analysis, some of the putative ORFs localised in 
this region encode membrane bound proteins, e.g. permeases (orf102-orf103) or a hypothetical 
protein with similarity to ATP-binding proteins (orf105).  
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5 Mobilisation of PAI II536 into recipient strain SY327 
5.1 A modified PAI II536 derivative is transferred by the conjugative plasmid RP4 
Studies of the instability of PAIs from UPEC strain 536 have revealed that four of them (PAI I536, 
PAI II536, PAI III536 and PAI V536) are able to delete from the chromosome with different 
frequencies. Additionally, extrachromosomal forms (circular intermediate, CI) of PAI II536 and 
PAI III536 were detected by a specific PCR assay (Middendorf et al., 2004). PAIs are thought to 
exist at least transiently as CIs after excision from the chromosome by integrase-mediated site-
specific recombination between the flanking direct repeats (Blum et al., 1994, Middendorf et al., 
2004, Hochhut unpublished). Since the islands of strain 536 contain no origin of replication, it 
has been also hypothesised that CIs are lost upon cell division if they fail to reintegrate into the 
chromosome. The processes involved in deletion and probably also in integration of PAIs are 
relatively well studied, but little is yet known about the mechanisms that have been involved in 
acquisition of PAIs by horizontal gene transfer. To evaluate the potential of PAIs to be 
transferred by conjugation, PAI II536 was labelled with a resistance gene (cat) for selection, an 
origin of replication (oriVR6K) and an origin of transfer (oriTRP4). 
An overview of the main steps of the mobilisation experiment is shown in Figure 24. First, the 
chloramphenicol resistant derivative pGS704 of the suicide vector pGP704 was integrated into a 
non-coding part of PAI II536 by homologous recombination. This plasmid carries a mobilisation 
region containing oriT, that served later as the origin of transfer and originates from the 
conjugative plasmid RP4. Furthermore, the plasmid contains an oriV derived from plasmid R6K 
that functions only in the presence of the trans encoded π-protein (pir). Second, after labelling 
PAI II536, the pir gene was integrated into the chromosome of strain 536 by inserting it into the λ 
attachment site (λatt) to ensure that PAI II536 can replicate and be stably maintained in the 
extrachromosomal form after excision from the chromosome. Finally, the plasmid RP4 was 
introduced to deliver the genes for mating pair formation and conjugative DNA metabolism (tra 
genes) that are required for transfer of PAI II536 by conjugation. As a recipient strain, the K-12 
derivative SY327 was used, that contains a λ phage carrying the pir gene and that is resistant to 
nalidixic acid due to a mutation in gyrA. Transconjugants were selected on agar plates containing 
Nal (for SY327), Cm (for labelled PAI II536) and 5% blood because PAI II536 codes for an α-
haemolysin determinant. 
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Fig. 24: A general overview of the main steps of the mobilisation experiment. PAI II536 was 
labelled and then transferred by conjugation. For more details, see text. 
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5.2 Labelling of PAI II536 with a resistance marker, an origin of replication and an origin of 
transfer 
For inserting a cat cassette into pGP704, the vector was cut with the restriction endonuclease 
PstI. Thereby, a 700-bp fragment that encompasses two thirds of the ampicillin resistance gene 
bla was deleted and replaced by the cat cassette that was amplified from pACYC184 with 
flanking PstI sites. This Cm-resistant pGP704 derivative was named pGS704. Into this plasmid, 
two PCR products that correspond to non-coding sequences of PAI II536 2500 bp downstream of 
leuX (using primer pairs paiII_1XhoI, paiII_1Sac and paiII_2Sac, paiII_2XhoI) were ligated into  
 
Fig. 25: PAI II536 was labelled by homologous recombination with a replication origin (oriV from 
plasmid R6K), a Cm resistance marker (cat), and a mob-region that contains oriT. 
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flanking PstI sites. This Cm-resistant pGP704 derivative was named pGS704. Into this plasmid, 
two PCR products that correspond to non-coding sequences of PAI II536 2500 bp downstream of 
leuX (using primer pairs paiII_1XhoI, paiII_1Sac and paiII_2Sac, paiII_2XhoI) were ligated into  
 
Fig. 25: PAI II536 was labelled by homologous recombination with a replication origin (oriV from 
plasmid R6K), a Cm resistance marker (cat), and a mob-region that contains oriT. 
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a SacI restriction site. The orientation of the two fragments was inverted in the circular form, and 
only corresponds to the original order in PAI II536 after linearization with XhoI (Figure 25.). 
The purified linearised vector with the flanking regions homologous to PAI II536 was 
electroporated into strain 536 containing pKD46. Recombinant colonies with the integrated 
pGS704 suicide vector were selected on antibiotics containing LB plates. Cm- and Sm-resistant 
clones were tested by PCR and then analysed by Southern hybridisation whether the insertion of 
the pGS704 was really correct (Figure 26). For further experiments, clone 10 (536mob_10) was 
chosen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26: Verification of pGS704 integration into the PAI II536 by Southern hybridisation. On the 
left side, the digested (EcoRV) chromosomal DNA of 10 candidate clones are shown that 
were hybridised with a specific probe to fragment 2 of PAI II536 (top) and with labelled 
pGS704 (bottom). Clones 1, 2, 3, 4, 6, 7, 8, and 10 appeared to be integrated as 
expected; (a 4-kb fragment hybridised with the PAI II536/2-specific probe and a 5-kb 
fragment hybridised with pGS704), while clones 5 and 9 were not correctly integrated. 
(thick black line: PAI II536 sequences for homologous recombination; middle thick black 
line: pGS704Cm, vertical lines: EcoRV sites). 
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With the help of the pLDR plasmid family, the pir gene was integrated into the chromosome of 
strain 536mob_10. The pir gene was amplified from strain Sm10λpir with the primers 
pir_fw_SacI and pir_revStop_EcoRI. Primer pir_revStop_EcoRI was designed cautiously because 
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when pir of plasmid R6K was cloned by partial digestion with HindIII, only a fragment 
containing the first two third of this gene was integrated into the chromosome of strain Sm10λpir 
(personal communication, J. Reidl and S. Schild). Downstream of the gene an alternative STOP 
codon is present. Transcription of the resulting 3' truncated pir allele is sufficient for activity of 
the π-protein. Based on the sequence of the pir gene, the reverse primer was designed in a way 
that a complementary STOP codon (TGA) was introduced and overlapped one bp with the 
HindIII recognition site (Figure 27).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Variations of the pir gene present in pR6K and E. coli strain Sm10λpir. For the 
integration into the λ-attB site of the E. coli 536mob_10, pir was amplified from the 
genome of E. coli strain Sm10λpir. Constructing this strain, the plasmid R6K was partially 
digested (HindIII) and pir was indirectly integrated into the chromosome (via λ phage). The 
last third of the original gene is missing and ends with an alternative STOP codon in 
Sm10λpir. Amplification of the incomplete pir gene (the first two third) was performed 
from the chromosome of Sm10λpir by using a primer that contained a complementary TGA 
STOP codon that overlaps with the HindIII recognition site (AAGCTT). 
 
The 950-bp PCR product (pir gene) was ligated with EcoRI and SacI restriction sites into 
pLDR9. After restriction with NotI the bigger fragment was religated and electroporated into the 
pLDR8 containing strain 536mob_10. Pools of clones were screened with PCRs (primers ATT1 
and ATT2) for the integration of pir into the λ attachment site (Figure 28). From positive clones, 
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a 3-kb fragment was amplified.  The 290-bp fragment corresponding to the size of the PCR 
product without integration remained there but became fainter. One clone was chosen and tested 
for the expression of π-protein. For this, a pCVD442 derivative with a tetracycline resistance 
cassette was used. pCVD442 carries an oriR6K and a functional π-protein supports the 
replication of pCVD442-Tc under selective conditions after electroporation. The clone 536-
19mob was chosen for further experiments. For the mobilisation experiments this clone was used 
as a negative control.  
 
Fig. 28: Detection of pir insertion into the λ-
attB site of strain 536mob_10. Candidate 
clones (lanes 1-12) were checked by 
PCR with the primer pair ATT1 and 
ATT2. Successful pir insertion into the 
chromosome resulted a 3 kb PCR 
product (lanes 3-7, 9-11). Without 
integration, a 290 bp fragment was only 
amplified (lanes 1, 2, 8, 12) similarly to 
the wild type strain 536 (last column).  
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5.4 The labelled PAI II536 is mobilisable by RP4 
After labelling of PAI II536 and integrating the pir gene into the chromosome, the plasmid RP4 
was conjugated into the strain 536-19mob. Conjugation with RP4 was very effective and one 
clone (536-19/1mob) was chosen for further experiments. Later, in the conjugation experiments, 
this strain was used as the donor strain. The recipient strain was the nalidixic acid resistant 
SY327 laboratory strain. For the first conjugation experiments O/N cultures were used with a 
donor to recipient ratio of 1:1. The total volume (200 µl) was spread on LB plates and incubated 
for 24 hours at 37 ºC, for 48 hours at 30 ºC, for 72 hours at 20 ºC and for 168 hours at 4 ºC. Cells 
were resuspended and for selection of transconjugants, 100-µl aliquots of the undiluted 
suspension, a 10-1-, and 10-2-dilution were plated on Cm-Nal-blood agar. We have found 90 
haemolytic clones that were further analysed by PCR. First we looked for those haemolytic 
clones that were not strain 536 but were the laboratory strain SY327, that is why the primers 
specific for E. coli strain 536 (orf4bico and orf5bico, bind in region 2 in the K15 gene cluster) 
and strain K-12 (K12R and K12L or K12R and K12ISL, Kuhnert et al., 1995), respectively, were 
used. Those 16 clones that were negative in the 536-specific PCR assay and positive in the K-12-
specific PCR assay were then tested with primer pairs specific to PAI II536. In this latter PCR the 
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following primer pairs were used: 17kDup and 17kDin, hlyDup and hlyDin, hec_down1 and 
hec_down2, dsdXin and dsdAup, ORFAin and Na-Anti_pdo (Fig. 28). From those six clones that 
were positive with all the five screening primer pairs, overlapping PCRs were carried out that 
covered the complete PAI II536 (102 kb). 53 primer pairs were designed that amplify overlapping 
products each with a size of 2 kb. With these PCRs, it was verified that the clones in question 
contained the complete PAI II536 without internal deletions. Subsequent PCRs were performed to 
check whether the mobilised PAI II536 was present in the recipient strain in the circular form or 
integrated into the chromosome. If there was no integration at leuX, the primer pair M803b and 
M805c allowed amplifying of an 800-bp product and if the mobilised PAI was present in the cell 
as a stable circular intermediate, the PCR with primers (leu2 and Concat1 or alternatively with 
PaiII_1rev and PaiII_53fw) was positive. These primers were designed in a way that they are 
oriented towards the ends of chromosomally integrated PAI II536 and only amplify a specific 
product when PAI II536 is present in the circular form. Finally, PAI II536 carrying transconjugants 
were analysed by pulse field gelelectrophoresis to reveal differences in the restriction pattern of 
the transconjugants carrying integrated or extrachromosomal PAI II536.  
 
5.4.1 Mobilisation of the whole pathogenicity island was detected 
Results of the first conjugation have successfully shown that intercellular transfer of a whole 
pathogenicity island could occur with our system, although with very low rates. These results are 
summarised in Figure 29.  
Altogether, 90 haemolytic that were also Cm/Nal resistant were isolated. However, checking 
these clones with 536- and K-12 specific PCRs revealed that most of them were only spontaneous 
nalidixic acid resistant mutants of strain 536. The remaining 16 clones were analysed with PAI 
II536-specific PCRs to determine whether they had obtained the complete PAI II536. Six 
transconjugants of SY327 seemed to contain the whole PAI II536 while the other 10 contained 
only parts of it (Figure 28). With the six clones, additional PCRs with primers amplifying 
overlapping products were carried out to verify that no internal deletion had occurred within PAI 
II536 (Figure 30). 
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Fig. 29: Detection of partial as well as complete transfer of PAI II536 into strain SY327 by PAI 
II536 specific PCRs. Primer binding places of the screening PCRs are shown with small 
dots under the line representing of PAI II536 in the upper part of the figure. 6 out of 16 
clones (shown in bold letters) were positive with all six primer pairs. PCRs with the leuX 
and cointegrate primers (right) suggested that in clones 23, 46 and 54 the mobilised PAI 
II536 has been integrated into the chromosome of strain SY327 at leuX, whereas clones 
26, 59 and 77 seem to carry the extrachromosomal form. Except clones 21-23 and 46, 
transconjugants result from matings at 20 °C. Orientation of “integration primers” and 
M803b and M805c are labelled above (see also Fig. 30) 
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23 46 54 59 7726
 
Fig. 30: Transfer of the complete PAI II536 into strain SY327 as verified with overlapping PCRs. 
All the six candidate clones were positive for every PAI II536-specific PCR (53x2kb). In 
clones 26, 59 and 77 the positive signal (◊) of the primers PaiII_1rev and PaiII_53fw 
(see Fig. 31/c) suggests that PAI II536 is present in the circular from as also indicated by 
circles beneath the gel photos. 
 
5.4.2 PAI II536 can integrate into leuX of the recipient’s chromosome 
Further analysis by PCR revealed that only three (no. 26, 59 and 77) out of the six 
transconjugants containing a complete PAI II536 carried the island in the extrachromosomal form 
(Figure 29). From the other three transconjugants (no. 23, 46 and 54) no product was obtained 
with primers specific for the circular form. Furthermore, leuX-specific primers failed to amplify a 
product suggesting that, as in E. coli strain 536, PAI II536 had integrated into leuX. Therefore, a 
PCR assay specific for the junctions between chromosome and island was designed to prove this 
assumption (Figure 31). From the results it became evident that after mobilisation and transfer of 
PAI II536, the island can either be maintained as a stable circular element or integrates into the 
recipient’s chromosome thereby using the same insertion site as in the donor. 
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Fig. 31: Integration of the mobilized PAI II536 into the chromosome of SY327 at leuX was 
detected by PCR. leuX and PAI II536 specific PCRs were carried out (a) with the laboratory 
K-12 strain SY327, the wild type strain 536, and the SY327 clones 23, 46, 54. For this 
purpose four testing primers (M803b, M805b, PaiIIrev1, PaiIIfw53) were used in different 
combinations (b) that is also detected on the bottom of the gelphotos (a). Orientation of the 
primers relative to leuX (green box) in a K-12 strain and in the wild type strain 536 is 
depicted in the lower part of the figure (c). 
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5.4.3 Clones with the mobilised PAI II536 were analysed by PFGE 
PAI II536 has a size of 102.3 kb. Deletion of the island from the chromosome (strain 536-225) 
could clearly be visualised by PFGE (dissertation of G. Blum). We also checked the six 
transconjugants with this method to see whether differences could be detected between isolates 
carrying the PAI integrated into the chromosome or in the circular form, respectively (Figure 32). 
NotI SfiI
L    23   26    46    54    59   77  536  SY327   L L    23   26    46    54    59   77  536  SY327   L
 
Fig. 32: Similarities and differences among the clones where PAI transfer has occured were 
confirmed by PFGE. DNA was digested with NotI (left) or SfiI (right). All the six clones 
where PAI II536 was present show the typical pattern of strain SY327, but because of the 
presence of PAI II536 additional bands are also present. (L –ladder, 23, 26, 46, 54, 59, 77 are the 
six transconjugants; 536, SY327 are controls; mark 'o': in these clones the mobilised PAI II536 is present as 
a circular form, while in clones 23, 46 and 54 integration of the mobilised PAI into the chromosome of 
strain SY327 has occurred.) 
 
First, the analysis by PFGE confirmed that the transconjugants are derivatives of SY327 as they 
show a similar restriction pattern to the K-12 strain, but not to 536. Furthermore, the 
transconjugants with the circular form of PAI II536 (26, 59 and 77) have an identical restriction 
pattern. Similarly, clones 23 and 46 (PAI II536 integrated into the chromosome) showed the same 
pattern with both restriction enzymes, but clone 54 showed a little difference compared to 23 and 
46. It can be speculated that other DNA rearrangements may have occurred in this strain, but this 
was not further investigated. 
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6 Remobilisation of PAI II536 from SY327 into 536-21 
We could successfully demonstrate that mobilisation of a whole pathogenicity island from one 
strain to another is possible. Following deletion from the chromosome, the modified PAI II536 
was transferred by conjugation mediated by plasmid RP4. In the recipient strain SY327, (i) the 
transferred PAI could either integrate into the chromosome or (ii) be stably maintained as a 
circular form that replicates via oriR6K in the pir containing recipient.  
In the next part of the mobilization experiments we wanted to know whether remobilisation of 
PAI II536 could occur or not. Experiments were divided into two groups according to the state of 
the mobilised PAI. In the first group, clone 77 was used as a donor strain with PAI II536 present in 
the circular form. In the second group, clones 23 and 54 were used as donor strains. As shown 
before, they both contain PAI II536 integrated into leuX in their chromosome, but could be 
distinguished by small differences in their restriction patterns.  
In all cases strain 536-21, a nonhaemolytic derivative of strain 536 lacking both islands encoding 
a haemolysin determinant (PAI I536 and PAI II536), was used as a recipient strain. Remobilisation 
experiments were carried out in a way that the π-protein was only expressed in the donor strains 
(SY327 – 23, 54 and 77) but not in the recipient strain 536-21.  
 
For selection M9 minimal agar was used with chloramphenicol because strain SY327 cannot use 
lactose as the only C-source due to a chromosomal deletion encompassing the lac operon. After 
mating at 37 ºC, 30 ºC and 20 ºC, respectively, transconjugants were checked by PCR. With 
clone 77 (with extrachromosomal PAI II536) as a donor strain, PAI II536 was transferred with 
relatively high frequencies (Table 6). 90 transconjugants were tested with strain 536 and K-12-
specific primers. For all the clones, the 536-specific PCRs were positive while the K-12-specific 
PCRs were negative. Similar results were obtained with clones 23 and 54 as donor strains 
although the transfer rate was less sufficient because in these strains, PAI II536 has to excise from 
the chromosome prior to conjugative transfer (Table 8). From four independent experiments, 127 
transconjugants were tested, and they all proved to be transconjugants of strain 536-21. 
Interestingly, remobilisation of PAI II536 from clones 23 and 54 was significantly higher at 20 ºC. 
At this temperature, a tenfold higher deletion rate of PAI II536 had been observed in the stationary 
growth phase (Middendorf et al., 2004).  
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In strain 536-21, the remobilised PAI II536 cannot be maintained as a circular intermediate 
because this strain does not contain pir. Integration of PAI II536 into the chromosome of strain 
536-21 was investigated using the primer combinations described before (Figure 31). With the 
SY327 transconjugant no. 77 as a donor strain, 9 clones of strain 536-21 were tested and all of 
them showed a PCR fragment pattern corresponding to integration of PAI II536 into leuX. With 
SY327 transconjugants no. 23 and 54 as donor strains, in eight out of nine transconjugants of 
strain 536-21 tested, integration had occurred into leuX, whereas in one 536-21 transconjugant 
integration may have occurred in another site, because it showed another PCR pattern. However, 
this was not further investigated.  
From these results, it can be concluded that PAI II536 was transferred with higher frequencies 
from those strains that carried the island in an extrachromosomal form. However, in the pir 
negative recipient 536-21, PAI II536 integrated specifically into the tRNA gene leuX, 
independently whether it had been present in the circular or integrated form in the donor.  
 
Table 6: Remobilisation of PAI II536 from strain SY327 into the strain 536-21.  
 
           a                                                             b 
 
 
 
 
 
 
 
 
 
 
           c 
 
 
 
Frequencies of the remobilisation are shown where PAI II536 was integrated into the chromosome of SY327 (a and b) 
and where PAI II536 was remobilised from the circular intermediate form (c ). More details can be found in 
Appendix.   
Starting conditions of conj. Results of the conjugation
Donor:Recipent ratio
Temperature 23:536/21 Efficiency of conjugation
A37 1,44:1 1x10-9
B30 1,44:1 7,3x10-8
C20 1,44:1 0
D37 7,6:1 0
E30 7,6:1 1x10-9
F20 7,6:1 3,1x10-6
G37 40,0:1 0
H30 40,0:1 6,6x10-8
I20 40,0:1 6,6x10-7
Starting conditions of conj. Results of the conjugation
Donor:Recipent ratio
Temperature 23:536/21 Efficiency of conjugation
A37 2,2:1 0
B30 2,2:1 3x10-7
C20 2,2:1 1,8x10-7
D37 6,9:1 0
E30 6,9:1 2,5x10-7
F20 6,9:1 5,75x10-7
G37 24,2:1 0
H30 24,2:1 5x10-7
I20 24,2:1 1,6x10-7
Starting conditions of conj. Results of the conjugation
Donor:Recipent ratio
Temperature 54:536/21 Efficiency of conjugation
A37 1,1:1 1x10-8
B30 1,1:1 2,14x10-7
C20 1,1:1 9x10-7
D37 5,8:1 0
E30 5,8:1 2,7x10-7
F20 5,8:1 3,15x10-7
G37 30,9:1 4x10-8
H30 30,9:1 2,3x10-8
I20 30,9:1 1x10-8
Starting conditions of conj. Results of the conjugation
Donor:Recipent ratio
Temperature 54:536/21 Efficiency of conjugation
A37 2,2:1 0
B30 2,2:1 6,25x10-7
C20 2,2:1 2x10-7
D37 6,9:1 0
E30 6,9:1 6,6x10-7
F20 6,9:1 4,5x10-7
G37 24,2:1 0
H30 24,2:1 0
I20 24,2:1 3,63x10-7
Starting conditions of conj. Results of the conjugation
Donor:Recipent ratio
Temperature 77:536/21 Efficiency of conjugation
A37 2,2:1 5,4x10-5
B30 2,2:1 1,2x10-4
C20 2,2:1 1,2x10-5
D37 6,9:1 4,2x10-5
E30 6,9:1 8,4x10-5
F20 6,9:1 1x10-5
G37 24,2:1 4,3x10-5
H30 24,2:1 6x10-5
I20 24,2:1 1,9x10-5
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6.2 Localisation of a possible growth factor on PAI II536 
Sequence and phenotypical analyses of PAI II536 have revealed that it carries a haemolysin 
determinant, a fimbrial- and a putative adhesin gene cluster. Additionally, several ORFs encoding 
hypothetical proteins with unknown functions are also present.  
During the remobilisation experiments, CFUs of the starting mixture and of the cell resuspension 
after coincubation of donor and recipient strains (PAI II536 transcjonjugants of SY327 and 536-
21) were determined. SY327 alone grows relatively slowly, due to several mutations (especially 
recA). Interestingly, when coincubated, PAI II536-containing SY327 was able to overgrow 536-
21. This phenomenon was only observed at 37 ºC and was not striking at 20 °C and 30 °C.  
 
Table 7: Analysis of the PAI II536-dependent growth advantage by competitive growth 
experiments between strain 536-21 and different PAI II536 fragment-containing SY327 
derivatives.  
 
In the left column transconjugants of the the laboratory strain SY327 are listed that contain the whole (77) and parts 
(21, 22, 27, 28) of the mobilized PAI II536 (see Fig. 28). Each strain was mixed in three different ratios (A, B, C) with 
strain 536-21 (middle main column) and was incubated at 37 °C. After 24 hours CFUs and ratios were determined 
(last column).   
 Start 
SY327 transconjugant 
: 536-21 
 Stop 
SY327 
transconjugant 
: 536-21 
SY327 
transconjugant 
no. 
Experim
ent no.  
Ratio of strains  Ratio of strains 
21 A 
B 
C 
0.18:1  
0.95:1  
5:1  
 0.022:1
0.3:1
0.66:1
22 A 
B 
C 
2.7:1  
14.2:1  
75:1  
 0.47:1
6:1
62:1
27 A 
B 
C 
0.87:1  
4.6:1  
24:1  
 3:1
13.8:1
3.,5:1
28 A 
B 
C 
0.24:1  
1.2:1  
6.6:1  
 0.038:1
0.2:1
0.83:1
77 A 
B 
C 
0.83:1  
4.37:1  
23:1  
 3.3:1
24.5:1
86:1
SY327 A 
B 
C 
0.036:1  
0.19:1  
1:1  
 0.026:1
0.067:1
0.16:1
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A competitive growth experiment was performed by using those clones that were received in the 
mobilisation experiments. Some of these SY327 derivatives did not contain the whole PAI II536 
but only a part of it. SY327 transconjugants 22, 28, 21, 27 (Figure 29) were chosen for a 
competitive growth experiment with wild type strain SY327 as a negative control and SY327 
transconjugant 77 as a positive control because this is one clone that contained the whole 
mobilized PAI II536.  
Comparing the cell ratios at the starting time point and after 24 h incubation, not only SY327 
transconjugant 77 was able to overgrow strain 536-21 but also transconjugant 27. In contrast, 
with transconjugant 21 that contains a smaller fragment of PAI II536 than transconjugant 27, no 
overgrowth could be detected. The comparison of the fragment length of PAI II536 in the different 
SY327 transconjugants suggests that genes located in the region between 32 kb and 58 kb 
account for the growth advantage of SY327 at 37 °C.  
 
 
Fig. 33: Localisation of the region within PAI II536 identified by competition experiments 
responsible for the growth advantage relative to PAI II536-negative strains. 
 
Precise localisation of the gene that can be responsible for this phenomenon has not been 
performed yet.  
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1. Genome plasticity and evolution of enterobacterial variants 
The sequence analysis of complete bacterial genomes made it possible to get detailed insight into 
the genetic structure of different bacterial genomes. The first bacterial genome sequence that was 
completely determined was that of Haemophilus influenzae (Fleischman et al., 1995) and since 
then complete genome sequences of more than 200 bacterial genomes have been finished 
(http://www.ncbi.nlm.nih.gov/genomes/MICROBES/Complete.html) or are in progress. 
Comparison of complete genome sequence information obtained from different pathogenic, 
symbiotic or non-pathogenic strains reveals characteristic differences between certain pathotypes 
or non-pathogenic variants. For a long time, phenotypic differences have been considered to be 
frequently associated with the presence of extrachromosomal elements such as plasmids, e.g. 
encoding toxins or invasion factors. The bacterial chromosome was generally regarded as a well 
conserved replicon that is relatively stable and static (Brunder and Karch, 2000). However, the 
increasing number of comparative studies of bacterial genomes demonstrates that they may be 
relatively variable structures constantly undergoing changes. This so-called genome plasticity 
depends on the bacterial organisms and is not only manifested by the acquisition or loss of 
genetic information, but also by large-scale rearrangements affecting genome organisation 
(Brunder and Karch, 2000). Resulting from genome plasticity, an enterobacterial bacterial 
genome is composed of a conserved ”core“ genome, which contains the genetic information that 
is required for essential cellular functions and a ”flexible“ gene pool, which encodes additional 
traits that can be beneficial under certain growth conditions (Dobrindt et al., 2004). This latter 
one also includes genetic information that codes for disease-related factors in pathogenic bacteria 
that are usually absent from non-pathogenic species. This flexible gene pool consists of, e.g. 
genomic islands (GEIs) and pathogenicity islands (PAIs) as well as of plasmids, bacteriophages 
and accessorial DNA elements such as IS elements and transposons (Dobrindt and Hacker, 2001).  
 
1.1 Pathogenicity islands and their contribution to genome plasticity of UPEC strain 536 
Spontaneous loss of the haemolytic activity of UPEC strain 536 due to deletion of two large 
alpha-haemolysin encoding genomic regions was the first observation that led to the concept of 
pathogenicity islands. It was the first clear indication that virulence-associated genes can be 
deleted from the core chromosome, resulting in attenuation of a bacterial pathogen (Blum et al., 
1994). Since these first experiments, four PAIs of strain 536 have been identified and 
characterised in detail. The four PAIs of strain 536 exhibit typical features of PAIs (Kaper and 
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Hacker, 1999). They carry least one virulence-associated gene, they have a different G+C content 
relative to that of the core chromosome, they are associated with a tRNA gene, they carry kryptic 
or functional “mobility” genes and phage sequences, and they have a typical mosaic-like 
structure indicative of multiple genetic rearrangements. 
 
With the help of suppressive subtractive hybridisation (SSH) analysis of strain 536 and the K-12 
strain MG1655, the genome of  this UPEC isolate was screened for additional DNA fragments 
absent from that of E. coli K-12 strain MG1655 representing so far uncharacterised PAIs that 
could be important during pathogenesis This analysis resulted in the identification of a DNA 
fragment that exhibited homology to the gene coding for the capsule transport protein KpsC of 
the K10 capsule (Janke et al., 2001). The E. coli strain 536-specific K15 capsule-encoding gene 
cluster was unknown at that time, but it was clear from the literature that kps loci were usually 
chromosomally integrated downstream of the tRNA genes pheV and serA (Orskov and Nyman, 
1974; Orskov et al., 1976; Swenson et al., 1996). Furthermore, more and more data accumulated 
suggesting that pheV and the highly homologous pheU gene are frequently associated with PAIs. 
Examples for pheV-associated PAIs are the she PAI of S. flexneri, the LEE PAI of the REPEC 
strain 84/110-1, PAI I of UPEC strain J96 and a putative PAI of an EHEC O157:H7 strain 
(Tauschek, 2002; Swenson et al., 1996). pheU has been shown to be the chromosomal integration 
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evolution of genomic regions of the flexible gene pool: genetic information that may be 
beneficial under certain growth conditions can be acquired and stabilised within the chromosome 
or others which are not important can be deleted. Comparison of PAI V536 with the pheV- and 
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pheU-associated islands of E. coli strain CFT073 revealed that these islands are partially similar. 
The acquisition of a functional phosphoglycerate transport system (pgt) on PAI V536 appears to 
have occurred via horizontal gene transfer. Its broad distribution among the different 
extraintestinal E. coli isolates (Appendix 5) suggests that the phosphoglycerate transport sytem 
may play role in the pathogenic process. We do not know much about the chromosomal 
localisation of the pgt clusters of the other strains of the IMIB strain collection, but the same pgt 
gene cluster as in strain 536 is also present in strain CFT073. In this strain, the pgt gene cluster is 
not located on the pheV- but on the pheU–associated island and is also flanked by mobile genetic 
elements, an R6 transposase gene and an IS2 element. Thus, it could be speculated that the 
phosphoglycerate transport system gene cluster could be deleted or integrated into the 
chromosome with the help of IS elements. This is supported by the fact that on PAI V536 this 
cluster is flanked by an R6 transposase gene and a truncated IS2 element that may have been 
involved in its transfer.  
It seems that IS2 elements served as a target site for integration of the pgt gene cluster into PAI V 
of strain 536. This hypothesis is based on the fact that this cluster is not flanked by IS2 remnants 
in the pheU island of strain CFT073, whereas this IS element is localised in the corresponding 
region of the pheV–associated islands of UPEC strain CFT073 and probiotic E. coli strain Nissle 
1917 (GEI IINissle 191). These latter two islands do not carry remnants of a pgt gene cluster. 
Interestingly, in case of GEI IINissle1917, IS2 sequences are involved in deletion of a chromosomal 
region (IS2-iuc-sat-ORFs-iha-IS2) flanked by them (L. Grozdanov, PhD thesis, Würzburg 2004).  
 
Downstream of the phosphoglycerate transport system-encoding gene cluster, a putative 
autotransporter gene (sap) was localised. Similar, but not identical genes are also located at the 
same chromosomal site on GEI IINissle 1917 and on the pheV island of strain CFT073. These genes 
code for an antigen 43-homologue.  Another variant of this autotransporter gene was localised on 
the chromosome of strain 536 which is encoded on PAI III536. It is well known that Ag43 
expression is important for biofilm formation of E. coli (Danese et al., 2000; Kjaergaard et al., 
2000; K.Michaelis and U. Dobrindt, personal communication). The two Agn43 variants of strain 
536 are similar and probably closely related. Their role and function requires further analysis but 
they represent a good example of genome plasticity: The fact that these autotransporter genes are 
always located on GEIs/PAIs or plasmids rather implies that these genes have been acquired by 
horizontal gene transfer. Even in K-12, the agn43 gene is part of a prophage. Multiple copies of 
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this gene can be the result of spontaneous chromosomal duplications that are common in 
populations of E. coli and Salmonella typhimurium, and under the selective pressure of laboratory 
conditions their frequency is in the range 10-2 to 10-4 (Haack and Roth, 1995).  
 
These three pheV-associated islands show another striking similarity: Downstream of the 
truncated copy of pheV ('pheV) the capsule determinant is localised. From this and from the fact 
that these islands carry the same integrase gene it can be concluded that PAI V536  and the pheV-
associated islands of strains CFT073 and Nissle 1917 might be considered as members of one and 
the same family of pheV-associated capsule-encoding islands of E. coli. The common origin 
could further be supported by the fact that in PAI V536 the pix fimbrial gene cluster (Lügering et 
al., 2003) is localised nearly 4 kb downstream of the pheV tRNA gene. Similarly, a complete pap 
fimbrial gene cluster is present in the same sequence context of the pheV island of strain CFT073. 
Interestingly, only remnants of the pap operon are present in the corresponding DNA context in 
GEI IINissle 1917 (Grozdanov et al., 2004). Instead of the 30-kb hly/pap region present in strain 
CFT073, only a fragment of papA (papA') and the intact papI gene exist in the corresponding 
region of GEI IINissle1917. The presence of the P-fimbriae family-encoding gene clusters implies 
that these three pheV-associated islands have a common ancestor. It could be speculated that the 
fimbrial cluster remained intact and functional in strain CFT073 but was almost completely 
deleted from GEI IINissle1917. Nevertheless, in strain 536 the situation is not so simple because the 
pix fimbriae-encoding gene cluster does not show significant homology to the pap fimbrial 
cluster of the pheV island of CFT073. Despite similarity of the genetic organisation between pix 
and pap (Figure 10), they show no significant homology to each other at the nucleotide level. 
Similarly, on the protein level, only the chaperone and usher proteins exhibit some similarity to 
the corresponding PapC and PapD proteins. We can hypothezise that the pix fimbrial cluster has 
been acquired and inserted later into the pheV island of strain 536 thereby replacing a pre-existing 
pap fimbrial gene cluster. Another option could be that pap and pix gene clusters are located on 
different mobile genetic elements and have been independently inserted into a pre-existing pheV 
PAI ancestor. Comparison of this region on the different pheV-associated PAIs revealed that in 
case of strain CFT073 upstream of the pap fimbrial cluster an alpha-hemolysin determinant is 
present, which is completely missing from the corresponding region of GEI IINissle 1917 and PAI 
V536. On PAI V536 only remnants of the upstream region of the alpha-hemolysin operon can be 
detected.  
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These data demonstrate that horisontal gene transfer and genetic rearrangements catalysed by 
homologous and site-specific recombination can result in acquisition and/or deletion of genetic 
information thus contributing to the generation of different variants of pheV and pheU-associated 
islands in pathogenic and non-pathogenic E. coli.  
Horisontal gene transfer includes a variety of processes by which bacterial genomes can be 
changed rapidly. These dramatic changes are those key factors that keep bacterial evolution in 
motion and that lead to 'evolution in quantum leaps' (Hacker and Carniel, 2001). By incorporating 
of transferred genetic elements directly into the genome of another organism, a 'genomic island' 
can be formed whose functions can increase bacterial fitness either directly or undirectly. The so 
called 'fitness islands' can be divided into several subtypes: 'ecological islands' in environmental 
bacteria and 'saprophytic islands', 'symbiosis islands' or 'pathogenicity islands' (PAIs) in 
microorganisms that interact with living hosts. Differences in the structure among the similar 
islands (islands with common origin) can also be observed that represents quite well that those 
genes that are not necessary for a certain pathotype are deleted while in the meantime new genes 
or entire locuses can be aquired by horisontal transfer. This leads to phenotypic (virulence) 
variations.  
 
1.2 Evolution of capsule gene clusters  
For the species E. coli alone, more than 80 chemically different capsular polysaccharides or K 
antigens have already been described (Ørskov, 1992). On the basis of chemical structure and 
gene organisation bacterial capsules can be divided into four groups (Whitfield, 1999).  
Gene duplication is considered to be the first step during evolution of group 1 and group 4 
capsules. Their genetic organisation and chromosome localisation suggests that these capsule 
gene clusters originated from the duplication and modification of the rfb gene cluster, which is 
responsible for the synthesis of the lipopolysaccharide (LPS). This hypothesis is supported by the 
analysis of the K30 capsule locus, one of the most studied archetypal group 1 gene clusters. This 
capsule locus is 16 kb in size and comprises 12 open reading frames. The first four genes (orfX, 
wza, wzb, wzc) of this polycistronic operon are highly conserved among different group 1 capsule 
gene clusters (Rahn, 1999) and have been designated as ”translocation-surface assembly“ region. 
Although the precise role of orfX remains unclear but the other components are thought to encode 
an outer membrane lipoprotein, a cytoplasmic phosphatase and an ATP binding protein, 
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respectively (Drummelsmith and Whitfield; 1999). Similar genes have been described in diverse 
systems including E. coli strain K-12 (wza, wzb, wzc) (Stevenson, 1996), Klebsiella K2 (orf4, 
orf5, orf6) (Arakawa, 1995), and Erwinia amylowora (amsH, amsI, amsA) (Bugert, 1995). 
According to the available data, biosynthesis and transport of group 1 capsule components to the 
cell surface is summarised in the current model: Individual repeat units are assembled on a carrier 
lipid (undecaprenyl phospate) by the sequential activities of glycosyltransferases. The initial step 
requires the enzyme WbaP (Drummelsmith, 2000) which is a member of an UDP-hexose family. 
Then, these repeat units are transported by the Wzx protein to the periplasmic face of the 
cytoplasma membrane. They are assembled by the Wzy protein, which catalyses the 
polymerisation step at the periplasmic site of the cytoplasma membrane. Translocation and 
surface assembly is carried out by the outer membrane proteins Wza, Wzb and Wzc (Whitfield, 
1999). In case of the group 4 capsule prototypes K40 and O111 (Amor, 1997; Wang, 1998), 
capsule synthesis also involves the Wzy-dependent pathways. Group 1 and 4 capsule 
polymerisation differs only in the initiating glycosyltransferase which is WecA in case of group 4 
capsules. This enzyme is able to transfer either GlcNAc-1-P or GalNAc-1-P to undecaprenyl 
phosphate. This step is common for group 4 capsules and all studied E. coli LPS O antigens 
(Valvano, 1994). Beside the genetic similarity, this functional similarity among group 1 and 4 
capsule determinants and the LPS gene clusters underlines their common origin. Beside the 
similarities, functional differences can be observed between regulation of the polysaccharide 
chain length of LPS and group 1 and 4 capsules. LPS side chain length is controlled by the chain-
length determining protein Wzz. This enzyme controls the Wzy-dependent chain elongation step 
with the ligase WaaL (Whitfield, 1997) which transfers the synthetised polymer (or 
oligosaccharide) from the lipid intermediate onto the lipid A-core acceptor (Heinrichs, 1998). It 
has been confirmed that this system does not function in case of group 1 and 4 capsules. In group 
1 gene clusters, the wzz gene is completely deleted whereas wzz exists in group 4 determinants 
but has evidently no effect on chain elongation (Dodgson, 1996; Amor, 1997; Drummelsmith, 
1999). Accordingly, it seems to be clear that there is an alternative polymerisation control for 
group 1 and 4 capsular antigens. This is presumably due to the fact that ligation to lipid A-core is 
not required for capsule expression on the cell surface (MacLachlan, 1993; Krallmann-Wenzel, 
1994). This probably was another important evolutionary step for capsule biosynthesis gene 
clusters: after gene duplication capsule biosynthesis gains independence from LPS synthesis and 
turns in a new direction that is different from that of the ancestral mechanisms. 
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Cloning and analysis of a large number of E. coli group 2 and 3 capsule gene clusters has 
revealed that they represent another alternative route for extracellular polysaccharide synthesis 
and transport. Their genetic organisation and localisation in the core chromosome is completely 
different from those of group 1 and 4 capsules. Most of the known group 2 and 3 capsule gene 
clusters are inserted at 64 minutes on the E. coli K-12 chromosome and are associated with the 
tRNA genes serA (K10, K54) and pheV (Ørskov, 1974; Ørskov, 1976; Vimr, 1991) (K5, K1, 
K15). This is far away from other sugar biosynthesis gene clusters (at 45 min on the E. coli 
chromosome (Berlyn, 1998)) like rfb (for LPS) and cps (for colanic acid capsule). The genetic 
structure of group 2 and 3 capsule determinants shows no similarity to that of the LPS gene 
cluster. Sequence analysis of different group 2 and 3 capsule clusters revealed their typical 
organisation: Two conserved regions (region 1 and region 3) flank a highly variable region 
(region 2). The genes of the conserved regions code for enzymes required for the transport of the 
capsule components through the cytoplasma membrane while the genes of the highly variable 
region 2 encode enzymes involved in the polymerisation of the polysaccharide and, where 
necessary, for the biosynthesis of the specific monosaccharide components of the polysaccharide 
(Roberts, 1996). The size variation of region 2 among different group 2 capsule types is indicated 
in Figure 33. 
 
 
 
 
 
 
Fig. 33: Schematic representation of the size variation of region 2 of different group 2 capsule 
types (Whitfield and Roberts, 1999). 
 
Whereas some ORFs of region 2 of different capsule types show homology on the nucleotide 
level to each other, others are completely different. In region 2 of the K15 capsule determinant of 
strain 536, we identified five ORFs that exhibited no homology to any known gene on the 
nucleotide level. The deduced amino acid sequences showed weak homology to sugar 
transferases like mannosyl- and glycosyltransferase. Analysis of the different capsule loci aims at 
Region 1 Region 2 Region 3 
K1 
K92 
K5 
K4 
~2kb 
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the answers to two main questions: (i) where does this high variability of the region 2 genes come 
from, and (ii) what is the mechanism by which a new region 2 variant can be acquired. 
The analysis of the different region 2 sequences of representatives of different group 2 and 3 
capsule gene clusters revealed, that the G+C content of this region is always lower than that of 
the two conserved flanking regions 1 and 3. This indicates that these genes have been acquired by 
horizontal gene transfer (Roberts, 1995).  
IS element-dependent deletion or integration is one way by which genes can be lost or acquired. 
If so, IS elements or remnants thereof should be present in the different capsule loci in the 
neighbourhood of region 2 genes. Studies to find evidence for the presence of such accessory 
genetic elements in different capsule loci were performed but were not successful in Gram-
negative bacteria (Roberts, 1996). However, acquisition of new capsule gene clusters by site-
specific transposition was more thoroughly investigated in Streptococcus pneumoniae. Analysis 
of the capsule gene clusters among S. pneumoniae strains supports an IS element-mediated 
recombination event that may play a role in the transmission of capsule genes between S. 
pneumoniae and other encapsulated pathogens (Caimano et al., 1998).  
 
In case of UPEC strain 536, analysis of the flanking sequences of region 2 has revealed four A+T 
rich repetitive sequences (between orf68-69 and orf73-74) that were 40-55 bases long and were 
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1994; Petit, 1995) that means that closer to the region 2 genes there is a higher variability of the 
C termini of region 1 and 3 has.  
 
The mixed genetic structure of the K15 capsule locus of strain 536 is reminiscent of genetic 
rearrangements and lateral gene transfer. The G+C content of region 2 is markedly lower than 
that of the conserved flanking regions, and the presence of repetitive up- and downstream  
 
Fig. 34: Genetic organization of the K15 capsule determinant shows the traces of genetic 
rearrangements. (A) Regions 1 to 3 of the kpsK15 gene cluster are indicated by different 
shades of gray. The IS1230B transposase gene is indicated by a hatched arrow. (B) Percent 
G+C plot of the kpsK15 gene cluster indicative of the segmental structure of this capsule 
locus representing DNA regions from different sources. The average percent G+C content 
of the E. coli chromosomal backbone (50.4%) is indicated by a horizontal line. 
 
sequences also suggests that genetic rearrangements occurred during evolution.  In the case of the 
K15 capsule locus an IS element-mediated genetic rearangement occured resulting in the fusion 
of a group 2 capsule determinant with that of a group 3 capsule type. According to the DNA 
sequence, it appears that IS1230B played a role in this process. As a consequence of the IS1230B 
integration into region 1 of a group 2 capsule gene cluster, the last gene (kpsS) of region 1 was 
deleted and the upstream located  kpsC gene was truncated. Consequently, the IS1230B insertion 
would have destroyed the ability to express extracellular K15 capsule as KpsC and KpsS are 
necessary for the translocation of capsule components through the cytoplasmic membrane. Lack 
of these proteins results in the accumulation of capsule components in the cytoplasm. The KpsC 
and KpsS proteins seem to be involved in the attachment of KDO (2 keto-3-deoxy-octulosanic 
acid) to the phospholipid and the subsequent ligation of the polysaccharide to the phosphatidyl-
KDO residue prior to its export across the cytoplasmic membrane catalyzed by KpsM and KpsT 
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(Bronner, 1993; Roberts, 1995). It appears that without these proteins there is no connection 
between capsule biosynthesis and the ABC transporter (KpsM and T)-mediated translocation 
through the inner membrane. However, in the K15 capsule-expressing strain 536, a complete 
kpsS and kpsC gene which exhibit homology to those of the K10 capsule type (a member of 
group 3 capsules) are located downstream of the IS1230B remnant. We demonstrated that these 
two genes compensate for the truncated kpsC and the deleted kpsS gene of the group 2 capsule-
specific region 1. From unpublished experimental results of Clarke and Roberts it was already 
clear that KpsC and KpsS are homologous among group 2 and 3 capsules and that they are 
functionally interchangeable (Whitfield and Roberts, 1999).  
 
IS element-mediated rearrangements resulting in inactivation of a functional kps gene have been 
described for the K10 capsule determinant of strain D1114 (O25:K10:H16): upstream of the 
functional kpsD gene a truncated kpsM was identified (Clarke et al., 1999) (Fig. 35). This  
 
Fig. 35: Traces of IS element-mediated rearrangements in the capsule locus of the E. coli strain 
D1114 was revealed. In this strain, that is one representative of the capsule type K10, 
upstream of the functional kps locus two IS elements and between them a truncated kpsM 
gene were localised. 
 
truncated kpsM gene represents a group 2 variant of the functional kpsM gene of the K10 capsule 
determinant that is localted downstream of kpsD. Between the truncated kpsM gene and the 
functional kpsD gene the 5'-end of a truncated IS3 element was identified. In the upstream region 
of the K10 capsule locus remnants another IS element (IS110) were found. IS110-specific 
sequences have also been identified next to the K54 capsule determinant, which belongs to group 
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3 capsules. The presence of the IS110 element in both, group 2 and 3 capsule gene clusters 
suggests that this IS element may have played a role in the acquisition of an ancestral group 3 
capsule gene cluster. The detection of IS3 remnants in region 1 of the K10 capsule gene cluster, 
but not in that of the K54-specific genes, indicate that the latter IS element has been involved in 
the events specific for evolution of the K10 capsule gene cluster (Clarke et al., 1999). The 
examples of K10 and K15 capsule loci where truncated IS elements and truncated homologous 
genes are both present mirror steps involved in evolution of bacterial capsule gene clusters in 
which both site-specific as well as homologous recombination events occurred.  
 
1.3 Distribution of DNA sequences homologous to PAI V536 among isolates from different 
origin 
In order to study the distribution of PAI V536-specific sequences among 137 non-pathogenic and 
pathogenic E. coli isolates as well as to find out whether an identical repertoir of genetic 
information can be detected in other E. coli strains, PCR reactions were designed for the 
amplification of selected regions of PAI V536 including the pixC, pgtC and gspD genes as well as 
parts of the region 1 to 3 of the kpsK15 determinant (see Figure 8 and 9). The results obtained (see 
Appendix A/5) demonstrate that generally PAI V536-specific sequences were more frequently 
distributed among ExPEC and, to a lesser extent, in commensal isolates than in diarrheagenic 
isolates. More than 50 % of the ExPEC strains tested carried kpsCK5 indicative of group 2 capsule 
determinants whereas kpsCK10 indicative of DNA regions of group 3 capsule-encoding gene 
clusters has been rarely detected among the strains included into this study. The general secretion 
pathway determinant, although more frequently distributed among ExPEC strains, was also 
detectable in at least 50 % of the diarrheagenic and commensal isolates. These findings underline 
that PAI V536-associated DNA regions are also detectable in commensal isolates indicating that 
the commensal flora represents the natural reservoir for extraintestinal pathogenic E. coli strains 
and that horizontal gene transfer plays an important role for the spread of pathogenicity islands. 
 
2. Characterization of virulence associated genes located on PAI V536 
For a successful urinary tract infection, bacteria should express virulence factors like adhesins, 
toxins, iron uptake sytems and LPS. These are the most important and best studied virulence 
factors that were also described for UPEC strain 536. The majority of these virulence factors are 
encoded on PAIs.  
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A major feature of uropathogenic E. coli is the expression of capsules (Johnson, 1991; Jann, 
1992). More than 80 capsule types have been described so far for E. coli, but only few of them 
are typically expressed by uropathogenic strains. The realisation that (i) certain capsule types 
(K1, K2, K5, K6, K12, K13, K29 and K51) are typical for uropathogenic strains, (ii) most of 
these capsule types are the members of group 2 capsules and (iii) in fecal isolates the presence of 
group 2 capsules is not as prevalent as in uropathogenic strains (Kaiser, 1977; Sandberg, 1988) 
led to the speculation that group 2 capsules contribute to urovirulence by means of their ability to 
impede phagocytosis (Timmis, 1985; Cross, 1986) and confer resistance to the bactericidal 
activity of serum (Cross, 1986; Allen, 1987; Leying, 1990; Russo, 1993). Furthermore, a 
signature-tagged mutagenesis screen has previously suggested the role of the K2 capsule of 
UPEC strain CFT073 in UTI (Bahrani-Mougeot et al., 2002). However, other findings do not 
support a role of group 2 capsules as a virulence factor of uropathogenic E. coli and favour a role 
rather in systemic infections than in an ascending UTI (Russo et al., 1993, 1994, 1996). These 
data from in vivo experiments suggest that LPS directly contributes to the development of UTI 
(Taylor, 1976). Several E. coli O serogroups are associated with UTIs (O1, O2, O4, O6, O7, O8, 
O16, O18, O25, O50 and O75) (Johnson, 1991). Nevertheless, the monocyte phagocytosis killing 
assays with capsule and LPS mutants of an O75:K5 UPEC strain suggested a more differentiated 
phenomenon: they demonstrated that the K5 capsule prevents bacterial attachment to phagocytic 
cells and that both, the O75 and K5, antigens confer protection from internalization (Moxon, 
1990).  
As not all K or O antigens may have identical biological functions, we have investigated whether 
the K15 capsule plays a role for uropathogensis. In vivo virulence assays with the capsule 
deficient mutants of UPEC strain 536 in an ascending urinary tract infection model revealed that 
loss of capsule drastically attenuates the virulent strain. As already suggested by others, a capsule 
may protect the bacteria by masking the underlying opsonized surface and serving as a physical 
barrier to the phagocytic cells like polymorphonuclear leukocytes and monocytes (Cross, 1990; 
Timmis, 1985; Horwitz, 1982; Moxon, 1990). Furthermore, we found out that capsule-deficient 
mutants were still serum resistant. It is worth to mention that one region 2 mutant of strain 536, 
that was constructed with the help of suicide vector pCVD442, was serum sensitive and showed a 
reduced expression of long chain LPS as well as a striking difference in the structure of the LPS 
core region (Figure 22). This mutant’s LPS core exhibited similarity to those of the K-12 strain 
MG1655 and the rough rfaH mutant of strain 536. From these results we concluded that the 
 113
A major feature of uropathogenic E. coli is the expression of capsules (Johnson, 1991; Jann, 
1992). More than 80 capsule types have been described so far for E. coli, but only few of them 
are typically expressed by uropathogenic strains. The realisation that (i) certain capsule types 
(K1, K2, K5, K6, K12, K13, K29 and K51) are typical for uropathogenic strains, (ii) most of 
these capsule types are the members of group 2 capsules and (iii) in fecal isolates the presence of 
group 2 capsules is not as prevalent as in uropathogenic strains (Kaiser, 1977; Sandberg, 1988) 
led to the speculation that group 2 capsules contribute to urovirulence by means of their ability to 
impede phagocytosis (Timmis, 1985; Cross, 1986) and confer resistance to the bactericidal 
activity of serum (Cross, 1986; Allen, 1987; Leying, 1990; Russo, 1993). Furthermore, a 
signature-tagged mutagenesis screen has previously suggested the role of the K2 capsule of 
UPEC strain CFT073 in UTI (Bahrani-Mougeot et al., 2002). However, other findings do not 
support a role of group 2 capsules as a virulence factor of uropathogenic E. coli and favour a role 
rather in systemic infections than in an ascending UTI (Russo et al., 1993, 1994, 1996). These 
data from in vivo experiments suggest that LPS directly contributes to the development of UTI 
(Taylor, 1976). Several E. coli O serogroups are associated with UTIs (O1, O2, O4, O6, O7, O8, 
O16, O18, O25, O50 and O75) (Johnson, 1991). Nevertheless, the monocyte phagocytosis killing 
assays with capsule and LPS mutants of an O75:K5 UPEC strain suggested a more differentiated 
phenomenon: they demonstrated that the K5 capsule prevents bacterial attachment to phagocytic 
cells and that both, the O75 and K5, antigens confer protection from internalization (Moxon, 
1990).  
As not all K or O antigens may have identical biological functions, we have investigated whether 
the K15 capsule plays a role for uropathogensis. In vivo virulence assays with the capsule 
deficient mutants of UPEC strain 536 in an ascending urinary tract infection model revealed that 
loss of capsule drastically attenuates the virulent strain. As already suggested by others, a capsule 
may protect the bacteria by masking the underlying opsonized surface and serving as a physical 
barrier to the phagocytic cells like polymorphonuclear leukocytes and monocytes (Cross, 1990; 
Timmis, 1985; Horwitz, 1982; Moxon, 1990). Furthermore, we found out that capsule-deficient 
mutants were still serum resistant. It is worth to mention that one region 2 mutant of strain 536, 
that was constructed with the help of suicide vector pCVD442, was serum sensitive and showed a 
reduced expression of long chain LPS as well as a striking difference in the structure of the LPS 
core region (Figure 22). This mutant’s LPS core exhibited similarity to those of the K-12 strain 
MG1655 and the rough rfaH mutant of strain 536. From these results we concluded that the 
 114
expression of the sugar biosynthetic genes may interfere with that of the O6 LPS expression. This 
idea was also supported by the fact that ORF71 of PAI V536 exhibits homology at the protein 
level to a putative lipopolysaccharide core biosynthesis protein of Pseudomonas putida strain 
(AE016492 / NP_745150). However, this mutant could not successfully be complemented. 
Possible other integration sites of suicide plasmid-derived sequences, e.g. in the LPS gene cluster, 
could not be detected by Southern blot analysis and overlapping PCRs. We can only conclude 
that during mutagenesis probably other mutations occured in this mutant that interfered with 
other chromosomal regions that are important for regulation of LPS- or sugar biosynthesis. This 
hypothesis can be supported by the fact that a point mutation within wzy gene is responsible for 
the semi-rough phenotype of strain Nissle 1917 (Grozdanov, 2003). This point mutation results in 
a defective O6 LPS side chain expression and in serum sensitivity. Consequently, we constructed 
another kpsK15 region 2 mutant using the method described by Datsenko and Wanner (2002). This 
mutant, E. coli strain 536∆R2-2, exhibited serum resistance and the same LPS side chain pattern 
as the wild type strain 536 (Figure 22). Also to clear up this question a complete kpsK15 deletion 
mutant (E. coli strain 536∆K15) was also constructed. This strain was serum resistant as well. 
From the above mentioned results we can conclude that the K15 capsule is essential for 
uropathogenesis, but does not play any role in resistance to human serum. This is in accordance 
with results published before (Burns, 1998).  
 
The pix gene cluster on PAI V536 was found to be incomplete. Compared to the structurally 
related pap operon, the negative regulatory gene pixB of the pix gene cluster is completely 
present and apparently transcribed at 37 ºC, whereas a corresponding positive regulatory gene 
pixI and upstream sequences that also play a role in regulation are absent. Transcriptional 
analysis of the pixC gene showed that the structural genes of this cluster are not transcribed under 
the conditions tested (Figure 11). We think that this cluster is permanently downregulated due to 
pixB expression as the positive regulator gene pixI is missing. 
Nevertheless, cloning of the truncated pix cluster of UPEC strain X2194 resulted in fimbriae 
expression in K-12 strain DH5α (Lügering et al., 2003). This could be an artifact resulting from 
the use of Sau3A digested DNA that the authors have used to clone the pix determinant. The 
Sau3A-DNA fragment contains only a truncated pixB gene that should be inactive. Accordingly, 
the inactivated negative regulator PixB could not repress tanscription of the pix structural genes 
and eventually Pix fimbriae expression was detected by electron microscopy. Because of the 
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truncated regulatory sequences upstream of the pix structural genes, the authors hypothesized that 
a fragmented R6 transposase gene somehow regulates this cluster as was demonstrated with lacZ 
fusions. Supporting this, they reported that deletion of the upstream region including the 
truncated R6 transposase gene drastically lowered transcription of the cloned pix operon. They 
showed that transcription of the cloned pix determinant seemed to be upregulated at 37 ºC and 
was downregulated already at 26 ºC (Lügering et al., 2003). This correlates with the observation 
that transcriptional regulation of pili expression can be modulated by environmental factors such 
as temperature (Uhlin, 1994). Further indication that pix536 is really inactive resulted from the 
characterisation of double mutants of strain 536 that lack the prf and sfa operons and in which no 
fimbriae expression under laboratory conditions was observed by electron microsocopy 
(Dobrindt, personal communication).  
On the other hand, the presence of a non-functional pix operon of strain 536 and a functional one 
in UPEC strain X2194 (O2:K-:H6) could be explained by the fact that some slight differences 
between the two pix cluster sequences can be observed. These slight differences may cause 
different transcriptional activities and eventually fimbrial expression. It is important to mention, 
that Schmidt and co-workers demonstrated that the cloned, truncated fimbrial determinant was 
expressed in strain DH5α (Lügering et al., 2003). It was not reported whether the UPEC strain 
X2194 itself expressed this fimbrial gene cluster. It was also not mentioned whether Pix fimbriae 
were involved in uropathogenesis or whether this strain also expresses other fimbrial gene 
clusters. Furthermore, the authors mentioned that binding and inhibition studies indicated that Pix 
pili apparently recognize surface antigens which are distinct from the known UTI E. coli adhesin 
receptors, which may contradict the role of pix in the uropathogenic process. The very low 
distribution of the pix fimbrial cluster among UTI isolates (see Appendix A/5) also supports this 
hypothesis. On the other hand we can not rule out that Pix could recognize so far unknown 
receptors on uroepithelial cells and may represent another alternative adhesion that contributes to 
uroepithelial colonisation. Interestingly, the presence of this fimbrial determinant was not only 
rare among UTI isolates but also among other non-fecal E. coli isolates.  
 
In strain 536, three other fimbrial gene clusters are known. In addition to the fim gene cluster 
located on the core chromosome, one pyelonephritis-associated fimbrial cluster (prf, papG allele 
III) is located on PAI II536. The third one is located on PAI III536 and codes for S-fimbriae (sfa). 
Additionally, two putative fimbrial gene clusters are located on PAI I536 (Dobrindt et al., 2002). 
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The mat fimbrial gene cluster described to be expressed by E. coli O18:K1 isolates (Pouttu et al., 
2001) is present, but silent in strain 536. It could be speculated that because of the presence of 
several functional fimbrial gene clusters, strain 536 can afford to possess a non-functional pix 
fimbrial gene cluster. This is an important aspect of genome plasticity implying that strain 536 
originally possessed several fimbrial gene clusters and that the most important one were selected 
while others, including the pix operon, became inactivated.  
 
3. Mobilisation of PAI II536 
An increasing number of studies of genes and genomes indicate that a considerable amount of 
horizontal gene transfer (HGT) has occurred between prokaryotes. The comparison of complete 
prokaryotic genomes revealed that HGT has significantly contributed to bacterial evolution.  
By accumulating a variety of fitness or virulence factors over long time periods, different 
pathotypes and pathogens have evolved from non-pathogenic strains. Virulence associated genes 
are mostly carried on plasmids, pathogenicity islands (PAIs) and bacteriophages (Hacker and 
Kaper, 2000).  
Discovery of transferable drug resistance R factor plasmids and their role in the spread of the 
antibiotic resistance genes have underlined the importance of horizontal gene transfer. Since then 
a number of conjugative plasmids have been isolated and characterised that beside resistance 
marker(s) encode proteins that mediate transfer from a donor cell to a recipient cell. Furthermore, 
novel genetic elements were found that also carried resistance genes but were integrated into the 
chromosome. These elements excise from and integrate into the chromosome similarly to 
bacteriophages, are transferred by conjugation similarly to plasmids, and have been described in 
various bacteria (overview in: Burrus et al., 2002). Traces of such elements have also been found 
in large unstable chromosomal regions that have been called pathogenicity islands. Beside 
virulence associated genes, PAIs typically carry mobility genes such as phage related integrases, 
transposases or part of insertion sequence (IS) elements. It has been hypothesised that these 
sequences have played a role in the acquisition of PAIs. Based on the current knowledge, two 
main theories have been proposed how PAIs have evolved. The role of bacteriophages in the 
evolution and transfer of bacterial virulence determinants was discussed by Cheetham and Katz 
(1995). A close functional association between PAIs and bacteriophages were reported for Gram-
negative Vibrio cholerae as well as for Gram-positive Staphylococcus aureus where 
bacteriophage mediated transfer of PAIs between bacterial isolates were shown. In V. cholerae 
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transfer of the entire 39.5 kb Vibrio Pathogenicity Island (VPI) by the general transducing phage 
CP-T1 was reported (O’Shea et al., 2002). In S. aureus the 15.2 kb SapI1 element, which encodes 
the toxic shock syndrome toxin requires the helper bacteriophage 80α to excise, replicate and to 
be transduced to recipient strains at very high frequencies (Lindsay et al., 1998; Boyd et al., 
2001). However, it has been argued that the 15.2 kb SaPl1 element does not entirely conform to 
the definition of a PAI and may rather represent a defective phage that requires a helper phage 
similar to the P2/P4 phage interaction (Boyd et al., 2001). Bacteriophage-mediated transfer is 
limited by the amount of DNA that can be packed into the phage capsid, but in some cases it can 
expand beyond 100 kb (Ochman, 2000).  
Beside transduction the other possible mechanism of acquisition of PAIs is by bacterial 
conjugation. This process requires a close cell-to-cell contact. Mating pair formation (Mpf) 
(Willetts, 1981) is essential for the transmission of genetic material and it has been shown that 
part of the chromosome (Hfr strains), conjugative plasmids (e.g. RP4) or in the presence of a 
helper plasmid other mobilisable plasmids (e.g. RSF1010) can be transmitted to recipient strains 
by this mechanism.  
Deletion of PAIs from the core chromosome was already described in the early eighties when the 
formation of spontanous non-haemolytic uropathogenic E. coli 536 mutants was observed 
(Hacker et al., 1983). This led to the discovery of PAIs and since then similar elements have been 
described in several bacterial species (see also introduction).  
The presence of direct repeat sequences (DRs) at the border of PAIs was found to be important 
for the instability of PAIs. Additionally, the presence and activity of integrase genes are 
necessary for the deletion from the core chromosome. The UPEC strain 536 carries at least five 
PAIs in its chromosome. Their stability was characterised in detail and showed differences 
(Middendorf et al., 2004). Furthermore, the deletion rates of PAI II536 and PAI III536 are 
influenced by certain environmental conditions such as temperature and salt concentration.  
The deletion rate of the newly characterised PAI V536 was also determined and was found to be 
relatively low (1x10-6) (Middendorf et al., 2004).  
 
Comparable to the excision mechanism of bacteriophages, PAIs are thought to exist at least 
transiently as circular intermediates after excision from the chromosome. Such extrachromosomal 
forms have been detected for PAI II536 and PAI III536 (Middendorf et al., 2004). It can be 
speculated that in the presence of a helper mechanism (for example a conjugative plasmid) the 
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deletion process could proceed and the circular intermediate could be transferred into a recipient 
strain. In our work, we have verified this hypothesis by constructing a derivative of PAI II536 that 
fulfils the criteria of a possible conjugative element. For this purpose PAI II536 was chosen for 
several reasons: (i) it shows a high deletion rate at 20ºC (~10-5), (ii) its deletion by site-specific 
recombination always shows the same pattern, (iii) a circular intermediate could be detected and 
(iv) it has a well detectable marker.  
It was also evident from the sequence of PAI II536 that similarly to other known PAIs and in 
contrast to conjugative transposons, a mobilisation machinery is not encoded on the island. 
Therefore, we introduced into PAI II536 a plasmid that helps the deleted and circularised PAI to 
replicate and to be mobilised by the self-transmissible IncPα plasmid RP4 (Pansegrau, 1994). 
This 60-kb plasmid has been known for its extremely broad host range and is stably maintained 
in all of the tested Gram-negative bacteria. Furthermore, RP4 has served as a widely used model 
system for the study of plasmid biology in general and in conjugation. It was shown that the 
mobilisable IncQ plasmid RSF1010 is efficiently transmitted in the presence of IncP plasmids. 
RSF1010 only encodes relaxosomal components and its transfer relies on an Mpf system from 
conjugative plasmids. A relaxosome is formed by the gene products TraH, TraI, TraJ and TraK at 
the transfer origin (oriT) (Fürste, 1998; Pansegrau, 1996). These four proteins are the products of 
the genes of the Tra1 region which beside Tra2 encodes the essential transfer functions of RP4. 
Tra1 region mainly codes DNA processing functions for generation of the single stranded DNA, 
which is transferred to the recipient cell (Pansegrau, 1996). DNA processing functions are also 
present on the suicide plasmid pGP704 that has been used for the mobilisation experiments. At 
the oriT site that was introduced into PAI II, a nick could be formed as the starting step of the 
conjugative process. Single stranded DNA was then transferred into the recipient strain through 
the membrane-spanning transfer apparatus that was encoded on the RP4 plasmid. 
With this construct we were able to detect the transfer of a complete pathogenicity island. 
However, the frequency of gene transfer with this construct was very low (10-8 and 10-9), even 
though we introduced the pir gene into the donor strain (E. coli 536). The pir encoded π-protein 
is necessary for the function of the introduced oriVR6K that should enable the deleted PAI II536 to 
replicate as a plasmid in the cell and thereby increasing the chance of a possible PAI transfer. 
When we started the mobilisation experiments with this relatively artificial construct, there were 
no data available about a possible PAI transfer by conjugation. Therefore it is quite interesting 
that recent data of Schubert et al. (2004) support the hypothesis that at least some PAIs may have 
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encoded a conjugation machinery in their early evolutionary steps that has played a role in their 
spread by horizontal transfer. In his work, Schubert concentrated on the evolution of the high-
pathogenicity island (HPI) by analysing and comparing the sequences of this island from 
different bacteria. HPI was previously identified in Y. pestis, Y. pseudotuberculosis and Y. 
enterocolitica, and a siderophore-mediated iron acquisition system has been characterized on it. 
Strikingly, an orthologous HPI is widely distributed among E. coli and other Enterobacteriaceae 
that cause extraintestinal infections (Schubert et al., 1998, 1999). Therefore, HPI is a good model 
to analyse the evolution of PAIs. Schubert and coworkers identified a novel variant of HPI in E. 
coli strain ECOR31 isolated from leopard stool. The right border of HPIECOR31 (RB-HPIECOR31) 
contained an additional 35 kb sequence that was not described before from any PAI. Analysis of 
this part revealed striking homology to conjugative plasmids. RB-HPIECOR31 consists of three 
regions that provide a mating pair formation system and a DNA-processing region for 
conjugative transfer.  
The newly found variant of the HPI also contains the P4-like integrase gene on the 5’-part of the 
island and is flanked by 17 bp DR sequences. Interestingly these flanking DRs are partially 
missing from other E. coli isolates but they are characteristic for the HPIs in most Yersinia spp. 
HPIECOR31 with the DRs, the integrase gene and the presence of RB-HPIECOR31 fulfils all structural 
criteria of the recently defined family of integrative and conjugative elements, ICE (Hochhut et 
al., 1999; Burrus et al., 2002). 
It is noteworthy, that no conserved repABC genes or any other indication of a plasmid replicon 
have been found on the RB-HPIECOR31. Till now, mobilisation of this island has not been shown 
but integrase specific excision and circularization have been demonstrated (Schubert et al., 2004). 
A functional replication system may significantly increase the chance of a possible PAI transfer 
as we have shown in the case of PAI II536. It can be hypothesised that HPIECOR31 had a progenitor 
encoding a plasmid replicon. For this, one argument could be that between region two and three 
in the RB-HPIECOR31 an IS element IS630 homologue was detected and nearby sequences can be 
found that show homology to the sequence of the conjugative plasmid R6K. We can only 
hypothetise that integration of the IS630 element might have eliminated the plasmid replicon and 
with this moment a stabilisation process of this PAI has started. The other side of the coin is that 
ICEs can be successfully transferred even though they are not able to replicate themselves 
(Hocchut, personal communication). 
 119
encoded a conjugation machinery in their early evolutionary steps that has played a role in their 
spread by horizontal transfer. In his work, Schubert concentrated on the evolution of the high-
pathogenicity island (HPI) by analysing and comparing the sequences of this island from 
different bacteria. HPI was previously identified in Y. pestis, Y. pseudotuberculosis and Y. 
enterocolitica, and a siderophore-mediated iron acquisition system has been characterized on it. 
Strikingly, an orthologous HPI is widely distributed among E. coli and other Enterobacteriaceae 
that cause extraintestinal infections (Schubert et al., 1998, 1999). Therefore, HPI is a good model 
to analyse the evolution of PAIs. Schubert and coworkers identified a novel variant of HPI in E. 
coli strain ECOR31 isolated from leopard stool. The right border of HPIECOR31 (RB-HPIECOR31) 
contained an additional 35 kb sequence that was not described before from any PAI. Analysis of 
this part revealed striking homology to conjugative plasmids. RB-HPIECOR31 consists of three 
regions that provide a mating pair formation system and a DNA-processing region for 
conjugative transfer.  
The newly found variant of the HPI also contains the P4-like integrase gene on the 5’-part of the 
island and is flanked by 17 bp DR sequences. Interestingly these flanking DRs are partially 
missing from other E. coli isolates but they are characteristic for the HPIs in most Yersinia spp. 
HPIECOR31 with the DRs, the integrase gene and the presence of RB-HPIECOR31 fulfils all structural 
criteria of the recently defined family of integrative and conjugative elements, ICE (Hochhut et 
al., 1999; Burrus et al., 2002). 
It is noteworthy, that no conserved repABC genes or any other indication of a plasmid replicon 
have been found on the RB-HPIECOR31. Till now, mobilisation of this island has not been shown 
but integrase specific excision and circularization have been demonstrated (Schubert et al., 2004). 
A functional replication system may significantly increase the chance of a possible PAI transfer 
as we have shown in the case of PAI II536. It can be hypothesised that HPIECOR31 had a progenitor 
encoding a plasmid replicon. For this, one argument could be that between region two and three 
in the RB-HPIECOR31 an IS element IS630 homologue was detected and nearby sequences can be 
found that show homology to the sequence of the conjugative plasmid R6K. We can only 
hypothetise that integration of the IS630 element might have eliminated the plasmid replicon and 
with this moment a stabilisation process of this PAI has started. The other side of the coin is that 
ICEs can be successfully transferred even though they are not able to replicate themselves 
(Hocchut, personal communication). 
 120
We could successfully demonstrate that in the presence of all the necessary components of a 
conjugative machinery and in the presence of a plasmid replicon a whole PAI can be mobilised 
after excision from the core chromosome. Even though several clones were isolated where only 
parts of PAI II were transferred, we focussed only on those clones where the whole 102.3 kb PAI 
with its nearly 6 kb (derivative of pGP704) insertion was transferred into the recipient strain. 
Two different classes of transconjugants were detected. In one class, PAI II536 was present as a 
circular intermediate and replicated further as a plasmid due to the prescence of the pir gene in 
the recipient. For the second class, integration of PAI II536 occurred at leuX, which is also the 
integration site of PAI II in the donor strain. This underlines the site-specificity of the integration 
mechanism of this island. Site-specific integration of PAIs has already been described previously; 
however, if more than one allele of the target tRNA gene is present on the chromosome, all sites 
may be used. HPI of Y. pestis is for example associated only with the asnT tRNA locus, but the 
HPI of Y. pseudotuberculosis shows no preference and can insert into any of the three asn tRNA 
loci in the chromosome (Buchrieser et al., 1998). The site-specific recombination events are 
determined by the recombinases that are encoded on the 5’ end of PAIs.  
These PAI-specific recombinases control the island’s excision and integration from and into the 
chromosome. Site-specific recombinases are grouped into two unrelated families, the serine 
recombinase family and the tyrosine recombinase family. Related serine recombinases were 
found to be involved in insertion or excision of some prophages and some other integrative 
elements (Smith and Thorpe, 2002), whereas the tyrosine recombinases are involved in 
integration and excision of a very large array of integrative elements including most of the 
prophages such as λ, ICEs and PAIs (Argos, 1986, Williams, 2002). Most of the integrases 
belonging to the tyrosine recombinase family catalyse site-specific integration into the 3’ end of a 
gene encoding a tRNA. Integrases are important components of the conjugative transposons or 
integrative and conjugative elements (ICEs) which show differences in their site-specificity. The 
conjugative transposon Tn5276 from Lactococcus lactis integrates into at least five chromosomal 
sites in L. lactis MG1614 (Rauch et al., 1992), and a large array of conjugative transposons was 
found in Bacterioides (Salyers, 1995; Smith, 1998) whose integration specificity is relatively 
narrow as they can be integrated only at three to seven chromosomal sites depending on the 
element. Elements with a high site-specificity were detected in Salmonella enterica (CTnscr94), 
and Streptococcus pneumoniae (Tn5252). Other conjugative elements, such as bph-sal from 
Pseudomonas putida, clc from Pseudomonas sp., symbiosis islands from Mezorhizobium loti and 
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SXT from Vibrio cholerae are also site-specific and integrative (O’Shea et al., 2002; overview in: 
Burrus et al., 2002). Certainly, in the case of PAI II536 we can not speak of an ICE although it is 
true that it excises and also integrates, but the proteins that were necessary for the conjugal 
transfer were encoded on a helper plasmid (RP4).  
Site-specific recombination was also observed in the case of PAI II536 when it was remobilised 
from the laboratory strain SY327 into E. coli 536-21. 536-21 is a spontaneous deletion mutant of 
strain 536 that has lost PAI I and PAI II. In this strain, leuX lacks the last 6 bp due to the deletion 
process, but still contains one copy of the 18-bp DR. As in 536, asnT, asnW, pheV, thrW and selC 
are occupied by other PAIs whereas other tRNA genes seem to be ‘empty’. All positive 
transconjugants must carry PAI II536 integrated into the chromosome, because 536-21 does not 
contain the pir gene. With the exception of one transconjugant where an incorrect integration 
process seem to have occurred, in all tested clones PAI II536 was found to be integrated into leuX 
thereby restoring the reading frame of this gene. This experiment underlines that leuX is the 
preferred integration site of PAI II536 not only in the uropathogenic strain but also in other strains 
such as E. coli K-12. 
One pivotal question is the frequency of successful mobilisation. With our construct which 
enables PAI II536 to replicate, the frequency of successful conjugation was also not very high but 
detectable. With the detection system where exconjugants were detected on Cm and Nal blood 
agar plates, the frequency of successful exconjugants was as low as 10-8 and 10-9. Several 
experiments were done with different dilutions and ratios of donor and recipient, and experiments 
were carried out at different temperatures. Positive clones resulted from those experiments where 
donor cells were in late logarithmic phase, which correlates with the results of Middendorf 
(2004). A more thorough statistic was done in the remobilisation experiments where a better 
selection system could be used (M9 lactose, Cm) with which the background with resistant donor 
mutant cells could be avoided. With this detection system the frequency of remobilisation was 
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beginning of the stationary phase and it was therefore expected that we also could detect a higher 
transfer at this temperature. Most of the exconjugants resulted indeed from matings at 20 °C, but 
some were also obtained at 30 and 37°C. Furthermore, the most exconjugants were detected from 
matings at 20 °C although many of them contained only part of PAI II536. In summary, these 
observations support that, presumably due to the activity of the integrase gene, excision 
frequency of PAI II536 is the highest at 20 ºC, but that the conditions for transfer of the complete 
PAI were not ideal. The assumption that the integrase gene is more expressed at lower 
temperature was also supported by the results of the remobilisation experiments. With PAI II536 
integrated into the core chromosome of SY327, successful transfer could mainly be detected at 20 
ºC and 30 ºC. It was also clear from the results that temperature had no effect on the conjugation 
rate in those cases where PAI II536 was present in SY327 as a circular form. This indicates that 
the conjugation machinery works effectively at all the examined temperatures. 
 
Taken together, we have successfully demonstrated that transfer of a complete PAI is possible by 
conjugation. The characterisation of PAIs in the last two decades has revealed their typical 
features and raised questions about their evolution. Striking similarities and association of PAIs 
with mobile genetic elements, such as prophages and DR sequences has suggested some 
mechanisms of acquisition.  
The role of phage-mediated transduction for the horizontal gene transfer of PAIs such as the VPI 
from V. cholerae or SaPI1 from S. aureus has already been mentioned (see above). Analysis of 
the features of the LEE PAIs of three rabbit-specific EPEC strains 83/39 (O15:H-), 84/1101 
(O103:H2), RDEC-1 and the human EPEC and EHEC strains E2348/69 and EDL933 has 
outlined another possible evolutionary process (Tauschek et al., 2002). They studied the role of 
site-specific integrases in the integration of PAIs into the tRNA genes but they hypothesised that 
P4-like bacteriophage has not played a role in the transfer, only integrated into the tRNA locus as 
a starting step (Fig 36a). This bacteriophage created a favourable environment for the integration 
of other mobile elements such as IS elements and transposases that were associated with different 
virulence determinants. Evidences for this hypothesis can be collected by analysing the sequence 
data of different PAIs where virulence associated genes are often flanked by complete or 
truncated IS elements.  
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Fig. 36: Possible routes of PAI evolution. (a) Life of a PAI can start by the integration of 
prophages into the host’s chromosome. Phage sequences help the integration of foreign 
elements and genes into the new part of the host’s chromosome. In the other model a 
transferred and integrated PAI can go through a stabilisation process (b) as it can be 
observed in the case of different PAIs of strain 536. The stabilisation process involves the 
mutation and loss of DRs that are essential for the excision of a PAI from the core 
chromosome. After some time, it becomes a stable part of the host’s chromosome. (DR – 
Direct Repeat, DRx – Direct Repeat with mutation, int’ - integrase) 
 
Beside mobility genes and phage related sequences, another typical feature of pathogenicity 
islands is the presence of flanking direct repeats (DRs) (Fig. 36b). It was verified that these short 
sequences (10-50 bp) play a crucial role for the deletion process of PAIs (Blum et al., 1994). 
Deletion of PAI I536 and PAI II536 has been shown to occur by recombination between these 
flanking DRs that serve as recognition sites of bacteriophage integrases which are usually 
encoded on the same PAI. Sequence analysis and the island-probing approach (Rajakumar et al., 
1997) of the five completely sequenced PAIs of UPEC strain 536 revealed, that there is a 
correlation between the instability of a PAI and the presence of flanking DRs (Middendorf et al., 
2003). Four PAIs (PAI I536, PAI II536, PAI III536 and PAI V536) out of five are able to be deleted 
by site-specific recombination, while PAI IV536 is stably integrated into the core chromosome.  
The comparison of the deletion frequency of PAI II536, which is the most unstable one (~2x10-5) 
with that of PAI V536, which is a relatively stable (~1x10-6), and analysis of the remaining 
boundary regions between which the deletion occured led to the conclusion that the lower 
deletion frequency of PAI V536 could at least be partially due to the fact that the site-specific 
recombination between  pheV (76 bp) and its truncated copy phe'V (22 bp) that also exhibits an 
internal 1 bp deletion is not as efficient as recombination between identical copies of pheV. The 
pheV  
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D D
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most stable island of strain 536 is PAI IV536, that completely lacks the flanking DRs. This island 
could be considered a stably integrated island (Middendorf et al., 2003), which is at an advanced 
homing stage.  
It has been hypothezised that PAIs acquired by horizontal gene transfer and integrated into the 
genome of the host go through a homing process in which, if their genetic features turn out to be 
advantageous, they favour such mutations that render the islands stable (Hacker and Kaper, 
2000). The two evolutionary models how PAIs may have been evolved are not one way streets. A 
single model cannot describe the formation of all PAIs, however, the role of some mechanisms 
involved in evolution of pathogenic bacterial variants is generally accepted.  
 
In summary, the study of the genetic organization of PAI V536 and in particular that of the K15 
capsule gene cluster of E. coli strain 536 supports the model that horizontal gene transfer and 
recombination play an important role for acquisition of additional genetic information and the 
generation of new variants of already existing determinants. Whereas the function of the K15 
capsule has been successfully analyzed, the transport and assembly pathway of the capsule 
polysaccharides across the outer membrane as well as the functional characterization of other PAI 
V536–localized genes will have to be further elucidated. 
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A/1 - Acronyms and abbreviations of units and chemicals 
 
A   amper 
aa   amino acid 
Ap/ApR  ampicillin/ampicillin resistence 
APS   NH4-persulfate 
bp   base pair 
°C   grad celsius 
cat   chloramphenicol-acetyl-transferase 
Da   dalton 
dATP   desoxyadenosin-5'-triphosphate 
dCTP   desoxycytosin-5'-triphosphate 
dGTP   desoxyguanosin-5'-triphosphate 
dH2O   distilled water 
DNA   desoxyribonucleic acid 
dNTP   desoxynucleotide 
dTTP   desoxythymidin-5'-triphosphate 
EDTA   ethylene-diamin-tetraacetate 
et al.   et alili (and others) 
EtBr   ethidium bromide 
EtOH   ethanol 
Fig.   figure 
g   gram 
h   hour 
IPTG   isopropyl-β-D-thiogalactopyranosid 
kb   kilobase (pairs) 
Km/KmR  kanamycin/kanamycin resistence 
l   liter 
LB   Luria Bertani broth 
m   meter; milli (1 × 10-3) 
M   molar, mega (1 × 106) 
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mg   milligram 
min   minute 
ml   milliliter 
OD   optical density 
ON   overnight 
ORF   open reading frame 
PAA   polyacrylamid 
PBS   phosphate buffered saline 
RNA   ribonucleic acid 
RNase   ribonuclease 
RT   room temperature 
SDS   sodium-dodecyl-sulfate 
sec   second 
Sm/SmR  streptomycin/streptomycin resistence 
SSC   standart saline citrate 
t   time 
Tab.   table 
TAE   Tris-acetate-EDTA 
TBE   Tris-borate-EDTA 
TCA   trichloroacetic acid 
TE   Tris-EDTA 
TEMED  N,N,N`,N`-tetramethyldiamin 
Tris   Tris-(hydroxymethyl)-aminomethan 
U   enzyme unit (1 U=1 µmol substrate × min-1) 
UV   ultraviolet irradiation 
V   volt 
v/v   volume/volume 
W   watt 
w/v   weight/volume 
WT   wild type 
X-gal   5-bromo-4-chloro-3-indolyl-β-glucoside 
YT   yeast triptone 
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µ   micro (1 × 10-6) 
µg   microgram 
µl   microliter 
 140
µ   micro (1 × 10-6) 
µg   microgram 
µl   microliter 
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A/2 - Abbreviations of biological expressions 
 
Afa  afimbrial adhesin 
CNF  cytotoxic-necrotizing factor  
EHEC  enterohaemorrhagic E. coli 
EPEC  enteropathogenic E. coli 
ExPEC  extraintestinal pathogenic E. coli 
Fim  type 1 fmbriae  
GEI  genomic island 
hly  haemolysin 
HPI  high pathogenicity island 
ICE  integrative and conjugative element 
Iha  putative non-fimbrial adhesin 
Int  integrase  
IPEC  intestinal pathogenic E.coli 
IS  insertion element 
Iuc  aerobactin  
kps  capsule locus 
LEE  locus of enterocyte effacement 
LPS  lipopolysaccharide 
ORF  open reading frame 
oriV  origin of replication (vegetative) 
oriT  origin of transfer 
PAI  pathogenicity island 
PCR  polymerase chain reaction 
PFGE  pulse field gelelectrophoresis 
PAP  pyelonephritis associated pilus  
PRF  pyelonephritis related fimbria  
REPEC rabbit specific enteropathogenic E. coli 
RT-PCR Reverse Transcription PCR 
Sap  Ag43-homologue 
SFA  S-fimbriae  
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SSH  suppression subtractive hybridisation  
Trs  transposase 
Tn  transposon  
UPEC  uropathogenic E. coli 
UTI  urinary tract infection 
VPI  Vibrio pathogenicity island 
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A/3 - Oligonucleotids used in this work 
Cutting sites in the primers are shown in bold . For primers not designed in this study, reference 
is given. 
Annealing temperatures were always calculated according to the following formula: 
(G+C) / length of oligo  x  41  +  69,3  -  650 / length of oligo . 
 
Designation Sequence (5` - 3`) Comment and reference 
SuperCos uni (F) CGGCCGCAATTAACCCTCAC 5‘-sequencing primer für pSuperCos1 
cosmid vector 
SuperCos rev (R) GCGGCCGCATAATACGACTCACT 3‘-sequencing primer für pSuperCos1 
cosmid vector 
Genrev 6buni TATCCGCTCTGGGTATAAGC 5‘-end of the right end („kps side“) of 
pCos6b38 
Genrev 6brev TTATCGCAGATAACTGGCGG 3‘-end of the right end („kps side“) of 
pCos6b38 
K5reg3down CCATTACGACCAATAAAGGCAA K5 specific primer 
K5reg3up CTTATCGTCTGGATGGCAGGT „ 
b2981fw ATTCATGTTCGGTAAACGGCACAAATC connects GSP and Saframycin synthase gene 
Safrev TGACGCCACGGGGAAAACGGG „ 
yghs_F CTTCGCAGATAACGCCCAAAAGGTG 7kb sequencing primer 
yghs_R GGATGTGATGGTTCAGGTAAATCGAC „ 
pitB_F GATGCCGATAATCGCACCAATCAAGG „ 
pitB_R CAATCAATGGTTTTCATGACACGGCGAA „ 
gsp_F TTCACCGCCTTTATCCCAGATAAGAAG „ 
gsp_R CCACAAGTGGCAATGCGTTGAATTTG „ 
hybF_F GATAATTTCAACGGCGCTCTGGCAAA „ 
hybF_R GACGGTGTTTCGCAATATCTCTCCTG „ 
hybD_F CGCTACCGCAATCAGGTTCACTTC „ 
hybD_R CAACCAAAGCCTCCGAAATGCTGAAA „ 
hybA_F GATAGTGGTATTCGCTGCCAGGCT „ 
hybA_R GGTGTGGAACGTCTCGATAAAGGC „ 
b2998_F GTCAGAATACCCGCTTCCCAGG „ 
b2998_R CGGGATTAAAAGCAACGCATGCCG „ 
b3001_F GCAAAATAACGGCGTGGGCTGTATTG „ 
b3001_R GCCATTTGCGCCATTGATTGTCCAC „ 
b3004_R CTGAAGATAGGTCTGGTCGGCGA „ 
K12_Eforw CAGGCAGGAGATTCGCTCT screening on the left side of pCos6b38 
K12_Erev TGATTCCCCTTTACTCTCTCG „ 
 Primers for the mutants of the kps locus  
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A/3 - Oligonucleotids used in this work 
Cutting sites in the primers are shown in bold . For primers not designed in this study, reference 
is given. 
Annealing temperatures were always calculated according to the following formula: 
(G+C) / length of oligo  x  41  +  69,3  -  650 / length of oligo . 
 
Designation Sequence (5` - 3`) Comment and reference 
SuperCos uni (F) CGGCCGCAATTAACCCTCAC 5‘-sequencing primer für pSuperCos1 
cosmid vector 
SuperCos rev (R) GCGGCCGCATAATACGACTCACT 3‘-sequencing primer für pSuperCos1 
cosmid vector 
Genrev 6buni TATCCGCTCTGGGTATAAGC 5‘-end of the right end („kps side“) of 
pCos6b38 
Genrev 6brev TTATCGCAGATAACTGGCGG 3‘-end of the right end („kps side“) of 
pCos6b38 
K5reg3down CCATTACGACCAATAAAGGCAA K5 specific primer 
K5reg3up CTTATCGTCTGGATGGCAGGT „ 
b2981fw ATTCATGTTCGGTAAACGGCACAAATC connects GSP and Saframycin synthase gene 
Safrev TGACGCCACGGGGAAAACGGG „ 
yghs_F CTTCGCAGATAACGCCCAAAAGGTG 7kb sequencing primer 
yghs_R GGATGTGATGGTTCAGGTAAATCGAC „ 
pitB_F GATGCCGATAATCGCACCAATCAAGG „ 
pitB_R CAATCAATGGTTTTCATGACACGGCGAA „ 
gsp_F TTCACCGCCTTTATCCCAGATAAGAAG „ 
gsp_R CCACAAGTGGCAATGCGTTGAATTTG „ 
hybF_F GATAATTTCAACGGCGCTCTGGCAAA „ 
hybF_R GACGGTGTTTCGCAATATCTCTCCTG „ 
hybD_F CGCTACCGCAATCAGGTTCACTTC „ 
hybD_R CAACCAAAGCCTCCGAAATGCTGAAA „ 
hybA_F GATAGTGGTATTCGCTGCCAGGCT „ 
hybA_R GGTGTGGAACGTCTCGATAAAGGC „ 
b2998_F GTCAGAATACCCGCTTCCCAGG „ 
b2998_R CGGGATTAAAAGCAACGCATGCCG „ 
b3001_F GCAAAATAACGGCGTGGGCTGTATTG „ 
b3001_R GCCATTTGCGCCATTGATTGTCCAC „ 
b3004_R CTGAAGATAGGTCTGGTCGGCGA „ 
K12_Eforw CAGGCAGGAGATTCGCTCT screening on the left side of pCos6b38 
K12_Erev TGATTCCCCTTTACTCTCTCG „ 
 Primers for the mutants of the kps locus  
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kpsSCrev_SacI ATTAGAGCTCGGGGATTATTTAGCTGACTCGTTTG „ 
Kan_BstBI AACGGTTCGAAGACACCCTCATCAGTGCCAAC „ 
KanBsiWI GGAATCGTACGCCGTCAAGTCAGCGTAATGCTC „ 
kpsCK5fwCm TGCGCCCTGTTCCGCAAGAAGTTGATGCTATCGCCG
TGTGGGGACATCGTCCCAGCGCGGCGAAACCAGTC
GCCATCGCCAAAGCAGCGGGGCTTGTCAGGGGGGC
GGAG 
Inactivaton of kpsCK5 
kpsCK5revCm AGTACAGCGACGTGAAAAACTCAGCCGGTTTGTTG
CCGTTTGCAAGAAAGGTTTCAGGATCGCTGACTTCC
ACAGCGTTAAGCCTGGCGCACCCTGCCCTGAACCGA
CGA 
„ 
CK5_elfw GGAGTCCATGCAGGAGCAG Checking the kpsCK5 mutant 
CK5-elrev CAGTGTTAACTGGCTGTGATTAAGC „ 
kpsCK10fwCm AATAATTAAATTTAATCCGCCAGCGTCTCCAACGAT
TTAGACCTACGACTGGAGTCTTATTTTGCCCTGCCA
TAAGATGAATTAATTGTTCGCTTGTCAGGGGGGCGG
AG 
Inactivaton of kpsCK10 
kpsCK10fwCm TATACAAATTCAAAAGGGATTTTAGCTAAGAAATA
TTATATACAATCCATCCTAAATATGGAATTGCGTTA
TTTAAAAAAACAACAAACCCACCCTGCCCTGAACCG
ACG 
„ 
CK10_elfw CATCACCACCATTGAAATTAACTTTTATAAC Checking the kpsCK10 mutant 
CK10_elrev GTAATTTAGCCGCTGAGAATAATGTC „ 
R2_pKD4_fw CTTCAATTGCAGAATATGATATATGACGATGTTTAA
AATTTTTCAGTTCCTGATGTTCACAAATAGGCATAC
GTAAACTACAAATATACGTGTAGGCTGGAGCTGCTT
C 
Inacivation Region2 
R2_pKD4-rev TACGTCTCCCTATGAAGGAGGCCCTGCATGTCTACC
TGAAGCTCTTGCAGCAGGTTGTTTAGTTTTTTCATCT
CGTAGTGGTATGGCTGAAGATCTCATATGAATATCCT
CCTTAGTTCCTATTCC 
„ 
kpsMfw_Cm ATGGCAAGAAGTGGATTTGAAGTCCAGAAAGCCGC
CGTTCATGCTCTATTTTTACGTGAGCTTAGAACAGT
GTAGGCTGGAAGCTGCTTC 
Inactivation of Region 3 
kpsTrev_Cm TTGAATATAATCTAGCAACAAATTTCACATTCTCTC
GTCCTGTCAGACTTCCTTGAAAACCGCCATATGAATA
TCCTCCTTAGTTCCTATTCC 
„ 
K15totpKD_ 
fw 
GCTGGCATACGTGACTCCAGCTCAACCGGAGATAA
TCACCATTGTTATTTTTCTATTTAATAATAATCTCCT
GAAAAATAGATATAGCAGTGTAGGCTGGAAGCTGCT
TC 
Knocking out the whole kps locus 
K15totpKD_ 
rev 
GCCCAATGGTGAGTGCGGAACTGTCAAACCCGCTC
ACCGGGCTGAGTTCCGATGTAGCAAGAATTATCTCC
CTCCAGACCACCACGGAATCATATGAATATCCTCCTT
AGTTCCTATTCC 
„ 
K15fw_ell GCCTGATGATTGCCTCTTTTCC Checking the total kps mutants 
K15rev_ell CACAAATTGATGTCAGTGCTGCTG „ 
gspD_Cm TGGAGCGCAGCGGCAACAGCCAGGTTTTCTATCTCA
AATACAGCAAAGCCGAAGATCTGGTCGATGTACTG
AAGCAGGTCAGCGGCACGCGCTTGTCAGGGGGGCG
GAG 
Inactivation of the Type II GSP 
gspL_Cm CCATTGCTGGAGACATTCATCAGCAACGTCAGGCC
AGATGCCGCACTCCACGTCGGCGGTACGACGCTGC
CAACGGATGGGAGCGGAAGCACCCTGCCCTGAACCG
„ 
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kpsSCrev_SacI ATTAGAGCTCGGGGATTATTTAGCTGACTCGTTTG „ 
Kan_BstBI AACGGTTCGAAGACACCCTCATCAGTGCCAAC „ 
KanBsiWI GGAATCGTACGCCGTCAAGTCAGCGTAATGCTC „ 
kpsCK5fwCm TGCGCCCTGTTCCGCAAGAAGTTGATGCTATCGCCG
TGTGGGGACATCGTCCCAGCGCGGCGAAACCAGTC
GCCATCGCCAAAGCAGCGGGGCTTGTCAGGGGGGC
GGAG 
Inactivaton of kpsCK5 
kpsCK5revCm AGTACAGCGACGTGAAAAACTCAGCCGGTTTGTTG
CCGTTTGCAAGAAAGGTTTCAGGATCGCTGACTTCC
ACAGCGTTAAGCCTGGCGCACCCTGCCCTGAACCGA
CGA 
„ 
CK5_elfw GGAGTCCATGCAGGAGCAG Checking the kpsCK5 mutant 
CK5-elrev CAGTGTTAACTGGCTGTGATTAAGC „ 
kpsCK10fwCm AATAATTAAATTTAATCCGCCAGCGTCTCCAACGAT
TTAGACCTACGACTGGAGTCTTATTTTGCCCTGCCA
TAAGATGAATTAATTGTTCGCTTGTCAGGGGGGCGG
AG 
Inactivaton of kpsCK10 
kpsCK10fwCm TATACAAATTCAAAAGGGATTTTAGCTAAGAAATA
TTATATACAATCCATCCTAAATATGGAATTGCGTTA
TTTAAAAAAACAACAAACCCACCCTGCCCTGAACCG
ACG 
„ 
CK10_elfw CATCACCACCATTGAAATTAACTTTTATAAC Checking the kpsCK10 mutant 
CK10_elrev GTAATTTAGCCGCTGAGAATAATGTC „ 
R2_pKD4_fw CTTCAATTGCAGAATATGATATATGACGATGTTTAA
AATTTTTCAGTTCCTGATGTTCACAAATAGGCATAC
GTAAACTACAAATATACGTGTAGGCTGGAGCTGCTT
C 
Inacivation Region2 
R2_pKD4-rev TACGTCTCCCTATGAAGGAGGCCCTGCATGTCTACC
TGAAGCTCTTGCAGCAGGTTGTTTAGTTTTTTCATCT
CGTAGTGGTATGGCTGAAGATCTCATATGAATATCCT
CCTTAGTTCCTATTCC 
„ 
kpsMfw_Cm ATGGCAAGAAGTGGATTTGAAGTCCAGAAAGCCGC
CGTTCATGCTCTATTTTTACGTGAGCTTAGAACAGT
GTAGGCTGGAAGCTGCTTC 
Inactivation of Region 3 
kpsTrev_Cm TTGAATATAATCTAGCAACAAATTTCACATTCTCTC
GTCCTGTCAGACTTCCTTGAAAACCGCCATATGAATA
TCCTCCTTAGTTCCTATTCC 
„ 
K15totpKD_ 
fw 
GCTGGCATACGTGACTCCAGCTCAACCGGAGATAA
TCACCATTGTTATTTTTCTATTTAATAATAATCTCCT
GAAAAATAGATATAGCAGTGTAGGCTGGAAGCTGCT
TC 
Knocking out the whole kps locus 
K15totpKD_ 
rev 
GCCCAATGGTGAGTGCGGAACTGTCAAACCCGCTC
ACCGGGCTGAGTTCCGATGTAGCAAGAATTATCTCC
CTCCAGACCACCACGGAATCATATGAATATCCTCCTT
AGTTCCTATTCC 
„ 
K15fw_ell GCCTGATGATTGCCTCTTTTCC Checking the total kps mutants 
K15rev_ell CACAAATTGATGTCAGTGCTGCTG „ 
gspD_Cm TGGAGCGCAGCGGCAACAGCCAGGTTTTCTATCTCA
AATACAGCAAAGCCGAAGATCTGGTCGATGTACTG
AAGCAGGTCAGCGGCACGCGCTTGTCAGGGGGGCG
GAG 
Inactivation of the Type II GSP 
gspL_Cm CCATTGCTGGAGACATTCATCAGCAACGTCAGGCC
AGATGCCGCACTCCACGTCGGCGGTACGACGCTGC
CAACGGATGGGAGCGGAAGCACCCTGCCCTGAACCG
„ 
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ACGA 
 Primers for RT-PCR   
papBrev GGAGCCTGAGCAACCGCAT RT-PCR  pixB 
papBfw GGATTGTTATCTAAGGATAGATATACCTC „ 
SfpCfwRT GGGTTCCTCCGTTCATTCCTC RT-PCR  pixC 
SfpCrevRT CCGTTCACCATTCAGGACCT „ 
pgtPfwRT GGAGTGATGAGTAGCCTTGCC RT-PCR  pgtP 
pgtPrevRT GCACGATCTCCATAGTCTGAAC „ 
C5in_fw CCCGTCATTCGTCTGGAAGATG RT-PCR kpsCK5 
C5in_rev CAGGTATGCTGCGGCAAAAAGTTCTT „ 
12000  AATCAATCGTTCAATACACTTATGGTAAC binds in kpsS 
13000rRT GAACAATTAATTCATCTTATGGCAGGG binds in kpsCK10 
ISfw GCCTTTTTAATCAGCCAGTTATCCGA RT-PCR for IS1230B transposase
ISrev GGTTCTCCCTAAGATAATTTTGTTTTAACTATG „ 
13165fRT CTGAACTAAGGCTTCGAATCCACT RT-PCR kpsCK10 
14167rRT GTTGGGTTTGAAGCATTGCTCTTG „ 
orf5RTrev GACATTATTCTCAGCGGCTAAATTAC RT-PCR Region2 
orf4RTfw CAAATGGGCATTCGGCAAATACATC „ 
kpsMRTfw GAACTAGGTTTGGCAAATATCGCTTG RT-PCR betwee Region1 and 2 
orf1RTrev CTGCGTATGATTTGGGTTCAATACTAA „ 
gspDfwRT GATCGTCCATCAGACCGCCAA RT-PCR  gspD 
gspDrevRT CAGTGTGATTGTCAGTGGTGAC „ 
 Primers for the mobilisation experiments  
Cm_fw_PstI CTGCAGGCTTGTCAGGGGGGCGGAG Cm castte in pGP704 
Cm_rev_PstI CTGCAGACCCTGCCCTGAACCGACGA „ 
pir_fw_SacI TTTGAGCTCCCGTCAAGTCAGCGTAATGCTC  
pir_revStop_ EcoRI TTTGAATTCTCAAGCTTCATCATCTTTATCGCCAGA PIR STOP codon is built in 
paiII_1XhoI TTTCTCGAGGGGAAGCACGATATGCAGCC labelling PAI II with homologue 
recombination with pSG704 
paiII_1SacI TTGAGCTCGATATTTTTTGGCTGCTTCAGCTTTACG „ 
paiII_2SacI TTTGAGCTCGGACAAGAACACAAAATCACTCTACT
GA 
„ 
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ACGA 
 Primers for RT-PCR   
papBrev GGAGCCTGAGCAACCGCAT RT-PCR  pixB 
papBfw GGATTGTTATCTAAGGATAGATATACCTC „ 
SfpCfwRT GGGTTCCTCCGTTCATTCCTC RT-PCR  pixC 
SfpCrevRT CCGTTCACCATTCAGGACCT „ 
pgtPfwRT GGAGTGATGAGTAGCCTTGCC RT-PCR  pgtP 
pgtPrevRT GCACGATCTCCATAGTCTGAAC „ 
C5in_fw CCCGTCATTCGTCTGGAAGATG RT-PCR kpsCK5 
C5in_rev CAGGTATGCTGCGGCAAAAAGTTCTT „ 
12000  AATCAATCGTTCAATACACTTATGGTAAC binds in kpsS 
13000rRT GAACAATTAATTCATCTTATGGCAGGG binds in kpsCK10 
ISfw GCCTTTTTAATCAGCCAGTTATCCGA RT-PCR for IS1230B transposase
ISrev GGTTCTCCCTAAGATAATTTTGTTTTAACTATG „ 
13165fRT CTGAACTAAGGCTTCGAATCCACT RT-PCR kpsCK10 
14167rRT GTTGGGTTTGAAGCATTGCTCTTG „ 
orf5RTrev GACATTATTCTCAGCGGCTAAATTAC RT-PCR Region2 
orf4RTfw CAAATGGGCATTCGGCAAATACATC „ 
kpsMRTfw GAACTAGGTTTGGCAAATATCGCTTG RT-PCR betwee Region1 and 2 
orf1RTrev CTGCGTATGATTTGGGTTCAATACTAA „ 
gspDfwRT GATCGTCCATCAGACCGCCAA RT-PCR  gspD 
gspDrevRT CAGTGTGATTGTCAGTGGTGAC „ 
 Primers for the mobilisation experiments  
Cm_fw_PstI CTGCAGGCTTGTCAGGGGGGCGGAG Cm castte in pGP704 
Cm_rev_PstI CTGCAGACCCTGCCCTGAACCGACGA „ 
pir_fw_SacI TTTGAGCTCCCGTCAAGTCAGCGTAATGCTC  
pir_revStop_ EcoRI TTTGAATTCTCAAGCTTCATCATCTTTATCGCCAGA PIR STOP codon is built in 
paiII_1XhoI TTTCTCGAGGGGAAGCACGATATGCAGCC labelling PAI II with homologue 
recombination with pSG704 
paiII_1SacI TTGAGCTCGATATTTTTTGGCTGCTTCAGCTTTACG „ 
paiII_2SacI TTTGAGCTCGGACAAGAACACAAAATCACTCTACT
GA 
„ 
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paiII_2XhoI TTTCTCGAGCCCGGCTTCATCGACAATGA „ 
ATT1 GAGGTACCAGCGCGGTTTGATC checking the integration into the 
λ attachment site (E. coli) 
ATT2 CAGATGGCGCAATGCCATCTGG „ 
17kD up CCCGGCTGAACAGACGATT screening PCRs for PAI II536 
17kD in GCAGCGGAGAGTCATTGTC „ 
hlyDup CGCGATAATCCGCTACATC „ 
hlyDin GGGTATGGCTGTCACTGCA „ 
hec_down1 CACACTGAAAGGCCGCAGC „ 
hec_down2 GTACAGCGTGCCGTTCTGC „ 
dsdXin GCTGTATCCCGACATCAGC „ 
dsdAup GCCACATCATTCTCCCGTA „ 
ORFAin CATCCCCTTCACTACAGGA „ 
Na-Anti_pdo CAGCGATGCTGGACCGTAT „ 
PaiII_1fw CAACCGTAGAAATACGTGCCG overlapping PCRs of PAI II536 
PaiII_1rev CCAGTATGAGGCAAACCCTAAAG „ 
PaiII_2fw GACAATAGCTGTCCATACGGTG „ 
PaiII_2rev CAATGCTGGCCATATCCATCAG „ 
PaiII_3fw GACTCACTACTGGGAAGGTC „ 
PaiII_3rev GATGGTCATGTGCAGGGAGG „ 
PaiII_4fw GTGATGTCACTGGCGGTAATAATC „ 
PaiII_4rev GGCGATGACCATGATACGGTA „ 
PaiII_5fw CGGAATACTGAACTGCGGATAA „ 
PaiII_5rev GCTGGATGCCAATCAATGATCG „ 
PaiII_6fw GCATCCATCTCCGTTCACAG „ 
PaiII_6rev GCATGGCTGGTTGTTCCTAAAC „ 
PaiII_7fw CCTCCTTTGGACTGAAGTTCA „ 
PaiII_7rev GCACAGGCGCTCTTTTATTGTTTG „ 
PaiII_8fw GGACACATGGCAGGGTCTG „ 
PaiII_8rev GGAACACGTCTTCTTGTTGACA „ 
PaiII_9fw CAGCGATTTGTCACCACCTG „ 
PaiII_9rev GTACTTGACGCGGCGGACA „ 
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paiII_2XhoI TTTCTCGAGCCCGGCTTCATCGACAATGA „ 
ATT1 GAGGTACCAGCGCGGTTTGATC checking the integration into the 
λ attachment site (E. coli) 
ATT2 CAGATGGCGCAATGCCATCTGG „ 
17kD up CCCGGCTGAACAGACGATT screening PCRs for PAI II536 
17kD in GCAGCGGAGAGTCATTGTC „ 
hlyDup CGCGATAATCCGCTACATC „ 
hlyDin GGGTATGGCTGTCACTGCA „ 
hec_down1 CACACTGAAAGGCCGCAGC „ 
hec_down2 GTACAGCGTGCCGTTCTGC „ 
dsdXin GCTGTATCCCGACATCAGC „ 
dsdAup GCCACATCATTCTCCCGTA „ 
ORFAin CATCCCCTTCACTACAGGA „ 
Na-Anti_pdo CAGCGATGCTGGACCGTAT „ 
PaiII_1fw CAACCGTAGAAATACGTGCCG overlapping PCRs of PAI II536 
PaiII_1rev CCAGTATGAGGCAAACCCTAAAG „ 
PaiII_2fw GACAATAGCTGTCCATACGGTG „ 
PaiII_2rev CAATGCTGGCCATATCCATCAG „ 
PaiII_3fw GACTCACTACTGGGAAGGTC „ 
PaiII_3rev GATGGTCATGTGCAGGGAGG „ 
PaiII_4fw GTGATGTCACTGGCGGTAATAATC „ 
PaiII_4rev GGCGATGACCATGATACGGTA „ 
PaiII_5fw CGGAATACTGAACTGCGGATAA „ 
PaiII_5rev GCTGGATGCCAATCAATGATCG „ 
PaiII_6fw GCATCCATCTCCGTTCACAG „ 
PaiII_6rev GCATGGCTGGTTGTTCCTAAAC „ 
PaiII_7fw CCTCCTTTGGACTGAAGTTCA „ 
PaiII_7rev GCACAGGCGCTCTTTTATTGTTTG „ 
PaiII_8fw GGACACATGGCAGGGTCTG „ 
PaiII_8rev GGAACACGTCTTCTTGTTGACA „ 
PaiII_9fw CAGCGATTTGTCACCACCTG „ 
PaiII_9rev GTACTTGACGCGGCGGACA „ 
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PaiII_10fw GCTTCTGAAAAACGGGTGAAGTC „ 
PaiII_10rev CATGGCGCATCATGAAATCATCA „ 
PaiII_11fw CTCTCGCGTATATTCAGCAAAAAC „ 
PaiII_11rev CGTCACATCGGATAACATTCGG „ 
PaiII_12fw CTGATATCTCTTTCAGACTTCAGAAC „ 
PaiII_12rev GTCACCTCAAGAACGTCTAACC „ 
PaiII_13fw CTGGCACCTATGGATCAGGT „ 
PaiII_13rev GTTCAGCAACTGAAGGTTCATACT „ 
PaiII_14fw GATGACCATCAGTGTTTCCGCT „ 
PaiII_14rev CGGGGATTTAAGTATTGGTCAGTT „ 
PaiII_15fw GCAACAATCTGACCTGCAAGCAT „ 
PaiII_15rev GGATGATGAGCTTCAGGTTCAG „ 
PaiII_16fw TGCCGTACAGCTTGTCATTACC „ 
PaiII_16rev CTGGGTACTGCACTTTCCTCA „ 
PaiII_17fw CTGACATTGCCACCAGATTTTTGT „ 
PaiII_17rev GGTGTAATGCGCTAACCTGTTTC „ 
PaiII_18fw CTACAAATGTTCAATATGGTGGGTATATC „ 
PaiII_18rev CGCTGTTGCCACTGGATTAATG „ 
PaiII_19fw GCCATCCACTACATATCATGCC „ 
PaiII_19rev CGACGGGTTTCTATGCTGAG „ 
PaiII_20fw CCTCAACTGGAGCAATTTTCTGTC „ 
PaiII_20rev GGACTTGGATCACTGAAGCTTTAC „ 
PaiII_21fw CCACAAGCTGTTGATTTTGGTACG „ 
PaiII_21rev GCGATAGTGGGCAATTTGCTATTG „ 
PaiII_22fw CGTAAACGTCCTCCAGAATTTATATC „ 
PaiII_22rev GGACGATGGCGATATGTCTG „ 
PaiII_23fw GTTCTTCATTTCTACGTTGCTTTGTC „ 
PaiII_23rev CCTACCAGAGATAACCCATGG „ 
PaiII_24fw CGGTTTCTCCTGAACATAACTTTG „ 
PaiII_24rev GGTGAAGTCCGTAACCAGAATG „ 
PaiII_25fw GCCTGTTTTTGCTGCTGTTCAC „ 
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PaiII_10fw GCTTCTGAAAAACGGGTGAAGTC „ 
PaiII_10rev CATGGCGCATCATGAAATCATCA „ 
PaiII_11fw CTCTCGCGTATATTCAGCAAAAAC „ 
PaiII_11rev CGTCACATCGGATAACATTCGG „ 
PaiII_12fw CTGATATCTCTTTCAGACTTCAGAAC „ 
PaiII_12rev GTCACCTCAAGAACGTCTAACC „ 
PaiII_13fw CTGGCACCTATGGATCAGGT „ 
PaiII_13rev GTTCAGCAACTGAAGGTTCATACT „ 
PaiII_14fw GATGACCATCAGTGTTTCCGCT „ 
PaiII_14rev CGGGGATTTAAGTATTGGTCAGTT „ 
PaiII_15fw GCAACAATCTGACCTGCAAGCAT „ 
PaiII_15rev GGATGATGAGCTTCAGGTTCAG „ 
PaiII_16fw TGCCGTACAGCTTGTCATTACC „ 
PaiII_16rev CTGGGTACTGCACTTTCCTCA „ 
PaiII_17fw CTGACATTGCCACCAGATTTTTGT „ 
PaiII_17rev GGTGTAATGCGCTAACCTGTTTC „ 
PaiII_18fw CTACAAATGTTCAATATGGTGGGTATATC „ 
PaiII_18rev CGCTGTTGCCACTGGATTAATG „ 
PaiII_19fw GCCATCCACTACATATCATGCC „ 
PaiII_19rev CGACGGGTTTCTATGCTGAG „ 
PaiII_20fw CCTCAACTGGAGCAATTTTCTGTC „ 
PaiII_20rev GGACTTGGATCACTGAAGCTTTAC „ 
PaiII_21fw CCACAAGCTGTTGATTTTGGTACG „ 
PaiII_21rev GCGATAGTGGGCAATTTGCTATTG „ 
PaiII_22fw CGTAAACGTCCTCCAGAATTTATATC „ 
PaiII_22rev GGACGATGGCGATATGTCTG „ 
PaiII_23fw GTTCTTCATTTCTACGTTGCTTTGTC „ 
PaiII_23rev CCTACCAGAGATAACCCATGG „ 
PaiII_24fw CGGTTTCTCCTGAACATAACTTTG „ 
PaiII_24rev GGTGAAGTCCGTAACCAGAATG „ 
PaiII_25fw GCCTGTTTTTGCTGCTGTTCAC „ 
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PaiII_25rev GCAGGACTAAAGTTGCAGAGC „ 
PaiII_26fw CGCTTTCGCCCCGATTTCTA „ 
PaiII_26rev ATGACCGTCGTACTGTGGAC „ 
PaiII_27fw GTCAGCCCGCTTTTCTTCTG „ 
PaiII_27rev GCTCCGTCGTATACCGATGA „ 
PaiII_28fw CGGTCAAGAAAATACGATGAGCC „ 
PaiII_28rev GAACGACAGCAAAATCCTCTCC „ 
PaiII_29fw CAGCACCTGCGCCGTCA „ 
PaiII_29rev GCGATGCCACGGTGAAAACC „ 
PaiII_30fw CCGGTATTACTGAATGTCCCG „ 
PaiII_30rev GAACATGAAGACAGCACTGACC „ 
PaiII_31fw CCTGAAGCAGAACATCATCCAG „ 
PaiII_31rev CGGCTGATATCCTGAGACTG „ 
PaiII_32fw CTCGCTTCCACGGACGTTG „ 
PaiII_32rev GTTGGCAGTGCTGAAAGCAG „ 
PaiII_33fw GGTCAGAATGTCCTCAGTGAG „ 
PaiII_33rev CAATGAAATTGACAGGAGAGATACC „ 
PaiII_34fw CCACTGGCATGATTTTTACCCTG „ 
PaiII_34rev CGGGCACATTCCTGCTGTC „ 
PaiII_35fw GGATACTGGGCGATGAGCG „ 
PaiII_35rev GAGCACGGTGAGCGAAATAG „ 
PaiII_36fw CCGCATTAGGTGACTTTACACG „ 
PaiII_36rev GACGCCGTACTGACCGATG „ 
PaiII_37fw CCAGGTTTGTTATCGAGGTAAGG „ 
PaiII_37rev GGCGCTATCGACTACGTCC „ 
PaiII_38fw GGCAGTATATCGATTCGGCGA „ 
PaiII_38rev GCTTCCCAGCCTGTCACTTC „ 
PaiII_39fw GGGCATCTTCAAAGTCAAAGCC „ 
PaiII_39rev CGCCCGTCTGTTTTTCAGTTTC „ 
PaiII_40fw GGGGCATCAAGGTCGCTATTT „ 
PaiII_40rev CAGAACCGCAGCCAGCCAT „ 
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PaiII_25rev GCAGGACTAAAGTTGCAGAGC „ 
PaiII_26fw CGCTTTCGCCCCGATTTCTA „ 
PaiII_26rev ATGACCGTCGTACTGTGGAC „ 
PaiII_27fw GTCAGCCCGCTTTTCTTCTG „ 
PaiII_27rev GCTCCGTCGTATACCGATGA „ 
PaiII_28fw CGGTCAAGAAAATACGATGAGCC „ 
PaiII_28rev GAACGACAGCAAAATCCTCTCC „ 
PaiII_29fw CAGCACCTGCGCCGTCA „ 
PaiII_29rev GCGATGCCACGGTGAAAACC „ 
PaiII_30fw CCGGTATTACTGAATGTCCCG „ 
PaiII_30rev GAACATGAAGACAGCACTGACC „ 
PaiII_31fw CCTGAAGCAGAACATCATCCAG „ 
PaiII_31rev CGGCTGATATCCTGAGACTG „ 
PaiII_32fw CTCGCTTCCACGGACGTTG „ 
PaiII_32rev GTTGGCAGTGCTGAAAGCAG „ 
PaiII_33fw GGTCAGAATGTCCTCAGTGAG „ 
PaiII_33rev CAATGAAATTGACAGGAGAGATACC „ 
PaiII_34fw CCACTGGCATGATTTTTACCCTG „ 
PaiII_34rev CGGGCACATTCCTGCTGTC „ 
PaiII_35fw GGATACTGGGCGATGAGCG „ 
PaiII_35rev GAGCACGGTGAGCGAAATAG „ 
PaiII_36fw CCGCATTAGGTGACTTTACACG „ 
PaiII_36rev GACGCCGTACTGACCGATG „ 
PaiII_37fw CCAGGTTTGTTATCGAGGTAAGG „ 
PaiII_37rev GGCGCTATCGACTACGTCC „ 
PaiII_38fw GGCAGTATATCGATTCGGCGA „ 
PaiII_38rev GCTTCCCAGCCTGTCACTTC „ 
PaiII_39fw GGGCATCTTCAAAGTCAAAGCC „ 
PaiII_39rev CGCCCGTCTGTTTTTCAGTTTC „ 
PaiII_40fw GGGGCATCAAGGTCGCTATTT „ 
PaiII_40rev CAGAACCGCAGCCAGCCAT „ 
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PaiII_41fw GCTGCGATGCGGATCCAC „ 
PaiII_41rev GGTTACCGCAATGGTGAAAGG „ 
PaiII_42fw GCTTTTACTGCGCCGACATCA „ 
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A/7 - Competitive growth experiments between 536-21 and SY327 containing different 
fragments from PAI II536 
 
                     Starting conditions 
                          X : 536-21 
        after 24h incubation 
                      X : 536-21 
X      µl : µl            cell number ratio 
 
     cell number ratio 
21 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
5,4x10-7 : 3x10-8 
5,7x10-7 : 6x10-7 
6x10-7 : 1,2x10-7 
0,18:1  
0,95:1  
5:1  
 2,1x10-8 : 9,6x10-9 
6,1x10-8 : 2,1x10-9 
5,3x10-8 : 8x10-8 
0,022:1 
0,3:1 
0,66:1 
22 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
8,1x10-8 : 3x10-8 
8,5x10-8 : 6x10-7 
9x10-8 : 1,2x10-7 
2,7:1  
14,2:1  
75:1  
 2,3x10-10 : 1x10-10 
3,1x10-10 : 5,1x10-9 
5x10-10 : 8x10-8 
0,47:1 
6:1 
62:1 
27 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
2,6x10-8 : 3x10-8 
2,8x10-8 : 6x10-7 
2,9x10-8 : 1,2x10-7 
0,87:1  
4,6:1  
24:1  
 2,3x10-10 : 7,7x10-9 
2,4x10-10 : 1,7x10-9 
2,4x10-10 : 6x10-8 
3:1 
13,8:1 
39,5:1 
28 A 
B 
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1800 : 500 
1900 : 100 
2000 : 20 
7,2x10-7 : 3x10-8 
7,6x10-7 : 6x10-7 
8x10-7 : 1,2x10-7 
0,24:1  
1,2:1  
6,6:1  
 3x10-8 : 8x10-9 
1,1x10-9 : 5,6x10-10 
5x10-8 : 6x10-8 
0,038:1 
0,2:1 
0,83:1 
77 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
2,5x10-8 : 3x10-8 
2,6x10-8 : 6x10-7 
2,8x10-8 : 1,2x10-7 
0,83:1  
4,37:1  
23:1  
 1,5x10-10 : 4,5x10-9 
1,7x10-10 : 7x10-8 
1,7x10-10 : 2x10-8 
3,3:1 
24,5:1 
86:1 
SY3
27 
A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
1,1x10-7:3x10-8 
1,1x10-7:6x10-7 
1,2x10-7:1,2x10-7 
0,036:1  
0,19:1  
1:1  
 1x10-9 : 3,8x10-10 
2,9x10-9 : 4,3x10-10 
3,9x10-9 : 2,3x10-10 
0,026:1 
0,067:1 
0,16:1 
 
 
 
 
 163 
A/7 - Competitive growth experiments between 536-21 and SY327 containing different 
fragments from PAI II536 
 
                     Starting conditions 
                          X : 536-21 
        after 24h incubation 
                      X : 536-21 
X      µl : µl            cell number ratio 
 
     cell number ratio 
21 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
5,4x10-7 : 3x10-8 
5,7x10-7 : 6x10-7 
6x10-7 : 1,2x10-7 
0,18:1  
0,95:1  
5:1  
 2,1x10-8 : 9,6x10-9 
6,1x10-8 : 2,1x10-9 
5,3x10-8 : 8x10-8 
0,022:1 
0,3:1 
0,66:1 
22 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
8,1x10-8 : 3x10-8 
8,5x10-8 : 6x10-7 
9x10-8 : 1,2x10-7 
2,7:1  
14,2:1  
75:1  
 2,3x10-10 : 1x10-10 
3,1x10-10 : 5,1x10-9 
5x10-10 : 8x10-8 
0,47:1 
6:1 
62:1 
27 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
2,6x10-8 : 3x10-8 
2,8x10-8 : 6x10-7 
2,9x10-8 : 1,2x10-7 
0,87:1  
4,6:1  
24:1  
 2,3x10-10 : 7,7x10-9 
2,4x10-10 : 1,7x10-9 
2,4x10-10 : 6x10-8 
3:1 
13,8:1 
39,5:1 
28 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
7,2x10-7 : 3x10-8 
7,6x10-7 : 6x10-7 
8x10-7 : 1,2x10-7 
0,24:1  
1,2:1  
6,6:1  
 3x10-8 : 8x10-9 
1,1x10-9 : 5,6x10-10 
5x10-8 : 6x10-8 
0,038:1 
0,2:1 
0,83:1 
77 A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
2,5x10-8 : 3x10-8 
2,6x10-8 : 6x10-7 
2,8x10-8 : 1,2x10-7 
0,83:1  
4,37:1  
23:1  
 1,5x10-10 : 4,5x10-9 
1,7x10-10 : 7x10-8 
1,7x10-10 : 2x10-8 
3,3:1 
24,5:1 
86:1 
SY3
27 
A 
B 
C 
1800 : 500 
1900 : 100 
2000 : 20 
1,1x10-7:3x10-8 
1,1x10-7:6x10-7 
1,2x10-7:1,2x10-7 
0,036:1  
0,19:1  
1:1  
 1x10-9 : 3,8x10-10 
2,9x10-9 : 4,3x10-10 
3,9x10-9 : 2,3x10-10 
0,026:1 
0,067:1 
0,16:1 
 
 
 
 
 164 
A/8 – Publications 
 
    Benedek O, Khan AS, Schneider Gy, Nagy G, Autar R, Pieters RJ, Emődy L.  
Mapping the laminin binding site of Yersinia pestis plasminogen activator (Pla) via phage 
display.  
In press- Accepted for publication in International Journal of Medical Microbiology  
 
*   Schneider G, Dobrindt U, Bruggemann H, Nagy G, Janke B, Blum-Oehler G, Buchrieser 
C, Gottschalk G, Emody L, Hacker J. 
The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic 
structure and correlates with virulence in uropathogenic Escherichia coli strain 536. 
Infect Immun. 2004 Oct;72(10):5993-6001.  
 
*  Hacker J, Hochhut B, Middendorf B, Schneider G, Buchrieser C, Gottschalk G, 
Dobrindt U. 
Pathogenomics of mobile genetic elements of toxigenic bacteria. 
Int J Med Microbiol. 2004 Apr;293(7-8):453-61. Review.  
 
    Fekete PZ, Schneider G, Olasz F, Blum-Oehler G, Hacker JH, Nagy B. 
Detection of a plasmid-encoded pathogenicity island in F18+ enterotoxigenic and 
verotoxigenic Escherichia coli from weaned pigs. 
Int J Med Microbiol. 2003 Aug;293(4):287-98.  
 
    Szakal D D, Schneider G, Pal T. 
A colony blot immune assay to identify enteroinvasive Escherichia coli and Shigella in stool 
samples. 
Diagn Microbiol Infect Dis. 2003 Mar;45(3):165-71.  
 
*  Dobrindt U, Blum-Oehler G, Nagy G, Schneider G, Johann A, Gottschalk G, Hacker J. 
Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of 
uropathogenic Escherichia coli strain 536. 
Infect Immun. 2002 Nov;70(11):6365-72.  
 
    Nagy G, Dobrindt U, Schneider G, Khan AS, Hacker J, Emody L. 
Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. 
Infect Immun. 2002 Aug;70(8):4406-13.  
 
 
 
 
* : papers based on the topic of the PhD Thesis 
 164 
A/8 – Publications 
 
    Benedek O, Khan AS, Schneider Gy, Nagy G, Autar R, Pieters RJ, Emődy L.  
Mapping the laminin binding site of Yersinia pestis plasminogen activator (Pla) via phage 
display.  
In press- Accepted for publication in International Journal of Medical Microbiology  
 
*   Schneider G, Dobrindt U, Bruggemann H, Nagy G, Janke B, Blum-Oehler G, Buchrieser 
C, Gottschalk G, Emody L, Hacker J. 
The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic 
structure and correlates with virulence in uropathogenic Escherichia coli strain 536. 
Infect Immun. 2004 Oct;72(10):5993-6001.  
 
*  Hacker J, Hochhut B, Middendorf B, Schneider G, Buchrieser C, Gottschalk G, 
Dobrindt U. 
Pathogenomics of mobile genetic elements of toxigenic bacteria. 
Int J Med Microbiol. 2004 Apr;293(7-8):453-61. Review.  
 
    Fekete PZ, Schneider G, Olasz F, Blum-Oehler G, Hacker JH, Nagy B. 
Detection of a plasmid-encoded pathogenicity island in F18+ enterotoxigenic and 
verotoxigenic Escherichia coli from weaned pigs. 
Int J Med Microbiol. 2003 Aug;293(4):287-98.  
 
    Szakal D D, Schneider G, Pal T. 
A colony blot immune assay to identify enteroinvasive Escherichia coli and Shigella in stool 
samples. 
Diagn Microbiol Infect Dis. 2003 Mar;45(3):165-71.  
 
*  Dobrindt U, Blum-Oehler G, Nagy G, Schneider G, Johann A, Gottschalk G, Hacker J. 
Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of 
uropathogenic Escherichia coli strain 536. 
Infect Immun. 2002 Nov;70(11):6365-72.  
 
    Nagy G, Dobrindt U, Schneider G, Khan AS, Hacker J, Emody L. 
Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. 
Infect Immun. 2002 Aug;70(8):4406-13.  
 
 
 
 
* : papers based on the topic of the PhD Thesis 
 165 
A/9 – Curriculum Vitae 
 
Name:   György Schneider 
Place of birth:  Szeged, Hungary 
Date of birth:  06. September, 1971 
Address:  7632 Pécs, Zsuzsanna street 2., Hungary 
 
 
 
Schools:  1985-89  Leöwey Klára Secondary School, Pécs (H) 
 
1989-90 Intensiv language course (English) 
 
1990-94 Janus Pannonius University of Pécs, Faculty of Biology and 
Chemistry; Qualification: teacher of biology and chemistry 
 
1994-97  Eötvös Lóránd University, Budapest, Faculty of Microbiology  
Qualification: microbiologist 
 
1997-      Medical University of Pécs, Institute of Immunology and Medical 
Microbiology, PhD student 
 
2000-04 Bayerische Julius-Maximilianus Universität, Würzburg, 
Research Center for Infectious Diseases, PhD student 
 
2004- Medical University of Pécs, Institute of Immunology and 
Medical Microbiology 
 
 
 
 
 
 165 
A/9 – Curriculum Vitae 
 
Name:   György Schneider 
Place of birth:  Szeged, Hungary 
Date of birth:  06. September, 1971 
Address:  7632 Pécs, Zsuzsanna street 2., Hungary 
 
 
 
Schools:  1985-89  Leöwey Klára Secondary School, Pécs (H) 
 
1989-90 Intensiv language course (English) 
 
1990-94 Janus Pannonius University of Pécs, Faculty of Biology and 
Chemistry; Qualification: teacher of biology and chemistry 
 
1994-97  Eötvös Lóránd University, Budapest, Faculty of Microbiology  
Qualification: microbiologist 
 
1997-      Medical University of Pécs, Institute of Immunology and Medical 
Microbiology, PhD student 
 
2000-04 Bayerische Julius-Maximilianus Universität, Würzburg, 
Research Center for Infectious Diseases, PhD student 
 
2004- Medical University of Pécs, Institute of Immunology and 
Medical Microbiology 
 
 
 
 
 
